BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010;12:247-256. [PMID: 20173740 DOI: 10.1038/ncb2024] [Cited by in Crossref: 921] [Cited by in F6Publishing: 899] [Article Influence: 76.8] [Reference Citation Analysis]
Number Citing Articles
1 Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861-874. [PMID: 22094949 DOI: 10.1038/nrg3074] [Cited by in Crossref: 2694] [Cited by in F6Publishing: 2587] [Article Influence: 244.9] [Reference Citation Analysis]
2 Wang CH, Li XF, Jin LF, Zhao Y, Zhu GJ, Shen WZ. Dieckol inhibits non-small-cell lung cancer cell proliferation and migration by regulating the PI3K/AKT signaling pathway. J Biochem Mol Toxicol 2019;33:e22346. [PMID: 31291034 DOI: 10.1002/jbt.22346] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
3 Yan H, Xin S, Ma J, Wang H, Zhang H, Liu J. A three microRNA‐based prognostic signature for small cell lung cancer overall survival. J Cell Biochem 2019;120:8723-30. [DOI: 10.1002/jcb.28159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Pandey AK, Zhang Y, Zhang S, Li Y, Tucker-Kellogg G, Yang H, Jha S. TIP60-miR-22 axis as a prognostic marker of breast cancer progression. Oncotarget 2015;6:41290-306. [PMID: 26512777 DOI: 10.18632/oncotarget.5636] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
5 Vrijens K, Bollati V, Nawrot TS. MicroRNAs as potential signatures of environmental exposure or effect: a systematic review. Environ Health Perspect 2015;123:399-411. [PMID: 25616258 DOI: 10.1289/ehp.1408459] [Cited by in Crossref: 181] [Cited by in F6Publishing: 171] [Article Influence: 25.9] [Reference Citation Analysis]
6 Ferracin M, Querzoli P, Calin GA, Negrini M. MicroRNAs: toward the clinic for breast cancer patients. Semin Oncol 2011;38:764-75. [PMID: 22082762 DOI: 10.1053/j.seminoncol.2011.08.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ding XM. MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT). Chin J Cancer. 2014;33:140-147. [PMID: 24016392 DOI: 10.5732/cjc.013.10094] [Cited by in Crossref: 63] [Cited by in F6Publishing: 71] [Article Influence: 7.0] [Reference Citation Analysis]
8 Sporn JC, Katsuta E, Yan L, Takabe K. Expression of MicroRNA-9 is Associated With Overall Survival in Breast Cancer Patients. J Surg Res 2019;233:426-35. [PMID: 30502282 DOI: 10.1016/j.jss.2018.08.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
9 Ebert MS, Sharp PA. MicroRNA sponges: progress and possibilities. RNA. 2010;16:2043-2050. [PMID: 20855538 DOI: 10.1261/rna.2414110] [Cited by in Crossref: 447] [Cited by in F6Publishing: 431] [Article Influence: 37.3] [Reference Citation Analysis]
10 Devasthanam AS, Tomasi TB. Dicer in immune cell development and function. Immunol Invest 2014;43:182-95. [PMID: 24303839 DOI: 10.3109/08820139.2013.863557] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
11 Gambari R, Brognara E, Spandidos DA, Fabbri E. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review). Int J Oncol 2016;49:5-32. [PMID: 27175518 DOI: 10.3892/ijo.2016.3503] [Cited by in Crossref: 108] [Cited by in F6Publishing: 114] [Article Influence: 18.0] [Reference Citation Analysis]
12 Lu J, Luo H, Liu X, Peng Y, Zhang B, Wang L, Xu X, Peng X, Li G, Tian W, He ML, Kung H, Li XP. miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma. Carcinogenesis 2014;35:554-63. [PMID: 24170200 DOI: 10.1093/carcin/bgt354] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 6.9] [Reference Citation Analysis]
13 Wu Y, Tang Y, Xie S, Zheng X, Zhang S, Mao J, Wang B, Hou Y, Hu L, Chai K, Chen W. Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer. Theranostics 2020;10:1151-65. [PMID: 31938057 DOI: 10.7150/thno.38327] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
14 Chakraborty S, Zawieja DC, Davis MJ, Muthuchamy M. MicroRNA signature of inflamed lymphatic endothelium and role of miR-9 in lymphangiogenesis and inflammation. Am J Physiol Cell Physiol 2015;309:C680-92. [PMID: 26354749 DOI: 10.1152/ajpcell.00122.2015] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
15 Gao L, Cheng D, Yang J, Wu R, Li W, Kong AN. Sulforaphane epigenetically demethylates the CpG sites of the miR-9-3 promoter and reactivates miR-9-3 expression in human lung cancer A549 cells. J Nutr Biochem 2018;56:109-15. [PMID: 29525530 DOI: 10.1016/j.jnutbio.2018.01.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
16 Urooj T, Wasim B, Mushtaq S, Shah SNN, Shah M. Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects. Curr Cancer Drug Targets 2020;20:168-86. [PMID: 31858911 DOI: 10.2174/1568009620666191220151856] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
17 Dong X, Zhang Q, Hao J, Xie Q, Xu B, Zhang P, Lu H, Huang Q, Yang T, Wei GH, Na R, Gao P. Large Multicohort Study Reveals a Prostate Cancer Susceptibility Allele at 5p15 Regulating TERT via Androgen Signaling-Orchestrated Chromatin Binding of E2F1 and MYC. Front Oncol 2021;11:754206. [PMID: 34858826 DOI: 10.3389/fonc.2021.754206] [Reference Citation Analysis]
18 Chan SH, Wang LH. Regulation of cancer metastasis by microRNAs. J Biomed Sci. 2015;22:9. [PMID: 25614041 DOI: 10.1186/s12929-015-0113-7] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 11.9] [Reference Citation Analysis]
19 Sandhu GK, Milevskiy MJG, Wilson W, Shewan AM, Brown MA. Non-coding RNAs in Mammary Gland Development and Disease. Adv Exp Med Biol 2016;886:121-53. [PMID: 26659490 DOI: 10.1007/978-94-017-7417-8_7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
20 Li Z, Liu YH, Diao HY, Ma J, Yao YL. MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT. Biochem Biophys Res Commun 2015;468:870-6. [PMID: 26585488 DOI: 10.1016/j.bbrc.2015.11.046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
21 Zhan Y, Liang X, Li L, Wang B, Ding F, Li Y, Wang X, Zhan Q, Liu Z. MicroRNA-548j functions as a metastasis promoter in human breast cancer by targeting Tensin1. Mol Oncol 2016;10:838-49. [PMID: 26949125 DOI: 10.1016/j.molonc.2016.02.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
22 Jeyabal P, Thandavarayan RA, Joladarashi D, Suresh Babu S, Krishnamurthy S, Bhimaraj A, Youker KA, Kishore R, Krishnamurthy P. MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1. Biochem Biophys Res Commun 2016;471:423-9. [PMID: 26898797 DOI: 10.1016/j.bbrc.2016.02.065] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 9.2] [Reference Citation Analysis]
23 Aghebati-Maleki A, Nami S, Baghbanzadeh A, Karzar BH, Noorolyai S, Fotouhi A, Aghebati-Maleki L. Implications of exosomes as diagnostic and therapeutic strategies in cancer. J Cell Physiol 2019;234:21694-706. [PMID: 31161617 DOI: 10.1002/jcp.28875] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
24 Annibali D, Gioia U, Savino M, Laneve P, Caffarelli E, Nasi S. A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2. PLoS One 2012;7:e40269. [PMID: 22848373 DOI: 10.1371/journal.pone.0040269] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
25 Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T, De Falco G, Githanga J, Horn H, Nyagol J, Ott G, Palatini J, Pfreundschuh M, Rogena E, Rosenwald A, Siebert R, Croce CM, Stein H. The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. Leukemia 2011;25:1869-76. [PMID: 21701491 DOI: 10.1038/leu.2011.156] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 7.2] [Reference Citation Analysis]
26 Heier CR, Zhang A, Nguyen NY, Tully CB, Panigrahi A, Gordish-Dressman H, Pandey SN, Guglieri M, Ryan MM, Clemens PR, Thangarajh M, Webster R, Smith EC, Connolly AM, McDonald CM, Karachunski P, Tulinius M, Harper A, Mah JK, Fiorillo AA, Chen YW, Cooperative International Neuromuscular Research Group Cinrg Investigators. Multi-Omics Identifies Circulating miRNA and Protein Biomarkers for Facioscapulohumeral Dystrophy. J Pers Med 2020;10:E236. [PMID: 33228131 DOI: 10.3390/jpm10040236] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
27 Barbato S, Solaini G, Fabbri M. MicroRNAs in Oncogenesis and Tumor Suppression. Int Rev Cell Mol Biol 2017;333:229-68. [PMID: 28729026 DOI: 10.1016/bs.ircmb.2017.05.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
28 Herrero Martín D, Boro A, Schäfer BW. Cell-based small-molecule compound screen identifies fenretinide as potential therapeutic for translocation-positive rhabdomyosarcoma. PLoS One 2013;8:e55072. [PMID: 23372815 DOI: 10.1371/journal.pone.0055072] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
29 Ling H, Calin GA. The Role of MicroRNAs and Ultraconserved Non-Coding RNAs in Cancer. Cancer Genomics. Elsevier; 2014. pp. 435-47. [DOI: 10.1016/b978-0-12-396967-5.00025-6] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
30 Nourmohammadi B, Tafsiri E, Rahimi A, Nourmohammadi Z, Daneshvar Kakhaki A, Cho W, Karimipoor M. Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran. Asian Pac J Cancer Prev 2019;20:1633-9. [PMID: 31244281 DOI: 10.31557/APJCP.2019.20.6.1633] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
31 Vasioukhin V. Adherens junctions and cancer. Subcell Biochem. 2012;60:379-414. [PMID: 22674080 DOI: 10.1007/978-94-007-4186-7_16] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
32 Di Leva G, Croce CM. Roles of small RNAs in tumor formation. Trends Mol Med. 2010;16:257-267. [PMID: 20493775 DOI: 10.1016/j.molmed.2010.04.001] [Cited by in Crossref: 171] [Cited by in F6Publishing: 171] [Article Influence: 14.3] [Reference Citation Analysis]
33 Yang F, Miao L, Mei Y, Wu M. Retinoic acid-induced HOXA5 expression is co-regulated by HuR and miR-130a. Cell Signal 2013;25:1476-85. [PMID: 23528537 DOI: 10.1016/j.cellsig.2013.03.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
34 Bing L, Hong C, Li-xin S, Wei G. MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression. Arch Gynecol Obstet 2014;290:533-41. [DOI: 10.1007/s00404-014-3219-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
35 Yanaihara N, Noguchi Y, Saito M, Takenaka M, Takakura S, Yamada K, Okamoto A. MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma. PLoS One 2016;11:e0162584. [PMID: 27612152 DOI: 10.1371/journal.pone.0162584] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
36 Wang Z, Humphries B, Xiao H, Jiang Y, Yang C. Epithelial to mesenchymal transition in arsenic-transformed cells promotes angiogenesis through activating β-catenin-vascular endothelial growth factor pathway. Toxicol Appl Pharmacol 2013;271:20-9. [PMID: 23643801 DOI: 10.1016/j.taap.2013.04.018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
37 Gomez GG, Volinia S, Croce CM, Zanca C, Li M, Emnett R, Gutmann DH, Brennan CW, Furnari FB, Cavenee WK. Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity. Cancer Res 2014;74:1429-39. [PMID: 24436148 DOI: 10.1158/0008-5472.CAN-13-2117] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
38 Cui T, Srivastava AK, Han C, Yang L, Zhao R, Zou N, Qu M, Duan W, Zhang X, Wang QE. XPC inhibits NSCLC cell proliferation and migration by enhancing E-Cadherin expression. Oncotarget 2015;6:10060-72. [PMID: 25871391 DOI: 10.18632/oncotarget.3542] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
39 Wang Q, Wang G, Niu L, Zhao S, Li J, Zhang Z, Jiang H, Zhang Q, Wang H, Sun P, Xiang R, Chang A, Yang S. Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1. J Oncol 2021;2021:6617700. [PMID: 33564307 DOI: 10.1155/2021/6617700] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Sleeman JP, Christofori G, Fodde R, Collard JG, Berx G, Decraene C, Rüegg C. Concepts of metastasis in flux: the stromal progression model. Semin Cancer Biol 2012;22:174-86. [PMID: 22374376 DOI: 10.1016/j.semcancer.2012.02.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 6.0] [Reference Citation Analysis]
41 McAnena P, Lowery A, Kerin MJ. Role of micro-RNAs in breast cancer surgery. Br J Surg 2018;105:e19-30. [PMID: 29341144 DOI: 10.1002/bjs.10790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
42 Rohrbach TD, Jones RB, Hicks PH, Weaver AN, Cooper TS, Eustace NJ, Yang ES, Jarboe JS, Anderson JC, Willey CD. MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell lines. Oncol Lett 2017;13:1216-22. [PMID: 28454237 DOI: 10.3892/ol.2016.5550] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
43 Feala JD, Cortes J, Duxbury PM, McCulloch AD, Piermarocchi C, Paternostro G. Statistical properties and robustness of biological controller-target networks. PLoS One 2012;7:e29374. [PMID: 22235289 DOI: 10.1371/journal.pone.0029374] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
44 Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol 2014;15:178-96. [DOI: 10.1038/nrm3758] [Reference Citation Analysis]
45 Zoni E, van der Pluijm G, Gray PC, Kruithof-de Julio M. Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT. J Oncol 2015;2015:198967. [PMID: 25883651 DOI: 10.1155/2015/198967] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
46 Ma F, Li W, Liu C, Li W, Yu H, Lei B, Ren Y, Li Z, Pang D, Qian C. MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling. Oncotarget 2017;8:69538-50. [PMID: 29050223 DOI: 10.18632/oncotarget.18422] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 11.2] [Reference Citation Analysis]
47 Nana-Sinkam SP, Croce CM. MicroRNAs as therapeutic targets in cancer. Transl Res 2011;157:216-25. [PMID: 21420032 DOI: 10.1016/j.trsl.2011.01.013] [Cited by in Crossref: 107] [Cited by in F6Publishing: 109] [Article Influence: 9.7] [Reference Citation Analysis]
48 Chien YC, Chen JN, Chen YH, Chou RH, Lee HC, Yu YL. Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells. Cancers (Basel) 2020;12:E1781. [PMID: 32635336 DOI: 10.3390/cancers12071781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Han D, Li J, Wang H, Su X, Hou J, Gu Y, Qian C, Lin Y, Liu X, Huang M, Li N, Zhou W, Yu Y, Cao X. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology. 2017;66:1151-1164. [PMID: 28520103 DOI: 10.1002/hep.29270] [Cited by in Crossref: 606] [Cited by in F6Publishing: 639] [Article Influence: 121.2] [Reference Citation Analysis]
50 Li X, Gao L, Cui Q, Gary BD, Dyess DL, Taylor W, Shevde LA, Samant RS, Dean-Colomb W, Piazza GA, Xi Y. Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs. Oncogene 2012;31:4979-86. [PMID: 22286762 DOI: 10.1038/onc.2011.655] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
51 Challagundla KB, Fanini F, Vannini I, Wise P, Murtadha M, Malinconico L, Cimmino A, Fabbri M. microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics. Expert Rev Mol Diagn. 2014;14:565-574. [PMID: 24844135 DOI: 10.1586/14737159.2014.922879] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
52 Christodoulatos GS, Dalamaga M. Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis? World J Clin Oncol 2014; 5(2): 71-81 [PMID: 24829853 DOI: 10.5306/wjco.v5.i2.71] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
53 Li L, Xiao B, Tong H, Xie F, Zhang Z, Xiao GG. Regulation of breast cancer tumorigenesis and metastasis by miRNAs. Expert Rev Proteomics 2012;9:615-25. [PMID: 23256672 DOI: 10.1586/epr.12.64] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
54 Kumari A, Shonibare Z, Monavarian M, Arend RC, Lee NY, Inman GJ, Mythreye K. TGFβ signaling networks in ovarian cancer progression and plasticity. Clin Exp Metastasis 2021;38:139-61. [PMID: 33590419 DOI: 10.1007/s10585-021-10077-z] [Reference Citation Analysis]
55 Kuşoğlu A, Biray Avcı Ç. Cancer stem cells: A brief review of the current status. Gene 2019;681:80-5. [PMID: 30268439 DOI: 10.1016/j.gene.2018.09.052] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 14.8] [Reference Citation Analysis]
56 Zaravinos A. The Regulatory Role of MicroRNAs in EMT and Cancer. J Oncol. 2015;2015:865816. [PMID: 25883654 DOI: 10.1155/2015/865816] [Cited by in Crossref: 160] [Cited by in F6Publishing: 163] [Article Influence: 22.9] [Reference Citation Analysis]
57 Han H, Sun D, Li W, Shen H, Zhu Y, Li C, Chen Y, Lu L, Li W, Zhang J, Tian Y, Li Y. A c-Myc-MicroRNA functional feedback loop affects hepatocarcinogenesis. Hepatology 2013;57:2378-89. [PMID: 23389829 DOI: 10.1002/hep.26302] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 6.9] [Reference Citation Analysis]
58 Xu T, Liu X, Han L, Shen H, Liu L, Shu Y. Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer. Clin Transl Oncol 2014;16:469-75. [DOI: 10.1007/s12094-013-1106-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
59 Xue M, Zhuo Y, Shan B. MicroRNAs, Long Noncoding RNAs, and Their Functions in Human Disease. Methods Mol Biol. 2017;1617:1-25. [PMID: 28540673 DOI: 10.1007/978-1-4939-7046-9_1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 68] [Article Influence: 15.3] [Reference Citation Analysis]
60 Vimalraj S, Miranda PJ, Ramyakrishna B, Selvamurugan N. Regulation of breast cancer and bone metastasis by microRNAs. Dis Markers. 2013;35:369-387. [PMID: 24191129 DOI: 10.1155/2013/451248] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 8.4] [Reference Citation Analysis]
61 White RA, Neiman JM, Reddi A, Han G, Birlea S, Mitra D, Dionne L, Fernandez P, Murao K, Bian L, Keysar SB, Goldstein NB, Song N, Bornstein S, Han Z, Lu X, Wisell J, Li F, Song J, Lu SL, Jimeno A, Roop DR, Wang XJ. Epithelial stem cell mutations that promote squamous cell carcinoma metastasis. J Clin Invest 2013;123:4390-404. [PMID: 23999427 DOI: 10.1172/JCI65856] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
62 Chen C, Ma Z, Jiang H. EMT Participates in the Regulation of Exosomes Secretion and Function in Esophageal Cancer Cells. Technol Cancer Res Treat 2021;20:15330338211033077. [PMID: 34278849 DOI: 10.1177/15330338211033077] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Yu MA, Kiang A, Wang-Rodriguez J, Rahimy E, Haas M, Yu V, Ellies LG, Chen J, Fan JB, Brumund KT, Weisman RA, Ongkeko WM. Nicotine promotes acquisition of stem cell and epithelial-to-mesenchymal properties in head and neck squamous cell carcinoma. PLoS One 2012;7:e51967. [PMID: 23300583 DOI: 10.1371/journal.pone.0051967] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
64 Liu M, Liu L, Bai M, Zhang L, Ma F, Yang X, Sun S. Hypoxia-induced activation of Twist/miR-214/E-cadherin axis promotes renal tubular epithelial cell mesenchymal transition and renal fibrosis. Biochem Biophys Res Commun 2018;495:2324-30. [PMID: 29277613 DOI: 10.1016/j.bbrc.2017.12.130] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
65 Kim DY, Hwang I, Muller FL, Paik JH. Functional regulation of FoxO1 in neural stem cell differentiation. Cell Death Differ 2015;22:2034-45. [PMID: 26470727 DOI: 10.1038/cdd.2015.123] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 7.6] [Reference Citation Analysis]
66 Missiaglia E, Shepherd CJ, Aladowicz E, Olmos D, Selfe J, Pierron G, Delattre O, Walters Z, Shipley J. MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas. Cancer Lett 2017;385:251-60. [PMID: 27984116 DOI: 10.1016/j.canlet.2016.10.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
67 Wen YC, Lee WJ, Tan P, Yang SF, Hsiao M, Lee LM, Chien MH. By inhibiting snail signaling and miR-23a-3p, osthole suppresses the EMT-mediated metastatic ability in prostate cancer. Oncotarget 2015;6:21120-36. [PMID: 26110567 DOI: 10.18632/oncotarget.4229] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 7.7] [Reference Citation Analysis]
68 Singh R, Pochampally R, Watabe K, Lu Z, Mo YY. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol Cancer. 2014;13:256. [PMID: 25428807 DOI: 10.1186/1476-4598-13-256] [Cited by in Crossref: 215] [Cited by in F6Publishing: 213] [Article Influence: 26.9] [Reference Citation Analysis]
69 Hussey G, Chaudhury A, Howe PH. Discovery of a metastatic pathway: implications for future cancer treatment. Future Oncol 2011;7:703-5. [PMID: 21675832 DOI: 10.2217/fon.11.47] [Reference Citation Analysis]
70 Liu J, Zhu S, Tang W, Huang Q, Mei Y, Yang H. Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p. Cancer Cell Int 2021;21:55. [PMID: 33451320 DOI: 10.1186/s12935-020-01659-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
71 Wong SHM, Fang CM, Chuah LH, Leong CO, Ngai SC. E-cadherin: Its dysregulation in carcinogenesis and clinical implications. Crit Rev OncolHematol. 2018;121:11-22. [PMID: 29279096 DOI: 10.1016/j.critrevonc.2017.11.010] [Cited by in Crossref: 107] [Cited by in F6Publishing: 118] [Article Influence: 21.4] [Reference Citation Analysis]
72 Ding L, Gu H, Xiong X, Ao H, Cao J, Lin W, Yu M, Lin J, Cui Q. MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer. Cells 2019;8:E1492. [PMID: 31766744 DOI: 10.3390/cells8121492] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 13.7] [Reference Citation Analysis]
73 Cosentino G, Romero-Cordoba S, Plantamura I, Cataldo A, Iorio MV. miR-9-Mediated Inhibition of EFEMP1 Contributes to the Acquisition of Pro-Tumoral Properties in Normal Fibroblasts. Cells 2020;9:E2143. [PMID: 32972039 DOI: 10.3390/cells9092143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
74 Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, Vega-Saenz de Miera E, Rakus JF, Dankert JF, Shang S, Kerbel RS, Bhardwaj N, Shao Y, Darvishian F, Zavadil J, Erlebacher A, Mahal LK, Osman I, Hernando E. miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 2011;20:104-18. [PMID: 21741600 DOI: 10.1016/j.ccr.2011.05.027] [Cited by in Crossref: 240] [Cited by in F6Publishing: 239] [Article Influence: 21.8] [Reference Citation Analysis]
75 Xue Y, Wu G, Wang X, Zou X, Zhang G, Xiao R, Yuan Y, Long D, Yang J, Wu Y, Xu H, Liu F, Liu M. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma. Med Oncol 2013;30:406. [PMID: 23275123 DOI: 10.1007/s12032-012-0406-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
76 Fang JH, Zhou HC, Zeng C, Yang J, Liu Y, Huang X, Zhang JP, Guan XY, Zhuang SM. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology. 2011;54:1729-1740. [PMID: 21793034 DOI: 10.1002/hep.24577] [Cited by in Crossref: 211] [Cited by in F6Publishing: 195] [Article Influence: 21.1] [Reference Citation Analysis]
77 Sarveswaran S, Ghosh R, Morisetty S, Ghosh J. MK591, a second generation leukotriene biosynthesis inhibitor, prevents invasion and induces apoptosis in the bone-invading C4-2B human prostate cancer cells: implications for the treatment of castration-resistant, bone-metastatic prostate cancer. PLoS One 2015;10:e0122805. [PMID: 25875826 DOI: 10.1371/journal.pone.0122805] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
78 Grishina KA, Khaylenko VA, Khaylenko DV, Karpukhin AV. Role of microRNAs in breast cancer development and their potential as biomarkers. Tumors of female reproductive system 2018;14:40-7. [DOI: 10.17650/1994-4098-2018-14-3-40-47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Ritter A, Hirschfeld M, Berner K, Rücker G, Jäger M, Weiss D, Medl M, Nöthling C, Gassner S, Asberger J, Erbes T. Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer? Int J Oncol 2020;56:47-68. [PMID: 31789396 DOI: 10.3892/ijo.2019.4920] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
80 Xu SH, Yang YL, Han SM, Wu ZH. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma. World J Surg Oncol 2014;12:195. [PMID: 24969351 DOI: 10.1186/1477-7819-12-195] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
81 Nicolini A, Ferrari P, Duffy MJ. Prognostic and predictive biomarkers in breast cancer: Past, present and future. Seminars in Cancer Biology 2018;52:56-73. [DOI: 10.1016/j.semcancer.2017.08.010] [Cited by in Crossref: 127] [Cited by in F6Publishing: 127] [Article Influence: 31.8] [Reference Citation Analysis]
82 Zhao L, Chen X, Cao Y. New role of microRNA: carcinogenesis and clinical application in cancer. Acta Biochim Biophys Sin (Shanghai). 2011;43:831-839. [PMID: 21908856 DOI: 10.1093/abbs/gmr080] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
83 Peng Y, Zhang X, Lin H, Deng S, Qin Y, Yuan Y, Feng X, Wang J, Chen W, Hu F, Yan R, Zhao Y, Cheng Y, Wei Y, Fan X, Ashktorab H, Smoot D, Li S, Meltzer SJ, Jin Z. SUFU mediates EMT and Wnt/β-catenin signaling pathway activation promoted by miRNA-324-5p in human gastric cancer. Cell Cycle 2020;19:2720-33. [PMID: 33017570 DOI: 10.1080/15384101.2020.1826632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
84 Landeros N, Santoro PM, Carrasco-Avino G, Corvalan AH. Competing Endogenous RNA Networks in the Epithelial to Mesenchymal Transition in Diffuse-Type of Gastric Cancer. Cancers (Basel) 2020;12:E2741. [PMID: 32987716 DOI: 10.3390/cancers12102741] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
85 Zou XZ, Liu T, Gong ZC, Hu CP, Zhang Z. MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases. Eur J Pharmacol 2017;796:190-206. [PMID: 27916556 DOI: 10.1016/j.ejphar.2016.12.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
86 Lujambio A, Lowe SW. The microcosmos of cancer. Nature. 2012;482:347-355. [PMID: 22337054 DOI: 10.1038/nature1088] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Liang Z, Xi Y. MicroRNAs mediate therapeutic and preventive effects of natural agents in breast cancer. Chin J Nat Med 2016;14:881-7. [PMID: 28262114 DOI: 10.1016/S1875-5364(17)30012-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
88 Hill BS, Sarnella A, D'Avino G, Zannetti A. Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer. Semin Cancer Biol 2020;60:202-13. [PMID: 31377307 DOI: 10.1016/j.semcancer.2019.07.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
89 Sondermann A, Andreghetto FM, Moulatlet AC, da Silva Victor E, de Castro MG, Nunes FD, Brandão LG, Severino P. MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer. Clin Exp Metastasis 2015;32:521-30. [PMID: 26007293 DOI: 10.1007/s10585-015-9724-3] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
90 Baroni S, Romero-Cordoba S, Plantamura I, Dugo M, D'Ippolito E, Cataldo A, Cosentino G, Angeloni V, Rossini A, Daidone MG, Iorio MV. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts. Cell Death Dis 2016;7:e2312. [PMID: 27468688 DOI: 10.1038/cddis.2016.224] [Cited by in Crossref: 124] [Cited by in F6Publishing: 129] [Article Influence: 20.7] [Reference Citation Analysis]
91 Fiaschetti G, Castelletti D, Zoller S, Schramm A, Schroeder C, Nagaishi M, Stearns D, Mittelbronn M, Eggert A, Westermann F, Ohgaki H, Shalaby T, Pruschy M, Arcaro A, Grotzer MA. Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma. Oncogene 2011;30:2823-35. [PMID: 21317922 DOI: 10.1038/onc.2011.10] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
92 Wang X, Zhao X, Gao P, Wu M. c-Myc modulates microRNA processing via the transcriptional regulation of Drosha. Sci Rep. 2013;3:1942. [PMID: 23735886 DOI: 10.1038/srep01942] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
93 Wang Y, Wang L, Chen C, Chu X. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.Mol Cancer. 2018;17:22. [PMID: 29415727 DOI: 10.1186/s12943-018-0766-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 14.3] [Reference Citation Analysis]
94 Lourenço AR, Coffer PJ. A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood. Oncogene 2017;36:5221-30. [PMID: 28504718 DOI: 10.1038/onc.2017.151] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
95 Dang CV. MYC on the path to cancer. Cell. 2012;149:22-35. [PMID: 22464321 DOI: 10.1016/j.cell.2012.03.003] [Cited by in Crossref: 1693] [Cited by in F6Publishing: 1612] [Article Influence: 169.3] [Reference Citation Analysis]
96 Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B, Amsellem-Ouazana D. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Int J Cancer. 2013;132:2479-2491. [PMID: 23169479 DOI: 10.1002/ijc.27949] [Cited by in Crossref: 119] [Cited by in F6Publishing: 127] [Article Influence: 13.2] [Reference Citation Analysis]
97 Gambari R, Fabbri E, Borgatti M, Lampronti I, Finotti A, Brognara E, Bianchi N, Manicardi A, Marchelli R, Corradini R. Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development. Biochem Pharmacol 2011;82:1416-29. [PMID: 21864506 DOI: 10.1016/j.bcp.2011.08.007] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 7.4] [Reference Citation Analysis]
98 Swier LJYM, Dzikiewicz-Krawczyk A, Winkle M, van den Berg A, Kluiver J. Intricate crosstalk between MYC and non-coding RNAs regulates hallmarks of cancer. Mol Oncol 2019;13:26-45. [PMID: 30451365 DOI: 10.1002/1878-0261.12409] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
99 Pardini B, De Maria D, Francavilla A, Di Gaetano C, Ronco G, Naccarati A. MicroRNAs as markers of progression in cervical cancer: a systematic review. BMC Cancer 2018;18:696. [PMID: 29945565 DOI: 10.1186/s12885-018-4590-4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 18.0] [Reference Citation Analysis]
100 Khoshbakht S, Mokhtari M, Moravveji SS, Azimzadeh Jamalkandi S, Masoudi-Nejad A. Re-wiring and gene expression changes of AC025034.1 and ATP2B1 play complex roles in early-to-late breast cancer progression. BMC Genom Data 2022;23:6. [PMID: 35031021 DOI: 10.1186/s12863-021-01015-9] [Reference Citation Analysis]
101 Pouya FD, Rasmi Y, Gazouli M, Zografos E, Nemati M. MicroRNAs as therapeutic targets in breast cancer metastasis. Drug Deliv Transl Res 2021. [PMID: 33987801 DOI: 10.1007/s13346-021-00999-2] [Reference Citation Analysis]
102 Li M, Huo X, Davuljigari CB, Dai Q, Xu X. MicroRNAs and their role in environmental chemical carcinogenesis. Environ Geochem Health 2019;41:225-47. [PMID: 30171477 DOI: 10.1007/s10653-018-0179-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
103 Hernandez AL, Young CD, Wang JH, Wang XJ. Lessons learned from SMAD4 loss in squamous cell carcinomas. Mol Carcinog 2019;58:1648-55. [PMID: 31140647 DOI: 10.1002/mc.23049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
104 Bure IV, Nemtsova MV. Methylation and Noncoding RNAs in Gastric Cancer: Everything Is Connected. Int J Mol Sci 2021;22:5683. [PMID: 34073603 DOI: 10.3390/ijms22115683] [Reference Citation Analysis]
105 Walayat A, Yang M, Xiao D. Therapeutic Implication of miRNA in Human Disease. In: Sharad S, Kapur S, editors. Antisense Therapy. IntechOpen; 2019. [DOI: 10.5772/intechopen.82738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
106 Tüfekci KU, Meuwissen RLJ, Genç Ş. The Role of MicroRNAs in Biological Processes. In: Yousef M, Allmer J, editors. miRNomics: MicroRNA Biology and Computational Analysis. Totowa: Humana Press; 2014. pp. 15-31. [DOI: 10.1007/978-1-62703-748-8_2] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 9.7] [Reference Citation Analysis]
107 Yasukawa K, Liew LC, Hagiwara K, Hironaka-Mitsuhashi A, Qin XY, Furutani Y, Tanaka Y, Nakagama H, Kojima S, Kato T, Ochiya T, Gailhouste L. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion. Cancer Sci 2020;111:869-80. [PMID: 31883160 DOI: 10.1111/cas.14292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
108 Zhang L, Valencia CA, Dong B, Chen M, Guan PJ, Pan L. Transfer of microRNAs by extracellular membrane microvesicles: a nascent crosstalk model in tumor pathogenesis, especially tumor cell-microenvironment interactions. J Hematol Oncol 2015;8:14. [PMID: 25885907 DOI: 10.1186/s13045-015-0111-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
109 Boratyn E, Nowak I, Horwacik I, Durbas M, Mistarz A, Kukla M, Kaczówka P, Łastowska M, Jura J, Rokita H. Monocyte Chemoattractant Protein-Induced Protein 1 Overexpression Modulates Transcriptome, Including MicroRNA, in Human Neuroblastoma Cells. J Cell Biochem 2016;117:694-707. [PMID: 26308737 DOI: 10.1002/jcb.25354] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
110 Suzuki HI, Katsura A, Matsuyama H, Miyazono K. MicroRNA regulons in tumor microenvironment. Oncogene 2015;34:3085-94. [PMID: 25132266 DOI: 10.1038/onc.2014.254] [Cited by in Crossref: 111] [Cited by in F6Publishing: 113] [Article Influence: 13.9] [Reference Citation Analysis]
111 Wu N, Liu X, Xu X, Fan X, Liu M, Li X, Zhong Q, Tang H. MicroRNA-373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma. FEBS J. 2011;278:2044-2054. [PMID: 21481188 DOI: 10.1111/j.1742-4658.2011.08120.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
112 Jia YL, Shi L, Zhou JN, Fu CJ, Chen L, Yuan HF, Wang YF, Yan XL, Xu YC, Zeng Q. Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis. Hepatology. 2011;54:1808-1818. [PMID: 22045676 DOI: 10.1002/hep.24562] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
113 Liang C, Xu L, Song G, Liu Z. Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy. Chem Soc Rev 2016;45:6250-69. [DOI: 10.1039/c6cs00458j] [Cited by in Crossref: 244] [Cited by in F6Publishing: 48] [Article Influence: 40.7] [Reference Citation Analysis]
114 Mercurio S, Cauteruccio S, Manenti R, Candiani S, Scarì G, Licandro E, Pennati R. Exploring miR-9 Involvement in Ciona intestinalis Neural Development Using Peptide Nucleic Acids. Int J Mol Sci 2020;21:E2001. [PMID: 32183450 DOI: 10.3390/ijms21062001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Kuo TC, Tan CT, Chang YW, Hong CC, Lee WJ, Chen MW, Jeng YM, Chiou J, Yu P, Chen PS, Wang MY, Hsiao M, Su JL, Kuo ML. Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility. J Clin Invest 2013;123:1082-95. [PMID: 23434592 DOI: 10.1172/JCI64044] [Cited by in Crossref: 58] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
116 Frixa T, Donzelli S, Blandino G. Oncogenic MicroRNAs: Key Players in Malignant Transformation. Cancers (Basel) 2015;7:2466-85. [PMID: 26694467 DOI: 10.3390/cancers7040904] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 10.9] [Reference Citation Analysis]
117 Armeanu-ebinger S, Herrmann D, Bonin M, Leuschner I, Warmann SW, Fuchs J, Seitz G. Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumor. Experimental Cell Research 2012;318:2567-77. [DOI: 10.1016/j.yexcr.2012.07.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
118 Lee K, Nelson CM. New insights into the regulation of epithelial-mesenchymal transition and tissue fibrosis. Int Rev Cell Mol Biol. 2012;294:171-221. [PMID: 22364874 DOI: 10.1016/B978-0-12-394305-7.00004-5] [Cited by in Crossref: 101] [Cited by in F6Publishing: 61] [Article Influence: 10.1] [Reference Citation Analysis]
119 Ding SZ, Yang YX, Li XL, Michelli-Rivera A, Han SY, Wang L, Pratheeshkumar P, Wang X, Lu J, Yin YQ, Budhraja A, Hitron AJ. Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells. Toxicol Appl Pharmacol 2013;269:61-71. [PMID: 23518002 DOI: 10.1016/j.taap.2013.03.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
120 Khew-Goodall Y, Goodall GJ. Myc-modulated miR-9 makes more metastases. Nat Cell Biol. 2010;12:209-211. [PMID: 20173743 DOI: 10.1038/ncb0310-209] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 6.0] [Reference Citation Analysis]
121 Ma L, Deng X, Wu M, Zhang G, Huang J. Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells. FEBS Lett 2014;588:1562-70. [PMID: 24613926 DOI: 10.1016/j.febslet.2014.02.039] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 7.0] [Reference Citation Analysis]
122 Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z, Sun J, Tan FW, Ding DP, Xu XH, Zhou F, Tan XG, Hang J, Shi SS, Feng XL, He J. microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J Biol Chem. 2011;286:10725-10734. [PMID: 21148309 DOI: 10.1074/jbc.m110.165654] [Cited by in Crossref: 104] [Cited by in F6Publishing: 68] [Article Influence: 8.7] [Reference Citation Analysis]
123 Fang D, Yang H, Lin J, Teng Y, Jiang Y, Chen J, Li Y. 17β-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner. Biochem Biophys Res Commun 2015;457:500-6. [PMID: 25592968 DOI: 10.1016/j.bbrc.2014.12.114] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
124 Nazari-Shafti TZ, Neuber S, Garcia Duran A, Xu Z, Beltsios E, Seifert M, Falk V, Stamm C. Human mesenchymal stromal cells and derived extracellular vesicles: Translational strategies to increase their proangiogenic potential for the treatment of cardiovascular disease. Stem Cells Transl Med 2020;9:1558-69. [PMID: 32761804 DOI: 10.1002/sctm.19-0432] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
125 Leonardi L, Scotlandi K, Pettinari I, Benassi MS, Porcellato I, Pazzaglia L. MiRNAs in Canine and Human Osteosarcoma: A Highlight Review on Comparative Biomolecular Aspects. Cells 2021;10:428. [PMID: 33670554 DOI: 10.3390/cells10020428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo T, Yuasa Y. MiR-9 downregulates CDX2 expression in gastric cancer cells. Int J Cancer 2011;129:2611-20. [PMID: 21225631 DOI: 10.1002/ijc.25923] [Cited by in Crossref: 92] [Cited by in F6Publishing: 90] [Article Influence: 8.4] [Reference Citation Analysis]
127 Feng Y, Zhu J, Ou C, Deng Z, Chen M, Huang W, Li L. MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1. Br J Cancer. 2014;110:2300-2309. [PMID: 24642628 DOI: 10.1038/bjc.2014.122] [Cited by in Crossref: 64] [Cited by in F6Publishing: 70] [Article Influence: 8.0] [Reference Citation Analysis]
128 Kim J, Yao F, Xiao Z, Sun Y, Ma L. MicroRNAs and metastasis: small RNAs play big roles. Cancer Metastasis Rev 2018;37:5-15. [PMID: 29234933 DOI: 10.1007/s10555-017-9712-y] [Cited by in Crossref: 96] [Cited by in F6Publishing: 95] [Article Influence: 32.0] [Reference Citation Analysis]
129 Zammit V, Baron B, Ayers D. MiRNA Influences in Neuroblast Modulation: An Introspective Analysis. Genes (Basel) 2018;9:E26. [PMID: 29315268 DOI: 10.3390/genes9010026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
130 Vetter G, Saumet A, Moes M, Vallar L, Le Béchec A, Laurini C, Sabbah M, Arar K, Theillet C, Lecellier CH. miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers. Oncogene. 2010;29:4436-4448. [PMID: 20543867 DOI: 10.1038/onc.2010.181] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 7.8] [Reference Citation Analysis]
131 Bian T, Jiang D, Liu J, Yuan X, Feng J, Li Q, Zhang Q, Li X, Liu Y, Zhang J. miR-1236-3p suppresses the migration and invasion by targeting KLF8 in lung adenocarcinoma A549 cells. Biochemical and Biophysical Research Communications 2017;492:461-7. [DOI: 10.1016/j.bbrc.2017.08.074] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
132 Tan X, Wang S, Yang B, Zhu L, Yin B, Chao T, Zhao J, Yuan J, Qiang B, Peng X. The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells. PLoS One 2012;7:e49570. [PMID: 23185366 DOI: 10.1371/journal.pone.0049570] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 6.4] [Reference Citation Analysis]
133 Markouli M, Strepkos D, Piperi C. Structure, Activity and Function of the SETDB1 Protein Methyltransferase. Life (Basel) 2021;11:817. [PMID: 34440561 DOI: 10.3390/life11080817] [Reference Citation Analysis]
134 To KKW, Fong W, Tong CWS, Wu M, Yan W, Cho WCS. Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments. Expert Opin Drug Discov 2020;15:63-83. [PMID: 31739699 DOI: 10.1080/17460441.2020.1690449] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
135 Yuva-Aydemir Y, Simkin A, Gascon E, Gao FB. MicroRNA-9: functional evolution of a conserved small regulatory RNA. RNA Biol 2011;8:557-64. [PMID: 21697652 DOI: 10.4161/rna.8.4.16019] [Cited by in Crossref: 99] [Cited by in F6Publishing: 104] [Article Influence: 9.0] [Reference Citation Analysis]
136 Wang B, Zheng L, Chou J, Li C, Zhang Y, Meng X, Xi T. CYP4Z1 3′UTR represses migration of human breast cancer cells. Biochemical and Biophysical Research Communications 2016;478:900-7. [DOI: 10.1016/j.bbrc.2016.08.048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
137 Rubtsova SN, Zhitnyak IY, Gloushankova NA. Dual role of E-cadherin in cancer cells. Tissue Barriers 2021;:2005420. [PMID: 34821540 DOI: 10.1080/21688370.2021.2005420] [Reference Citation Analysis]
138 Li M, Guan H. Noncoding RNAs Regulating NF-κB Signaling. Adv Exp Med Biol 2016;927:317-36. [PMID: 27376741 DOI: 10.1007/978-981-10-1498-7_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
139 Pencik J, Pham HT, Schmoellerl J, Javaheri T, Schlederer M, Culig Z, Merkel O, Moriggl R, Grebien F, Kenner L. JAK-STAT signaling in cancer: From cytokines to non-coding genome. Cytokine 2016;87:26-36. [PMID: 27349799 DOI: 10.1016/j.cyto.2016.06.017] [Cited by in Crossref: 98] [Cited by in F6Publishing: 101] [Article Influence: 16.3] [Reference Citation Analysis]
140 Barillari G, Bei R, Manzari V, Modesti A. Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events? Int J Mol Sci 2021;22:13543. [PMID: 34948338 DOI: 10.3390/ijms222413543] [Reference Citation Analysis]
141 Cai L, Cai X. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. Diagn Pathol. 2014;9:1000. [PMID: 25552204 DOI: 10.1186/s13000-014-0228-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
142 Xu J, Chen Y, Olopade OI. MYC and Breast Cancer. Genes Cancer 2010;1:629-40. [PMID: 21779462 DOI: 10.1177/1947601910378691] [Cited by in Crossref: 163] [Cited by in F6Publishing: 157] [Article Influence: 14.8] [Reference Citation Analysis]
143 Zhang WC, Chin TM, Yang H, Nga ME, Lunny DP, Lim EK, Sun LL, Pang YH, Leow YN, Malusay SR, Lim PX, Lee JZ, Tan BJ, Shyh-Chang N, Lim EH, Lim WT, Tan DS, Tan EH, Tai BC, Soo RA, Tam WL, Lim B. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. Nat Commun. 2016;7:11702. [PMID: 27325363 DOI: 10.1038/ncomms11702] [Cited by in Crossref: 92] [Cited by in F6Publishing: 102] [Article Influence: 15.3] [Reference Citation Analysis]
144 Bustelo XR. Intratumoral stages of metastatic cells: A synthesis of ontogeny, Rho/Rac GTPases, epithelial-mesenchymal transitions, and more. Bioessays 2012;34:748-59. [DOI: 10.1002/bies.201200041] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
145 Dhar S, Kumar A, Gomez CR, Akhtar I, Hancock JC, Lage JM, Pound CR, Levenson AS. MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness. FEBS Lett 2017;591:924-33. [PMID: 28231399 DOI: 10.1002/1873-3468.12603] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
146 van den Boorn JG, Dassler J, Coch C, Schlee M, Hartmann G. Exosomes as nucleic acid nanocarriers. Adv Drug Deliv Rev 2013;65:331-5. [PMID: 22750807 DOI: 10.1016/j.addr.2012.06.011] [Cited by in Crossref: 134] [Cited by in F6Publishing: 130] [Article Influence: 13.4] [Reference Citation Analysis]
147 Heiler S, Wang Z, Zöller M. Pancreatic cancer stem cell markers and exosomes - the incentive push. World J Gastroenterol 2016; 22(26): 5971-6007 [PMID: 27468191 DOI: 10.3748/wjg.v22.i26.5971] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 45] [Article Influence: 8.3] [Reference Citation Analysis]
148 Nantajit D, Lin D, Li JJ. The network of epithelial-mesenchymal transition: potential new targets for tumor resistance. J Cancer Res Clin Oncol 2015;141:1697-713. [PMID: 25270087 DOI: 10.1007/s00432-014-1840-y] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 8.4] [Reference Citation Analysis]
149 Krell J, Frampton AE, Jacob J, Castellano L, Stebbing J. miRNAs in breast cancer: ready for real time? Pharmacogenomics 2012;13:709-19. [PMID: 22515613 DOI: 10.2217/pgs.12.15] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
150 Suzuki H, Maruyama R, Yamamoto E, Niinuma T, Kai M. Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer. In: Song E, editor. The Long and Short Non-coding RNAs in Cancer Biology. Singapore: Springer; 2016. pp. 109-35. [DOI: 10.1007/978-981-10-1498-7_4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
151 Kropivšek K, Pickford J, Carter DA. Postnatal dynamics of Zeb2 expression in rat brain: analysis of novel 3' UTR sequence reveals a miR-9 interacting site. J Mol Neurosci 2014;52:138-47. [PMID: 24458742 DOI: 10.1007/s12031-013-0146-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
152 Chi Y, Wang F, Zhang T, Xu H, Zhang Y, Shan Z, Wu S, Fan Q, Sun Y. miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway. J Cell Mol Med 2019;23:6295-307. [PMID: 31273950 DOI: 10.1111/jcmm.14515] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
153 Melo SA, Esteller M. Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett. 2011;585:2087-2099. [PMID: 20708002 DOI: 10.1016/j.febslet.2010.08.009] [Cited by in Crossref: 199] [Cited by in F6Publishing: 198] [Article Influence: 16.6] [Reference Citation Analysis]
154 Anura A, Das RK, Pal M, Paul RR, Ray AK, Chatterjee J. Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis. Pathology - Research and Practice 2014;210:1054-63. [DOI: 10.1016/j.prp.2014.06.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
155 Leucci E, Zriwil A, Gregersen LH, Jensen KT, Obad S, Bellan C, Leoncini L, Kauppinen S, Lund AH. Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Oncogene. 2012;31:5081-5089. [PMID: 22310293 DOI: 10.1038/onc.2012.15] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
156 Chen L, Huang K, Yi K, Huang Y, Tian X, Kang C. Premature MicroRNA-Based Therapeutic: A "One-Two Punch" against Cancers. Cancers (Basel) 2020;12:E3831. [PMID: 33353171 DOI: 10.3390/cancers12123831] [Reference Citation Analysis]
157 Cheung IY, Farazi TA, Ostrovnaya I, Xu H, Tran H, Mihailovic A, Tuschl T, Cheung NK. Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis. Genes Chromosomes Cancer 2014;53:803-14. [PMID: 24898736 DOI: 10.1002/gcc.22189] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
158 Wu J, Gao W, Tang Q, Yu Y, You W, Wu Z, Fan Y, Zhang L, Wu C, Han G, Zuo X, Zhang Y, Chen Z, Ding W, Li X, Lin F, Shen H, Tang J, Zhang Y, Wang X. M2 Macrophage-Derived Exosomes Facilitate HCC Metastasis by Transferring αM β2 Integrin to Tumor Cells. Hepatology 2021;73:1365-80. [PMID: 32594528 DOI: 10.1002/hep.31432] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
159 Li Y, Li Y, Liu J, Fan Y, Li X, Dong M, Liu H, Chen J. Expression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancer. Cancer Biol Ther 2016;17:272-9. [PMID: 26909466 DOI: 10.1080/15384047.2016.1139242] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
160 Jayachandran J, Srinivasan H, Mani KP. Molecular mechanism involved in epithelial to mesenchymal transition. Arch Biochem Biophys 2021;710:108984. [PMID: 34252392 DOI: 10.1016/j.abb.2021.108984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178-196. [PMID: 24556840 DOI: 10.1038/nrm3758] [Cited by in Crossref: 3878] [Cited by in F6Publishing: 3852] [Article Influence: 484.8] [Reference Citation Analysis]
162 Baumgart A, Mazur PK, Anton M, Rudelius M, Schwamborn K, Feuchtinger A, Behnke K, Walch A, Braren R, Peschel C, Duyster J, Siveke JT, Dechow T. Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model. Oncogene 2015;34:578-88. [PMID: 24509876 DOI: 10.1038/onc.2013.592] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
163 Lin LT, Choong CY, Tai CJ. Solanine Attenuated Hepatocarcinoma Migration and Invasion Induced by Acetylcholine. Integr Cancer Ther 2020;19:1534735420909895. [PMID: 32975458 DOI: 10.1177/1534735420909895] [Reference Citation Analysis]
164 Wang W, Luo YP. MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential. J Zhejiang Univ Sci B 2015;16:18-31. [PMID: 25559952 DOI: 10.1631/jzus.B1400184] [Cited by in Crossref: 83] [Cited by in F6Publishing: 47] [Article Influence: 11.9] [Reference Citation Analysis]
165 Penna E, Orso F, Cimino D, Tenaglia E, Lembo A, Quaglino E, Poliseno L, Haimovic A, Osella-Abate S, De Pittà C, Pinatel E, Stadler MB, Provero P, Bernengo MG, Osman I, Taverna D. microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J 2011;30:1990-2007. [PMID: 21468029 DOI: 10.1038/emboj.2011.102] [Cited by in Crossref: 183] [Cited by in F6Publishing: 176] [Article Influence: 16.6] [Reference Citation Analysis]
166 Xiao ZD, Diao LT, Yang JH, Xu H, Huang MB, Deng YJ, Zhou H, Qu LH. Deciphering the transcriptional regulation of microRNA genes in humans with ACTLocater. Nucleic Acids Res. 2013;41:e5. [PMID: 22941648 DOI: 10.1093/nar/gks821] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
167 Yahya SM, Elsayed GH. A summary for molecular regulations of miRNAs in breast cancer. Clin Biochem 2015;48:388-96. [PMID: 25541018 DOI: 10.1016/j.clinbiochem.2014.12.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
168 Maruyama R, Suzuki H, Yamamoto E, Imai K, Shinomura Y. Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer. Tumour Biol 2012;33:277-85. [PMID: 22219034 DOI: 10.1007/s13277-011-0308-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
169 Howley BV, Howe PH. TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1. Cytokine 2019;118:19-26. [PMID: 29396052 DOI: 10.1016/j.cyto.2017.12.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
170 Kim CW, Hwang KA, Choi KC. Anti-metastatic potential of resveratrol and its metabolites by the inhibition of epithelial-mesenchymal transition, migration, and invasion of malignant cancer cells. Phytomedicine 2016;23:1787-96. [PMID: 27912881 DOI: 10.1016/j.phymed.2016.10.016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
171 Herranz H, Hong X, Hung NT, Voorhoeve PM, Cohen SM. Oncogenic cooperation between SOCS family proteins and EGFR identified using a Drosophila epithelial transformation model. Genes Dev 2012;26:1602-11. [PMID: 22802531 DOI: 10.1101/gad.192021.112] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 6.3] [Reference Citation Analysis]
172 Shi M, Liu D, Duan H, Shen B, Guo N. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis. Cancer Metastasis Rev 2010;29:785-99. [DOI: 10.1007/s10555-010-9265-9] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 6.1] [Reference Citation Analysis]
173 Naser Al Deen N, Nassar F, Nasr R, Talhouk R. Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability. In: Ahmad A, editor. Breast Cancer Metastasis and Drug Resistance. Cham: Springer International Publishing; 2019. pp. 335-64. [DOI: 10.1007/978-3-030-20301-6_18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
174 Taylor MA, Schiemann WP. Therapeutic Opportunities for Targeting microRNAs in Cancer. Mol Cell Ther. 2014;2:1-13. [PMID: 25717380 DOI: 10.1186/2052-8426-2-30] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
175 Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov. 2014;13:622-638. [PMID: 25011539 DOI: 10.1038/nrd4359] [Cited by in Crossref: 618] [Cited by in F6Publishing: 601] [Article Influence: 77.3] [Reference Citation Analysis]
176 Zhao Y, Wang Y, Chen W, Bai S, Peng W, Zheng M, Yang Y, Cheng B, Luan Z. Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling. Cancer Cell Int 2021;21:670. [PMID: 34906136 DOI: 10.1186/s12935-021-02390-0] [Reference Citation Analysis]
177 Krishnan AR, Zheng H, Kwok JG, Qu Y, Zou AE, Korrapati A, Li PX, Califano JA, Hovell MF, Wang-Rodriguez J, Ongkeko WM. A comprehensive study of smoking-specific microRNA alterations in head and neck squamous cell carcinoma. Oral Oncol 2017;72:56-64. [PMID: 28797462 DOI: 10.1016/j.oraloncology.2017.07.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
178 Qin LX, Tuschl T, Singer S. An Empirical Evaluation of Normalization Methods for MicroRNA Arrays in a Liposarcoma Study. Cancer Inform 2013;12:83-101. [PMID: 23589668 DOI: 10.4137/CIN.S11384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
179 Miroshnichenko S, Patutina O. Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics. Front Pharmacol 2019;10:488. [PMID: 31156429 DOI: 10.3389/fphar.2019.00488] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
180 Nakagawa H, Hikiba Y, Hirata Y, Font-Burgada J, Sakamoto K, Hayakawa Y, Taniguchi K, Umemura A, Kinoshita H, Sakitani K. Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis. Proc Natl Acad Sci USA. 2014;111:1090-1095. [PMID: 24395807 DOI: 10.1073/pnas.1322731111] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 8.9] [Reference Citation Analysis]
181 Al-Abedi R, Tuncay Cagatay S, Mayah A, Brooks SA, Kadhim M. Ionising Radiation Promotes Invasive Potential of Breast Cancer Cells: The Role of Exosomes in the Process. Int J Mol Sci 2021;22:11570. [PMID: 34769002 DOI: 10.3390/ijms222111570] [Reference Citation Analysis]
182 Bui TV, Mendell JT. Myc: Maestro of MicroRNAs. Genes Cancer 2010;1:568-75. [PMID: 20882107 DOI: 10.1177/1947601910377491] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 8.1] [Reference Citation Analysis]
183 Georgakopoulos-Soares I, Chartoumpekis DV, Kyriazopoulou V, Zaravinos A. EMT Factors and Metabolic Pathways in Cancer. Front Oncol 2020;10:499. [PMID: 32318352 DOI: 10.3389/fonc.2020.00499] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 20.0] [Reference Citation Analysis]
184 Krell J, Frampton AE, Jacob J, Pellegrino L, Roca-Alonso L, Zeloof D, Alifrangis C, Lewis JS, Jiao LR, Stebbing J, Castellano L. The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis. Mol Diagn Ther 2012;16:167-72. [PMID: 22489664 DOI: 10.1007/BF03262205] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
185 Liu Y, Zhang A, Bao PP, Lin L, Wang Y, Wu H, Shu XO, Liu A, Cai Q. MicroRNA-374b inhibits breast cancer progression through regulating CCND1 and TGFA genes. Carcinogenesis 2021;42:528-36. [PMID: 33480984 DOI: 10.1093/carcin/bgab005] [Reference Citation Analysis]
186 Cortez MA, Ivan C, Zhou P, Wu X, Ivan M, Calin GA. microRNAs in cancer: from bench to bedside. Adv Cancer Res. 2010;108:113-157. [PMID: 21034967 DOI: 10.1016/b978-0-12-380888-2.00004-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
187 Coolen M, Katz S, Bally-Cuif L. miR-9: a versatile regulator of neurogenesis. Front Cell Neurosci 2013;7:220. [PMID: 24312010 DOI: 10.3389/fncel.2013.00220] [Cited by in Crossref: 162] [Cited by in F6Publishing: 152] [Article Influence: 18.0] [Reference Citation Analysis]
188 Dugo M, Huang X, Iorio MV, Cataldo A, Tagliabue E, Daidone MG, Wu J, Orlandi R. MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer. The Breast 2018;39:46-52. [DOI: 10.1016/j.breast.2018.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
189 Pan Y, Li J, Zhang Y, Wang N, Liang H, Liu Y, Zhang CY, Zen K, Gu H. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression. Sci Rep 2016;6:25798. [PMID: 27174021 DOI: 10.1038/srep25798] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
190 Kim BG, Gao MQ, Kang S, Choi YP, Lee JH, Kim JE, Han HH, Mun SG, Cho NH. Mechanical compression induces VEGFA overexpression in breast cancer via DNMT3A-dependent miR-9 downregulation. Cell Death Dis. 2017;8:e2646. [PMID: 28252641 DOI: 10.1038/cddis.2017.73] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
191 Ren J, Li W, Yan L, Jiao W, Tian S, Li D, Tang Y, Gu G, Liu H, Xu Z. Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival. Br J Cancer 2011;105:1905-11. [PMID: 22075943 DOI: 10.1038/bjc.2011.492] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
192 Zadran S, Remacle F, Levine R. Surprisal analysis of Glioblastoma Multiform (GBM) microRNA dynamics unveils tumor specific phenotype. PLoS One 2014;9:e108171. [PMID: 25265448 DOI: 10.1371/journal.pone.0108171] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
193 Nieto MA, Cano A. The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin Cancer Biol. 2012;22:361-368. [PMID: 22613485 DOI: 10.1016/j.semcancer.2012.05.003] [Cited by in Crossref: 178] [Cited by in F6Publishing: 161] [Article Influence: 17.8] [Reference Citation Analysis]
194 Xu XZ, Li XA, Luo Y, Liu JF, Wu HW, Huang G. MiR-9 promotes synovial sarcoma cell migration and invasion by directly targeting CDH1. Int J Biochem Cell Biol 2019;112:61-71. [PMID: 30959202 DOI: 10.1016/j.biocel.2019.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
195 Liang YJ, Wang QY, Zhou CX, Yin QQ, He M, Yu XT, Cao DX, Chen GQ, He JR, Zhao Q. MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 2013;34:713-22. [PMID: 23250910 DOI: 10.1093/carcin/bgs383] [Cited by in Crossref: 138] [Cited by in F6Publishing: 134] [Article Influence: 13.8] [Reference Citation Analysis]
196 Chen X, Zhu L, Ma Z, Sun G, Luo X, Li M, Zhai S, Li P, Wang X. Oncogenic miR-9 is a target of erlotinib in NSCLCs. Sci Rep 2015;5:17031. [PMID: 26593208 DOI: 10.1038/srep17031] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
197 Hoshino I, Matsubara H. MicroRNAs in cancer diagnosis and therapy: from bench to bedside. Surg Today. 2013;43:467-478. [PMID: 23129027 DOI: 10.1007/s00595-012-0392-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
198 Ha NH, Hunter KW. Using a systems biology approach to understand and study the mechanisms of metastasis. Wiley Interdiscip Rev Syst Biol Med 2014;6:107-14. [PMID: 23873855 DOI: 10.1002/wsbm.1237] [Reference Citation Analysis]
199 Song R, Sponer N, He L. Methods to quantify microRNAs in the Myc gene network for posttranscriptional gene repression. Methods Mol Biol 2013;1012:135-44. [PMID: 24006063 DOI: 10.1007/978-1-62703-429-6_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
200 Li Y, Fan L, Liu S, Liu W, Zhang H, Zhou T, Wu D, Yang P, Shen L, Chen J, Jin Y. The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a. Biomaterials 2013;34:5048-58. [PMID: 23578559 DOI: 10.1016/j.biomaterials.2013.03.052] [Cited by in Crossref: 135] [Cited by in F6Publishing: 136] [Article Influence: 15.0] [Reference Citation Analysis]
201 Kumps C, Fieuw A, Mestdagh P, Menten B, Lefever S, Pattyn F, De Brouwer S, Sante T, Schulte JH, Schramm A. Focal DNA copy number changes in neuroblastoma target MYCN regulated genes. PLoS One. 2013;8:e52321. [PMID: 23308108 DOI: 10.1371/journal.pone.0052321] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
202 Liu W, Gao G, Hu X, Wang Y, Schwarz JK, Chen JJ, Grigsby PW, Wang X. Activation of miR-9 by human papillomavirus in cervical cancer. Oncotarget 2014;5:11620-30. [PMID: 25344913 DOI: 10.18632/oncotarget.2599] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.7] [Reference Citation Analysis]
203 Liu B, Sun X. miR-25 promotes invasion of human non-small cell lung cancer via CDH1. Bioengineered 2019;10:271-81. [PMID: 31208279 DOI: 10.1080/21655979.2019.1632668] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
204 Song H, Zhang Y, Liu N, Zhao S, Kong Y, Yuan L. miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/β-Catenin and Notch-1/Akt Signaling Pathways. Int J Mol Sci 2016;17:E1799. [PMID: 27801803 DOI: 10.3390/ijms17111799] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
205 Bertoni N, Pereira LM, Severino FE, Moura R, Yoshida WB, Reis PP. Integrative meta-analysis identifies microRNA-regulated networks in infantile hemangioma. BMC Med Genet 2016;17:4. [PMID: 26772808 DOI: 10.1186/s12881-015-0262-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
206 Borok Z, Whitsett JA, Bitterman PB, Thannickal VJ, Kotton DN, Reynolds SD, Krasnow MA, Bianchi DW, Morrisey EE, Hogan BL, Kurie JM, Walker DC, Radisky DC, Nishimura SL, Violette SM, Noble PW, Shapiro SD, Blaisdell CJ, Chapman HA, Kiley J, Gail D, Hoshizaki D. Cell plasticity in lung injury and repair: report from an NHLBI workshop, April 19-20, 2010. Proc Am Thorac Soc 2011;8:215-22. [PMID: 21653526 DOI: 10.1513/pats.201012-067CB] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
207 Kan CW, Howell VM, Hahn MA, Marsh DJ. Genomic alterations as mediators of miRNA dysregulation in ovarian cancer. Genes Chromosomes Cancer 2015;54:1-19. [PMID: 25280227 DOI: 10.1002/gcc.22221] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
208 Ghiggeri GM, Gigante M, Di Donato A. Constitutional Nephrin Deficiency in Conditionally Immortalized Human Podocytes Induced Epithelial-Mesenchymal Transition, Supported by β-Catenin/NF-kappa B Activation: A Consequence of Cell Junction Impairment? Int J Nephrol 2013;2013:457490. [PMID: 24392227 DOI: 10.1155/2013/457490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
209 Sereno M, Videira M, Wilhelm I, Krizbai IA, Brito MA. miRNAs in Health and Disease: A Focus on the Breast Cancer Metastatic Cascade towards the Brain. Cells 2020;9:E1790. [PMID: 32731349 DOI: 10.3390/cells9081790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
210 Samadi AK, Bilsland A, Georgakilas AG, Amedei A, Amin A, Bishayee A, Azmi AS, Lokeshwar BL, Grue B, Panis C, Boosani CS, Poudyal D, Stafforini DM, Bhakta D, Niccolai E, Guha G, Vasantha Rupasinghe HP, Fujii H, Honoki K, Mehta K, Aquilano K, Lowe L, Hofseth LJ, Ricciardiello L, Ciriolo MR, Singh N, Whelan RL, Chaturvedi R, Ashraf SS, Shantha Kumara HMC, Nowsheen S, Mohammed SI, Keith WN, Helferich WG, Yang X. A multi-targeted approach to suppress tumor-promoting inflammation. Semin Cancer Biol 2015;35 Suppl:S151-84. [PMID: 25951989 DOI: 10.1016/j.semcancer.2015.03.006] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 8.4] [Reference Citation Analysis]
211 Frenzel A, Lovén J, Henriksson MA. Targeting MYC-Regulated miRNAs to Combat Cancer. Genes Cancer 2010;1:660-7. [PMID: 21779463 DOI: 10.1177/1947601910377488] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
212 Lenarduzzi M, Hui AB, Alajez NM, Shi W, Williams J, Yue S, O'Sullivan B, Liu FF. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1. PLoS One 2013;8:e53765. [PMID: 23335975 DOI: 10.1371/journal.pone.0053765] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
213 Murray MJ, Raby KL, Saini HK, Bailey S, Wool SV, Tunnacliffe JM, Enright AJ, Nicholson JC, Coleman N. Solid tumors of childhood display specific serum microRNA profiles. Cancer Epidemiol Biomarkers Prev 2015;24:350-60. [PMID: 25416717 DOI: 10.1158/1055-9965.EPI-14-0669] [Cited by in Crossref: 43] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
214 Wang J, Zhao H, Tang D, Wu J, Yao G, Zhang Q. Overexpressions of microRNA-9 and microRNA-200c in human breast cancers are associated with lymph node metastasis. Cancer Biother Radiopharm 2013;28:283-8. [PMID: 23617747 DOI: 10.1089/cbr.2012.1293] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
215 Volovat SR, Volovat C, Hordila I, Hordila DA, Mirestean CC, Miron OT, Lungulescu C, Scripcariu DV, Stolniceanu CR, Konsoulova-Kirova AA, Grigorescu C, Stefanescu C, Volovat CC, Augustin I. MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review. Front Oncol 2020;10:526850. [PMID: 33330019 DOI: 10.3389/fonc.2020.526850] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
216 Bui T, Schade B, Cardiff RD, Aina OH, Sanguin-Gendreau V, Muller WJ. β-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model. Proc Natl Acad Sci U S A 2017;114:E707-16. [PMID: 28096336 DOI: 10.1073/pnas.1610383114] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
217 Atri C, Guerfali FZ, Laouini D. MicroRNAs in diagnosis and therapeutics. AGO-Driven Non-Coding RNAs. Elsevier; 2019. pp. 137-77. [DOI: 10.1016/b978-0-12-815669-8.00006-3] [Cited by in Crossref: 8] [Article Influence: 2.7] [Reference Citation Analysis]
218 Khafaei M, Rezaie E, Mohammadi A, Shahnazi Gerdehsang P, Ghavidel S, Kadkhoda S, Zorrieh Zahra A, Forouzanfar N, Arabameri H, Tavallaie M. miR-9: From function to therapeutic potential in cancer. J Cell Physiol 2019. [PMID: 30693512 DOI: 10.1002/jcp.28210] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
219 Bushnell GG, Hardas TP, Hartfield RM, Zhang Y, Oakes RS, Ronquist S, Chen H, Rajapakse I, Wicha MS, Jeruss JS, Shea LD. Biomaterial Scaffolds Recruit an Aggressive Population of Metastatic Tumor Cells In Vivo. Cancer Res 2019;79:2042-53. [PMID: 30808673 DOI: 10.1158/0008-5472.CAN-18-2502] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
220 Goswami CP, Nakshatri H. PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data. J Clin Bioinforma 2012;2:23. [PMID: 23272654 DOI: 10.1186/2043-9113-2-23] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
221 DesRochers TM, Shamis Y, Alt-Holland A, Kudo Y, Takata T, Wang G, Jackson-Grusby L, Garlick JA. The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma. Epigenetics 2012;7:34-46. [PMID: 22207358 DOI: 10.4161/epi.7.1.18546] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
222 Ali AS, Ali S, Ahmad A, Bao B, Philip PA, Sarkar FH. Expression of microRNAs: potential molecular link between obesity, diabetes and cancer. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2011;12:1050-1062. [PMID: 21767342 DOI: 10.1111/j.1467-789x.2011.00906.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
223 Fiaschetti G, Schroeder C, Castelletti D, Arcaro A, Westermann F, Baumgartner M, Shalaby T, Grotzer MA. NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma. Acta Neuropathol Commun 2014;2:39. [PMID: 24708907 DOI: 10.1186/2051-5960-2-39] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
224 Plantamura I, Cosentino G, Cataldo A. MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers. Front Oncol 2018;8:352. [PMID: 30234015 DOI: 10.3389/fonc.2018.00352] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
225 Wei C, Dong X, Lu H, Tong F, Chen L, Zhang R, Dong J, Hu Y, Wu G, Dong X. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. J Exp Clin Cancer Res 2019;38:95. [PMID: 30791942 DOI: 10.1186/s13046-019-1092-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
226 Liang H, Studach L, Hullinger RL, Xie J, Andrisani OM. Down-regulation of RE-1 silencing transcription factor (REST) in advanced prostate cancer by hypoxia-induced miR-106b~25. Exp Cell Res 2014;320:188-99. [PMID: 24135225 DOI: 10.1016/j.yexcr.2013.09.020] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
227 Larsson LG, Henriksson MA. The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy. Exp Cell Res. 2010;316:1429-1437. [PMID: 20382143 DOI: 10.1016/j.yexcr.2010.03.025] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 6.1] [Reference Citation Analysis]
228 Rutnam ZJ, Wight TN, Yang BB. miRNAs regulate expression and function of extracellular matrix molecules. Matrix Biol. 2013;32:74-85. [PMID: 23159731 DOI: 10.1016/j.matbio.2012.11.003] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 7.4] [Reference Citation Analysis]
229 Nishiuchi A, Hisamori S, Sakaguchi M, Fukuyama K, Hoshino N, Itatani Y, Honma S, Maekawa H, Nishigori T, Tsunoda S, Obama K, Miyoshi H, Shimono Y, Taketo MM, Sakai Y. MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients with Stage II/III Colorectal Cancer. Cancers (Basel) 2019;11:E1891. [PMID: 31783700 DOI: 10.3390/cancers11121891] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
230 Su M, Yi H, He X, Luo L, Jiang S, Shi Y. miR-9 regulates melanocytes adhesion and migration during vitiligo repigmentation induced by UVB treatment. Exp Cell Res 2019;384:111615. [PMID: 31499059 DOI: 10.1016/j.yexcr.2019.111615] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
231 Kaller M, Liffers ST, Oeljeklaus S, Kuhlmann K, Röh S, Hoffmann R, Warscheid B, Hermeking H. Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis. Mol Cell Proteomics. 2011;10:M111.010462. [PMID: 21566225 DOI: 10.1074/mcp.m111.010462] [Cited by in Crossref: 131] [Cited by in F6Publishing: 92] [Article Influence: 11.9] [Reference Citation Analysis]
232 Kaboli PJ, Rahmat A, Ismail P, Ling K. MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment. Pharmacological Research 2015;97:104-21. [DOI: 10.1016/j.phrs.2015.04.015] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 10.9] [Reference Citation Analysis]
233 Wang DP, Tang XZ, Liang QK, Zeng XJ, Yang JB, Xu J. Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma. J Cell Physiol 2020;235:2403-13. [PMID: 31556116 DOI: 10.1002/jcp.29145] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
234 Xue J, Niu J, Wu J, Wu ZH. MicroRNAs in cancer therapeutic response: Friend and foe. World J Clin Oncol 2014; 5(4): 730-743 [PMID: 25302173 DOI: 10.5306/wjco.v5.i4.730] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
235 Zhang T, Wu Y, Yang D, Wu C, Li H. Preparation, characterization, and in vitro tumor-suppressive effect of anti-miR-21-equipped RNA nanoparticles. Biochem Biophys Res Commun 2021;558:107-13. [PMID: 33906109 DOI: 10.1016/j.bbrc.2021.04.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Wang XH, Wu HY, Gao J, Wang XH, Gao TH, Zhang SF. FGF represses metastasis of neuroblastoma regulated by MYCN and TGF-β1 induced LMO1 via control of let-7 expression. Brain Res 2019;1704:219-28. [PMID: 30321496 DOI: 10.1016/j.brainres.2018.10.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
237 Findlay VJ, Wang C, Watson DK, Camp ER. Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer. Cancer Gene Ther. 2014;21:181-187. [PMID: 24787239 DOI: 10.1038/cgt.2014.15] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 9.9] [Reference Citation Analysis]
238 Sun C, Li N, Yang Z, Zhou B, He Y, Weng D, Fang Y, Wu P, Chen P, Yang X, Ma D, Zhou J, Chen G. miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition. J Natl Cancer Inst 2013;105:1750-8. [PMID: 24168967 DOI: 10.1093/jnci/djt302] [Cited by in Crossref: 101] [Cited by in F6Publishing: 96] [Article Influence: 11.2] [Reference Citation Analysis]
239 Ding W, Ma Y, Zhu W, Pu W, Zhang J, Qian F, Zhou Y, Deng Y, Guo S, Wang J, Zhou X. MICA 012:01 Allele Facilitates the Metastasis of KRAS-Mutant Colorectal Cancer. Front Genet 2020;11:511. [PMID: 32528529 DOI: 10.3389/fgene.2020.00511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
240 Banyard J, Bielenberg DR. The role of EMT and MET in cancer dissemination. Connect Tissue Res 2015;56:403-13. [PMID: 26291767 DOI: 10.3109/03008207.2015.1060970] [Cited by in Crossref: 87] [Cited by in F6Publishing: 87] [Article Influence: 12.4] [Reference Citation Analysis]
241 Ewida HA, Shabayek M, Seleem M. Evaluation of miRNAs 9 and 342 expressions in sera as diagnostic and prognostic biomarkers for breast cancer. Breast Dis 2021;40:241-50. [PMID: 34092580 DOI: 10.3233/BD-201076] [Reference Citation Analysis]
242 Erstad DJ, Tumusiime G, Cusack JC. Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon. Ann Surg Oncol 2015;22:3433-50. [DOI: 10.1245/s10434-015-4706-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
243 Wang S, Wu W, Claret FX. Mutual regulation of microRNAs and DNA methylation in human cancers. Epigenetics. 2017;12:187-197. [PMID: 28059592 DOI: 10.1080/15592294.2016.1273308] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 13.2] [Reference Citation Analysis]
244 Alizadeh Naini M, Kavousipour S, Hasanzarini M, Nasrollah A, Monabati A, Mokarram P. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer. Asian Pac J Cancer Prev. 2018;19:1223-1227. [PMID: 29801405 DOI: 10.22034/apjcp.2018.19.5.1223] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
245 Grewal R, Cucuianu A, Swanepoel C, Dima D, Petrushev B, Pop B, Berindan-Neagoe I, Abayomi EA, Tomuleasa C. The role of microRNAs in the pathogenesis of HIV-related lymphomas. Crit Rev Clin Lab Sci 2015;52:232-41. [PMID: 26218036 DOI: 10.3109/10408363.2015.1030063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
246 Zhang Y, Eades G, Yao Y, Li Q, Zhou Q. Estrogen receptor α signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2. J Biol Chem. 2012;287:41514-41522. [PMID: 23060440 DOI: 10.1074/jbc.m112.404871] [Cited by in Crossref: 85] [Cited by in F6Publishing: 60] [Article Influence: 8.5] [Reference Citation Analysis]
247 Tavakolian S, Goudarzi H, Faghihloo E. Evaluating the expression level of miR-9-5p and miR-192-5p in gastrointestinal cancer: introducing novel screening biomarkers for patients. BMC Res Notes 2020;13:226. [PMID: 32307002 DOI: 10.1186/s13104-020-05071-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
248 Öner Ç. Two different mechanisms of two different non-coding RNAs—MicroRNAs and PIWI-interacting RNAs: From origin to cancer. AGO-Driven Non-Coding RNAs. Elsevier; 2019. pp. 3-34. [DOI: 10.1016/b978-0-12-815669-8.00001-4] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
249 Yang J, Eddy JA, Pan Y, Hategan A, Tabus I, Wang Y, Cogdell D, Price ND, Pollock RE, Lazar AJ. Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug. Mol Cell Proteomics. 2010;9:2405-2413. [PMID: 20651304 DOI: 10.1074/mcp.m110.000240] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
250 Tomesz A, Szabo L, Molnar R, Deutsch A, Darago R, Mathe D, Budan F, Ghodratollah N, Varjas T, Nemeth B, Kiss I. Effect of 7,12-Dimethylbenz(α)anthracene on the Expression of miR-330, miR-29a, miR-9-1, miR-9-3 and the mTORC1 Gene in CBA/Ca Mice. In Vivo 2020;34:2337-43. [PMID: 32871758 DOI: 10.21873/invivo.12046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
251 Canel M, Serrels A, Frame MC, Brunton VG. E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci. 2013;126:393-401. [PMID: 23525005 DOI: 10.1242/jcs.100115] [Cited by in Crossref: 364] [Cited by in F6Publishing: 360] [Article Influence: 40.4] [Reference Citation Analysis]
252 Roy Chowdhury M, Schumann C, Bhakta-guha D, Guha G. Cancer nanotheranostics: Strategies, promises and impediments. Biomedicine & Pharmacotherapy 2016;84:291-304. [DOI: 10.1016/j.biopha.2016.09.035] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
253 Kabekkodu SP, Shukla V, Varghese VK, Adiga D, Vethil Jishnu P, Chakrabarty S, Satyamoorthy K. Cluster miRNAs and cancer: Diagnostic, prognostic and therapeutic opportunities. Wiley Interdiscip Rev RNA 2020;11:e1563. [PMID: 31436881 DOI: 10.1002/wrna.1563] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
254 Klymenko Y, Kim O, Stack MS. Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer. Cancers (Basel) 2017;9:E104. [PMID: 28792442 DOI: 10.3390/cancers9080104] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
255 Nair MG, Somashekaraiah VM, Ramamurthy V, Prabhu JS, Sridhar TS. miRNAs: Critical mediators of breast cancer metastatic programming. Exp Cell Res 2021;401:112518. [PMID: 33607102 DOI: 10.1016/j.yexcr.2021.112518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
256 Sartorius K, Swadling L, An P, Makarova J, Winkler C, Chuturgoon A, Kramvis A. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways. Viruses 2020;12:E746. [PMID: 32664401 DOI: 10.3390/v12070746] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
257 Jin W, Chen F, Wang K, Song Y, Fei X, Wu B. miR-15a/miR-16 cluster inhibits invasion of prostate cancer cells by suppressing TGF-β signaling pathway. Biomed Pharmacother 2018;104:637-44. [PMID: 29803177 DOI: 10.1016/j.biopha.2018.05.041] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
258 Anauate AC, Leal MF, Calcagno DQ, Gigek CO, Karia BTR, Wisnieski F, Dos Santos LC, Chen ES, Burbano RR, Smith MAC. The Complex Network between MYC Oncogene and microRNAs in Gastric Cancer: An Overview. Int J Mol Sci 2020;21:E1782. [PMID: 32150871 DOI: 10.3390/ijms21051782] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
259 Wendt MK, Tian M, Schiemann WP. Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression. Cell Tissue Res 2012;347:85-101. [PMID: 21691718 DOI: 10.1007/s00441-011-1199-1] [Cited by in Crossref: 149] [Cited by in F6Publishing: 140] [Article Influence: 13.5] [Reference Citation Analysis]
260 Sun KT, Chen MY, Tu MG, Wang IK, Chang SS, Li CY. MicroRNA-20a regulates autophagy related protein-ATG16L1 in hypoxia-induced osteoclast differentiation. Bone 2015;73:145-53. [PMID: 25485521 DOI: 10.1016/j.bone.2014.11.026] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
261 Heery R, Finn SP, Cuffe S, Gray SG. Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells. Cancers (Basel). 2017;9. [PMID: 28430163 DOI: 10.3390/cancers9040038] [Cited by in Crossref: 88] [Cited by in F6Publishing: 96] [Article Influence: 17.6] [Reference Citation Analysis]
262 Chen PP, Zhang ZS, Wu JC, Zheng JF, Lin F. LncRNA SNHG12 promotes proliferation and epithelial mesenchymal transition in hepatocellular carcinoma through targeting HEG1 via miR-516a-5p. Cell Signal 2021;84:109992. [PMID: 33774129 DOI: 10.1016/j.cellsig.2021.109992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
263 Wright JA, Richer JK, Goodall GJ. microRNAs and EMT in Mammary Cells and Breast Cancer. J Mammary Gland Biol Neoplasia 2010;15:213-23. [DOI: 10.1007/s10911-010-9183-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
264 De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013;13:97-110. [PMID: 23344542 DOI: 10.1038/nrc3447] [Cited by in Crossref: 1460] [Cited by in F6Publishing: 1424] [Article Influence: 162.2] [Reference Citation Analysis]
265 Gang W, Tanjun W, Yong H, Jiajun Q, Yi Z, Hao H. Inhibition of miR-9 decreases osteosarcoma cell proliferation. Bosn J Basic Med Sci 2020;20:218-25. [PMID: 31724522 DOI: 10.17305/bjbms.2019.4434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
266 Nampoothiri SS, Rajanikant GK. miR-9 Upregulation Integrates Post-ischemic Neuronal Survival and Regeneration In Vitro. Cell Mol Neurobiol 2019;39:223-40. [PMID: 30539420 DOI: 10.1007/s10571-018-0642-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
267 Tiwari N, Gheldof A, Tatari M, Christofori G. EMT as the ultimate survival mechanism of cancer cells. Seminars in Cancer Biology 2012;22:194-207. [DOI: 10.1016/j.semcancer.2012.02.013] [Cited by in Crossref: 306] [Cited by in F6Publishing: 280] [Article Influence: 30.6] [Reference Citation Analysis]
268 Lima JF, Cerqueira L, Figueiredo C, Oliveira C, Azevedo NF. Anti-miRNA oligonucleotides: A comprehensive guide for design. RNA Biol 2018;15:338-52. [PMID: 29570036 DOI: 10.1080/15476286.2018.1445959] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 13.8] [Reference Citation Analysis]
269 Tan GC, Chan E, Molnar A, Sarkar R, Alexieva D, Isa IM, Robinson S, Zhang S, Ellis P, Langford CF, Guillot PV, Chandrashekran A, Fisk NM, Castellano L, Meister G, Winston RM, Cui W, Baulcombe D, Dibb NJ. 5' isomiR variation is of functional and evolutionary importance. Nucleic Acids Res 2014;42:9424-35. [PMID: 25056318 DOI: 10.1093/nar/gku656] [Cited by in Crossref: 145] [Cited by in F6Publishing: 129] [Article Influence: 18.1] [Reference Citation Analysis]
270 Jusufović E, Rijavec M, Keser D, Korošec P, Sodja E, Iljazović E, Radojević Z, Košnik M. let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non--small--cell lung cancer. PLoS One 2012;7:e45577. [PMID: 23029111 DOI: 10.1371/journal.pone.0045577] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 6.9] [Reference Citation Analysis]
271 Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E, Olson EN. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell. 2010;18:282-293. [PMID: 20832755 DOI: 10.1016/j.ccr.2010.08.013.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
272 Coolen M, Bally-Cuif L. [miR-9: a key factor of the physiopathological regulation of the neural progenitor state]. Med Sci (Paris) 2013;29:1010-7. [PMID: 24280505 DOI: 10.1051/medsci/20132911018] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
273 D’amato NC, Howe EN, Richer JK. MicroRNA regulation of epithelial plasticity in cancer. Cancer Letters 2013;341:46-55. [DOI: 10.1016/j.canlet.2012.11.054] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
274 Park S, Eom K, Kim J, Bang H, Wang HY, Ahn S, Kim G, Jang H, Kim S, Lee D, Park KH, Lee H. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer. BMC Cancer 2017;17:658. [PMID: 28934937 DOI: 10.1186/s12885-017-3642-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 58] [Article Influence: 9.8] [Reference Citation Analysis]
275 Sun X, Xue H, Xiong Y, Yu R, Gao X, Qian M, Wang S, Wang H, Xu J, Chen Z, Deng L, Li G. GALE Promotes the Proliferation and Migration of Glioblastoma Cells and Is Regulated by miR-let-7i-5p. Cancer Manag Res 2019;11:10539-54. [PMID: 31908526 DOI: 10.2147/CMAR.S221585] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
276 Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J, Cheng C. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest 2011;121:1064-74. [PMID: 21393860 DOI: 10.1172/JCI44540] [Cited by in Crossref: 376] [Cited by in F6Publishing: 249] [Article Influence: 34.2] [Reference Citation Analysis]
277 Jiang WG, Sanders AJ, Katoh M, Ungefroren H, Gieseler F, Prince M, Thompson SK, Zollo M, Spano D, Dhawan P, Sliva D, Subbarayan PR, Sarkar M, Honoki K, Fujii H, Georgakilas AG, Amedei A, Niccolai E, Amin A, Ashraf SS, Ye L, Helferich WG, Yang X, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Azmi AS, Keith WN, Bilsland A, Bhakta D, Halicka D, Nowsheen S, Pantano F, Santini D. Tissue invasion and metastasis: Molecular, biological and clinical perspectives. Semin Cancer Biol. 2015;35 Suppl:S244-S275. [PMID: 25865774 DOI: 10.1016/j.semcancer.2015.03.008] [Cited by in Crossref: 243] [Cited by in F6Publishing: 248] [Article Influence: 34.7] [Reference Citation Analysis]
278 Wong W, Hardikar AA, Joglekar MV. Generation of Human Islet Progenitor Cells via Epithelial-to-Mesenchymal Transition. In: A. Hardikar A, editor. Pancreatic Islet Biology. Cham: Springer International Publishing; 2016. pp. 217-40. [DOI: 10.1007/978-3-319-45307-1_9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
279 Yu B, Yu X, Xiong J, Ma M. Methylation Modification, Alternative Splicing, and Noncoding RNA Play a Role in Cancer Metastasis through Epigenetic Regulation. Biomed Res Int 2021;2021:4061525. [PMID: 34660788 DOI: 10.1155/2021/4061525] [Reference Citation Analysis]
280 Rask L, Fregil M, Høgdall E, Mitchelmore C, Eriksen J. Development of a metastatic fluorescent Lewis Lung carcinoma mouse model: identification of mRNAs and microRNAs involved in tumor invasion. Gene 2013;517:72-81. [PMID: 23296057 DOI: 10.1016/j.gene.2012.12.083] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
281 Orang AV, Petersen J, McKinnon RA, Michael MZ. Micromanaging aerobic respiration and glycolysis in cancer cells. Mol Metab 2019;23:98-126. [PMID: 30837197 DOI: 10.1016/j.molmet.2019.01.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
282 Feng M, Li Z, Aau M, Wong CH, Yang X, Yu Q. Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation. Oncogene 2011;30:2242-51. [DOI: 10.1038/onc.2010.602] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 6.0] [Reference Citation Analysis]
283 Wilmott JS, Zhang XD, Hersey P, Scolyer RA. The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. Pathology 2011;43:657-71. [PMID: 21876471 DOI: 10.1097/PAT.0b013e32834a7358] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
284 Song W, Yan D, Wei T, Liu Q, Zhou X, Liu J. Tumor-derived extracellular vesicles in angiogenesis. Biomed Pharmacother 2018;102:1203-8. [PMID: 29710539 DOI: 10.1016/j.biopha.2018.03.148] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
285 Ma X, Huang J, Tian Y, Chen Y, Yang Y, Zhang X, Zhang F, Xue L. Myc suppresses tumor invasion and cell migration by inhibiting JNK signaling. Oncogene 2017;36:3159-67. [PMID: 28068320 DOI: 10.1038/onc.2016.463] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
286 Li G, Wu F, Yang H, Deng X, Yuan Y. MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2. Biomed Pharmacother 2017;96:1170-8. [PMID: 29239816 DOI: 10.1016/j.biopha.2017.11.105] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 9.6] [Reference Citation Analysis]
287 Wang H, Li M, Zhang R, Wang Y, Zang W, Ma Y, Zhao G, Zhang G. Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299. Tumour Biol. 2013;34:3101-3109. [PMID: 23740614 DOI: 10.1007/s13277-013-0878-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
288 Wang L, Ho J, Glackin C, Martins-Green M. Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis. Transl Oncol 2012;5:344-55. [PMID: 23066443 DOI: 10.1593/tlo.12190] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
289 Chen D, Yuan M, Ye Q, Wang X, Xu J, Shi G, Hu Z. Cyanidin-3-O-glucoside inhibits epithelial-to-mesenchymal transition, and migration and invasion of breast cancer cells by upregulating KLF4. Food Nutr Res 2020;64. [PMID: 33240028 DOI: 10.29219/fnr.v64.4240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
290 Behbahani GD, Ghahhari NM, Javidi MA, Molan AF, Feizi N, Babashah S. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer. Pathol Oncol Res 2017;23:1-12. [DOI: 10.1007/s12253-016-0101-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
291 Bell RE, Levy C. The three M's: melanoma, microphthalmia-associated transcription factor and microRNA. Pigment Cell Melanoma Res 2011;24:1088-106. [PMID: 22004179 DOI: 10.1111/j.1755-148X.2011.00931.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
292 Novotny GW, Lundh M, Backe MB, Christensen DP, Hansen JB, Dahllöf MS, Pallesen EM, Mandrup-Poulsen T. Transcriptional and translational regulation of cytokine signaling in inflammatory β-cell dysfunction and apoptosis. Arch Biochem Biophys 2012;528:171-84. [PMID: 23063755 DOI: 10.1016/j.abb.2012.09.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
293 Lutful Kabir FM, Deinnocentes P, Bird RC. Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models: C OMPREHENSIVE E XPRESSION P ROFILES OF miRNA s IN CMTs. J Cell Biochem 2015;116:2956-69. [DOI: 10.1002/jcb.25243] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
294 Liu F, Gu LN, Shan BE, Geng CZ, Sang MX. Biomarkers for EMT and MET in breast cancer: An update. Oncol Lett 2016;12:4869-76. [PMID: 28105194 DOI: 10.3892/ol.2016.5369] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 8.3] [Reference Citation Analysis]
295 Xiang X, Zhuang X, Ju S, Zhang S, Jiang H, Mu J, Zhang L, Miller D, Grizzle W, Zhang HG. miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT. Oncogene. 2011;30:3440-3453. [PMID: 21460854 DOI: 10.1038/onc.2011.54] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 6.4] [Reference Citation Analysis]
296 Jin K, Wang S, Zhang Y, Xia M, Mo Y, Li X, Li G, Zeng Z, Xiong W, He Y. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis. Cell Mol Life Sci 2019;76:4275-89. [PMID: 31309249 DOI: 10.1007/s00018-019-03222-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 15.0] [Reference Citation Analysis]
297 Liu R, Li J, Lai Y, Liao Y, Liu R, Qiu W. Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1. Int J Biol Macromol 2015;81:491-7. [PMID: 26275461 DOI: 10.1016/j.ijbiomac.2015.08.016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
298 Hutchins EJ, Bronner ME. A Spectrum of Cell States During the Epithelial-to-Mesenchymal Transition. Methods Mol Biol 2021;2179:3-6. [PMID: 32939707 DOI: 10.1007/978-1-0716-0779-4_1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
299 Xia H, Hui KM. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. Cancer Gene Ther. 2012;19:723-730. [PMID: 22975591 DOI: 10.1038/cgt.2012.58] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
300 Wang Y, Zhou Y, Yang Z, Chen B, Huang W, Liu Y, Zhang Y. MiR-204/ZEB2 axis functions as key mediator for MALAT1-induced epithelial-mesenchymal transition in breast cancer. Tumour Biol 2017;39:1010428317690998. [PMID: 28675122 DOI: 10.1177/1010428317690998] [Cited by in Crossref: 26] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
301 Miller DL, Davis JW, Taylor KH, Johnson J, Shi Z, Williams R, Atasoy U, Lewis JS Jr, Stack MS. Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas. Am J Pathol 2015;185:679-92. [PMID: 25572154 DOI: 10.1016/j.ajpath.2014.11.018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
302 Liu N, Li P, Zang S, Liu Q, Ma D, Sun X, Ji C. Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis. PLoS One 2015;10:e0116880. [PMID: 25647305 DOI: 10.1371/journal.pone.0116880] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
303 Rothschild SI. microRNA therapies in cancer. Mol Cell Ther. 2014;2:7. [PMID: 26056576 DOI: 10.1186/2052-8426-2-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 9.0] [Reference Citation Analysis]
304 Yin X, Li YW, Jin JJ, Zhou Y, Ren ZG, Qiu SJ, Zhang BH. The clinical and prognostic implications of pluripotent stem cell gene expression in hepatocellular carcinoma. Oncol Lett. 2013;5:1155-1162. [PMID: 23599755 DOI: 10.3892/ol.2013.1151] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
305 Drak Alsibai K, Meseure D. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis. Dev Dyn. 2018;247:405-431. [PMID: 28691356 DOI: 10.1002/dvdy.24548] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
306 Gong Y, Himmerkus N, Plain A, Bleich M, Hou J. Epigenetic regulation of microRNAs controlling CLDN14 expression as a mechanism for renal calcium handling. J Am Soc Nephrol 2015;26:663-76. [PMID: 25071082 DOI: 10.1681/ASN.2014020129] [Cited by in Crossref: 36] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
307 Li G, Hu J, Hu G. Biomarker Studies in Early Detection and Prognosis of Breast Cancer. Adv Exp Med Biol 2017;1026:27-39. [PMID: 29282678 DOI: 10.1007/978-981-10-6020-5_2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
308 Li Z, Gao W, Fei Y, Gao P, Xie Q, Xie J, Xu Z. NLGN3 promotes neuroblastoma cell proliferation and growth through activating PI3K/AKT pathway. Eur J Pharmacol 2019;857:172423. [PMID: 31150649 DOI: 10.1016/j.ejphar.2019.172423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
309 Cottonham CL, Kaneko S, Xu L. miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem. 2010;285:35293-35302. [PMID: 20826792 DOI: 10.1074/jbc.m110.160069] [Cited by in Crossref: 186] [Cited by in F6Publishing: 119] [Article Influence: 15.5] [Reference Citation Analysis]
310 Valastyan S, Weinberg RA. Roles for microRNAs in the regulation of cell adhesion molecules. J Cell Sci 2011;124:999-1006. [PMID: 21402873 DOI: 10.1242/jcs.081513] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 7.1] [Reference Citation Analysis]
311 Minor J, Wang X, Zhang F, Song J, Jimeno A, Wang XJ, Lu X, Gross N, Kulesz-Martin M, Wang D. Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncol. 2012;48:73-78. [PMID: 22133638 DOI: 10.1016/j.oraloncology.2011.11.006] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
312 Jang MH, Kim HJ, Gwak JM, Chung YR, Park SY. Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer. Hum Pathol 2017;68:69-78. [PMID: 28882698 DOI: 10.1016/j.humpath.2017.08.026] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
313 Chen P, Guo X, Zhang L, Zhang W, Zhou Q, Tian Z, Zheng Y, Liao Q, Wang H, Li G, Huang J, Li X. MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN. Oncotarget 2017;8:5206-18. [PMID: 28029649 DOI: 10.18632/oncotarget.14123] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
314 Sekar TV, Mohanram RK, Foygel K, Paulmurugan R. Therapeutic evaluation of microRNAs by molecular imaging. Theranostics 2013;3:964-85. [PMID: 24396507 DOI: 10.7150/thno.4928] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
315 Yoon C, Kim J, Park G, Kim S, Kim D, Hur DY, Kim B, Kim YS. Delivery of miR-155 to retinal pigment epithelial cells mediated by Burkitt's lymphoma exosomes. Tumour Biol 2016;37:313-21. [PMID: 26211004 DOI: 10.1007/s13277-015-3769-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
316 Chi L, Zou Y, Qin L, Ma W, Hao Y, Tang Y, Luo R, Wu Z. TIMELESS contributes to the progression of breast cancer through activation of MYC. Breast Cancer Res 2017;19:53. [PMID: 28464854 DOI: 10.1186/s13058-017-0838-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
317 Park JH, Theodoratou E, Calin GA, Shin JI. From cell biology to immunology: Controlling metastatic progression of cancer via microRNA regulatory networks. Oncoimmunology 2016;5:e1230579. [PMID: 27999740 DOI: 10.1080/2162402X.2016.1230579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
318 Zhang J, Chintalgattu V, Shih T, Ai D, Xia Y, Khakoo AY. MicroRNA-9 is an activation-induced regulator of PDGFR-beta expression in cardiomyocytes. J Mol Cell Cardiol 2011;51:337-46. [PMID: 21684288 DOI: 10.1016/j.yjmcc.2011.05.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
319 Li J, Zucker S, Pulkoski-Gross A, Kuscu C, Karaayvaz M, Ju J, Yao H, Song E, Cao J. Conversion of stationary to invasive tumor initiating cells (TICs): role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) trafficking. PLoS One 2012;7:e38403. [PMID: 22679501 DOI: 10.1371/journal.pone.0038403] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
320 Lovat F, Valeri N, Croce CM. MicroRNAs in the pathogenesis of cancer. Semin Oncol. 2011;38:724-733. [PMID: 22082758 DOI: 10.1053/j.seminoncol.2011.08.006] [Cited by in Crossref: 144] [Cited by in F6Publishing: 145] [Article Influence: 13.1] [Reference Citation Analysis]
321 Takwi AA, Li Y, Becker Buscaglia LE, Zhang J, Choudhury S, Park AK, Liu M, Young KH, Park WY, Martin RC, Li Y. A statin-regulated microRNA represses human c-Myc expression and function. EMBO Mol Med 2012;4:896-909. [PMID: 22887866 DOI: 10.1002/emmm.201101045] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 6.8] [Reference Citation Analysis]
322 Zhang Y, Li L, Yu C, Senyuk V, Li F, Quigley JG, Zhu T, Qian Z. miR-9 upregulation leads to inhibition of erythropoiesis by repressing FoxO3. Sci Rep 2018;8:6519. [PMID: 29695725 DOI: 10.1038/s41598-018-24628-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
323 Epstein Y, Perry N, Volin M, Zohar-Fux M, Braun R, Porat-Kuperstein L, Toledano H. miR-9a modulates maintenance and ageing of Drosophila germline stem cells by limiting N-cadherin expression. Nat Commun 2017;8:600. [PMID: 28928361 DOI: 10.1038/s41467-017-00485-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
324 Ramírez-Moya J, Wert-Lamas L, Santisteban P. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN. Oncogene 2018;37:3369-83. [PMID: 29353884 DOI: 10.1038/s41388-017-0088-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 11.8] [Reference Citation Analysis]
325 Huang S, Chen L. MiR-888 regulates side population properties and cancer metastasis in breast cancer cells. Biochem Biophys Res Commun 2014;450:1234-40. [PMID: 24845571 DOI: 10.1016/j.bbrc.2014.05.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
326 Barbano R, Pasculli B, Rendina M, Fontana A, Fusilli C, Copetti M, Castellana S, Valori VM, Morritti M, Graziano P, Luigi C, Coco M, Picardo F, Mazza T, Evron E, Murgo R, Maiello E, Esteller M, Fazio VM, Parrella P. Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients. Sci Rep 2017;7:45283. [PMID: 28345661 DOI: 10.1038/srep45283] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
327 Sengupta P, Banerjee N, Roychowdhury T, Dutta A, Chattopadhyay S, Chatterjee S. Site-specific amino acid substitution in dodecameric peptides determines the stability and unfolding of c-MYC quadruplex promoting apoptosis in cancer cells. Nucleic Acids Res 2018;46:9932-50. [PMID: 30239898 DOI: 10.1093/nar/gky824] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
328 Gupta I, Sareyeldin RM, Al-Hashimi I, Al-Thawadi HA, Al Farsi H, Vranic S, Al Moustafa AE. Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity. Cancers (Basel) 2019;11:E363. [PMID: 30871273 DOI: 10.3390/cancers11030363] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
329 Zare M, Bastami M, Solali S, Alivand MR. Aberrant miRNA promoter methylation and EMT‐involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications. J Cell Physiol 2018;233:3729-44. [DOI: 10.1002/jcp.26116] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 9.6] [Reference Citation Analysis]
330 Kutanzi KR, Yurchenko OV, Beland FA, Checkhun VF, Pogribny IP. MicroRNA-mediated drug resistance in breast cancer. Clin Epigenetics 2011;2:171-85. [PMID: 21949547 DOI: 10.1007/s13148-011-0040-8] [Cited by in Crossref: 112] [Cited by in F6Publishing: 99] [Article Influence: 10.2] [Reference Citation Analysis]
331 Fenger JM, Bear MD, Volinia S, Lin TY, Harrington BK, London CA, Kisseberth WC. Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis. BMC Cancer. 2014;14:84. [PMID: 24517413 DOI: 10.1186/1471-2407-14-84] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
332 Chakraborty C, Sharma AR, Sharma G, Sarkar BK, Lee SS. The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer. Oncotarget 2018;9:10164-74. [PMID: 29515800 DOI: 10.18632/oncotarget.24309] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 11.8] [Reference Citation Analysis]
333 Miyo M, Yamamoto H, Konno M, Colvin H, Nishida N, Koseki J, Kawamoto K, Ogawa H, Hamabe A, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Doki Y, Mori M, Ishii H. Tumour-suppressive function of SIRT4 in human colorectal cancer. Br J Cancer 2015;113:492-9. [PMID: 26086877 DOI: 10.1038/bjc.2015.226] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 11.7] [Reference Citation Analysis]
334 Nguyen DX. Tracing the origins of metastasis. J Pathol 2011;223:195-204. [PMID: 21125675 DOI: 10.1002/path.2801] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
335 Wang CA, Drasin D, Pham C, Jedlicka P, Zaberezhnyy V, Guney M, Li H, Nemenoff R, Costello JC, Tan AC, Ford HL. Homeoprotein Six2 promotes breast cancer metastasis via transcriptional and epigenetic control of E-cadherin expression. Cancer Res 2014;74:7357-70. [PMID: 25348955 DOI: 10.1158/0008-5472.CAN-14-0666] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
336 Prabhu KS, Raza A, Karedath T, Raza SS, Fathima H, Ahmed EI, Kuttikrishnan S, Therachiyil L, Kulinski M, Dermime S, Junejo K, Steinhoff M, Uddin S. Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells. Cancers (Basel) 2020;12:E351. [PMID: 32033146 DOI: 10.3390/cancers12020351] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
337 Morales-prieto DM, Schleussner E, Markert UR. Reduction in miR-141 is Induced by Leukemia Inhibitory Factor and Inhibits Proliferation in Choriocarcinoma Cell Line JEG-3: LIF-REDUCED MIR-141 INHIBITS CELL PROLIFERATION. American Journal of Reproductive Immunology 2011;66:57-62. [DOI: 10.1111/j.1600-0897.2011.01037.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
338 Greene SB, Herschkowitz JI, Rosen JM. Small players with big roles: microRNAs as targets to inhibit breast cancer progression. Curr Drug Targets 2010;11:1059-73. [PMID: 20545613 DOI: 10.2174/138945010792006762] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
339 Shibuya N, Kakeji Y, Shimono Y. MicroRNA-93 targets WASF3 and functions as a metastasis suppressor in breast cancer. Cancer Sci 2020;111:2093-103. [PMID: 32307765 DOI: 10.1111/cas.14423] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
340 Guo F, Parker Kerrigan BC, Yang D, Hu L, Shmulevich I, Sood AK, Xue F, Zhang W. Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions. J Hematol Oncol. 2014;7:19. [PMID: 24598126 DOI: 10.1186/1756-8722-7-19] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 9.9] [Reference Citation Analysis]
341 Karolina D, Jeyaseelan K. micro RNAs as Therapeutic Agents and Targets. In: Cheng K, Mahato RI, editors. Advanced Delivery and Therapeutic Applications of RNAi. Chichester: John Wiley and Sons, Ltd; 2013. pp. 439-82. [DOI: 10.1002/9781118610749.ch19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
342 Verissimo CS, Molenaar JJ, Fitzsimons CP, Vreugdenhil E. Neuroblastoma therapy: what is in the pipeline? Endocr Relat Cancer 2011;18:R213-31. [PMID: 21971288 DOI: 10.1530/ERC-11-0251] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
343 Jiang Z, Liu W, Wang Y, Gao Z, Gao G, Wang X. Rational design of microRNA-siRNA chimeras for multifunctional target suppression. RNA 2013;19:1745-54. [PMID: 24145823 DOI: 10.1261/rna.039677.113] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
344 Eguchi T, Sogawa C, Okusha Y, Uchibe K, Iinuma R, Ono K, Nakano K, Murakami J, Itoh M, Arai K, Fujiwara T, Namba Y, Murata Y, Ohyama K, Shimomura M, Okamura H, Takigawa M, Nakatsura T, Kozaki KI, Okamoto K, Calderwood SK. Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment. PLoS One 2018;13:e0191109. [PMID: 29415026 DOI: 10.1371/journal.pone.0191109] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 15.5] [Reference Citation Analysis]
345 Delpu Y, Larrieu D, Gayral M, Arvanitis D, Dufresne M, Cordelier P, Torrisani J. Noncoding RNAs. Drug Discovery in Cancer Epigenetics. Elsevier; 2016. pp. 305-26. [DOI: 10.1016/b978-0-12-802208-5.00012-6] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
346 Gandellini P, Profumo V, Folini M, Zaffaroni N. MicroRNAs as new therapeutic targets and tools in cancer. Expert Opinion on Therapeutic Targets 2011;15:265-79. [DOI: 10.1517/14728222.2011.550878] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
347 Beierle EA. MYCN, neuroblastoma and focal adhesion kinase (FAK). Front Biosci (Elite Ed) 2011;3:421-33. [PMID: 21196322 DOI: 10.2741/e257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
348 Wang H, Zhang W, Zuo Y, Ding M, Ke C, Yan R, Zhan H, Liu J, Wang J. miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer. Tumour Biol 2015;36:9631-40. [PMID: 26150338 DOI: 10.1007/s13277-015-3713-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
349 Ning P, Wu Z, Hu A, Li X, He J, Gong X, Xia Y, Shang Y, Bian H. Integrated genomic analyses of lung squamous cell carcinoma for identification of a possible competitive endogenous RNA network by means of TCGA datasets. PeerJ 2018;6:e4254. [PMID: 29340250 DOI: 10.7717/peerj.4254] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
350 Hashemi A, Gorji-Bahri G. MicroRNA: Promising Roles in Cancer Therapy. Curr Pharm Biotechnol 2020;21:1186-203. [PMID: 32310047 DOI: 10.2174/1389201021666200420101613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
351 Zhang Q, Wang LQ, Wong KY, Li ZY, Chim CS. Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma. J Clin Pathol 2015;68:557-61. [PMID: 25855800 DOI: 10.1136/jclinpath-2014-202817] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
352 Xu XY, Zhou LL, Yu C, Shen B, Feng JF, Yu SR. Advances of circular RNAs in carcinoma. Biomed Pharmacother. 2018;107:59-71. [PMID: 30077838 DOI: 10.1016/j.biopha.2018.07.164] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
353 Jiang Z, Song Q, Zeng R, Li J, Lin X, Chen X, Zhang J, Zheng Y. MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer. Oncotarget. 2016;7:45622-45636. [PMID: 27285984 DOI: 10.18632/oncotarget.9850] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
354 Zhou Y, Hu Y, Yang M, Jat P, Li K, Lombardo Y, Xiong D, Coombes RC, Raguz S, Yagüe E. The miR-106b~25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300. Cell Death Differ 2014;21:462-74. [PMID: 24270410 DOI: 10.1038/cdd.2013.167] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 6.0] [Reference Citation Analysis]
355 Pappalardo-Carter DL, Balaraman S, Sathyan P, Carter ES, Chen WJ, Miranda RC. Suppression and epigenetic regulation of MiR-9 contributes to ethanol teratology: evidence from zebrafish and murine fetal neural stem cell models. Alcohol Clin Exp Res 2013;37:1657-67. [PMID: 23800254 DOI: 10.1111/acer.12139] [Cited by in Crossref: 15] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
356 Chen X, Fan S, Song E. Noncoding RNAs: New Players in Cancers. Adv Exp Med Biol 2016;927:1-47. [PMID: 27376730 DOI: 10.1007/978-981-10-1498-7_1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
357 Paladini L, Fabris L, Bottai G, Raschioni C, Calin GA, Santarpia L. Targeting microRNAs as key modulators of tumor immune response. J Exp Clin Cancer Res 2016;35:103. [PMID: 27349385 DOI: 10.1186/s13046-016-0375-2] [Cited by in Crossref: 99] [Cited by in F6Publishing: 99] [Article Influence: 16.5] [Reference Citation Analysis]
358 Kaur S, Lotsari-Salomaa JE, Seppänen-Kaijansinkko R, Peltomäki P. MicroRNA Methylation in Colorectal Cancer. Adv Exp Med Biol 2016;937:109-22. [PMID: 27573897 DOI: 10.1007/978-3-319-42059-2_6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
359 Ma L. Determinants of breast cancer progression. Sci Transl Med 2014;6:243fs25. [PMID: 24990878 DOI: 10.1126/scitranslmed.3009587] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
360 Bhalala OG, Pan L, Sahni V, McGuire TL, Gruner K, Tourtellotte WG, Kessler JA. microRNA-21 regulates astrocytic response following spinal cord injury. J Neurosci 2012;32:17935-47. [PMID: 23238710 DOI: 10.1523/JNEUROSCI.3860-12.2012] [Cited by in Crossref: 148] [Cited by in F6Publishing: 85] [Article Influence: 16.4] [Reference Citation Analysis]
361 Bell ES, Lammerding J. Causes and consequences of nuclear envelope alterations in tumour progression. Eur J Cell Biol 2016;95:449-64. [PMID: 27397692 DOI: 10.1016/j.ejcb.2016.06.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 8.3] [Reference Citation Analysis]
362 Piccolo S. LIF-ting Hippo averts metastasis. Nat Med 2012;18:1463-5. [PMID: 23042347 DOI: 10.1038/nm.2955] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
363 Singh AS, Heery R, Gray SG. In Silico and In Vitro Analyses of LncRNAs as Potential Regulators in the Transition from the Epithelioid to Sarcomatoid Histotype of Malignant Pleural Mesothelioma (MPM). Int J Mol Sci 2018;19:E1297. [PMID: 29701689 DOI: 10.3390/ijms19051297] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
364 Jin C, Yan B, Lu Q, Lin Y, Ma L. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development. Tumour Biol 2016;37:7383-94. [PMID: 26676637 DOI: 10.1007/s13277-015-4605-6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 76] [Article Influence: 9.4] [Reference Citation Analysis]
365 Anwar SL, Lehmann U. DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. World J Gastroenterol 2014; 20(24): 7894-7913 [PMID: 24976726 DOI: 10.3748/wjg.v20.i24.7894] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 50] [Article Influence: 6.5] [Reference Citation Analysis]
366 Dupasquier S, Delmarcelle AS, Marbaix E, Cosyns JP, Courtoy PJ, Pierreux CE. Validation of housekeeping gene and impact on normalized gene expression in clear cell renal cell carcinoma: critical reassessment of YBX3/ZONAB/CSDA expression. BMC Mol Biol 2014;15:9. [PMID: 24885929 DOI: 10.1186/1471-2199-15-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
367 Salm F, Dimitrova V, von Bueren AO, Ćwiek P, Rehrauer H, Djonov V, Anderle P, Arcaro A. The Phosphoinositide 3-Kinase p110α Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma. PLoS One 2015;10:e0123958. [PMID: 25915540 DOI: 10.1371/journal.pone.0123958] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
368 Amawi H, Ashby CR, Samuel T, Peraman R, Tiwari AK. Polyphenolic Nutrients in Cancer Chemoprevention and Metastasis: Role of the Epithelial-to-Mesenchymal (EMT) Pathway. Nutrients 2017;9:E911. [PMID: 28825675 DOI: 10.3390/nu9080911] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 8.4] [Reference Citation Analysis]
369 Xiong K, Shao LH, Zhang HQ, Jin L, Wei W, Dong Z, Zhu YQ, Wu N, Jin SZ, Xue LX. MicroRNA-9 functions as a tumor suppressor and enhances radio-sensitivity in radio-resistant A549 cells by targeting neuropilin 1. Oncol Lett 2018;15:2863-70. [PMID: 29435012 DOI: 10.3892/ol.2017.7705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
370 Romero-Cordoba SL, Salido-Guadarrama I, Rodriguez-Dorantes M, Hidalgo-Miranda A. miRNA biogenesis: biological impact in the development of cancer. Cancer Biol Ther 2014;15:1444-55. [PMID: 25482951 DOI: 10.4161/15384047.2014.955442] [Cited by in Crossref: 136] [Cited by in F6Publishing: 132] [Article Influence: 19.4] [Reference Citation Analysis]
371 Roberts TC, Wood MJ. Therapeutic targeting of non-coding RNAs. Essays Biochem 2013;54:127-45. [PMID: 23829532 DOI: 10.1042/bse0540127] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
372 Schraivogel D, Weinmann L, Beier D, Tabatabai G, Eichner A, Zhu JY, Anton M, Sixt M, Weller M, Beier CP, Meister G. CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells. EMBO J 2011;30:4309-22. [PMID: 21857646 DOI: 10.1038/emboj.2011.301] [Cited by in Crossref: 111] [Cited by in F6Publishing: 107] [Article Influence: 10.1] [Reference Citation Analysis]
373 Reda El Sayed S, Cristante J, Guyon L, Denis J, Chabre O, Cherradi N. MicroRNA Therapeutics in Cancer: Current Advances and Challenges. Cancers (Basel) 2021;13:2680. [PMID: 34072348 DOI: 10.3390/cancers13112680] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
374 Brozovic A. The relationship between platinum drug resistance and epithelial-mesenchymal transition. Arch Toxicol 2017;91:605-19. [PMID: 28032148 DOI: 10.1007/s00204-016-1912-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
375 Trigg RM, Shaw JA, Turner SD. Opportunities and challenges of circulating biomarkers in neuroblastoma. Open Biol 2019;9:190056. [PMID: 31088252 DOI: 10.1098/rsob.190056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
376 Wa Q, Li L, Lin H, Peng X, Ren D, Huang Y, He P, Huang S. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer. Oncol Rep 2018;39:81-90. [PMID: 29138858 DOI: 10.3892/or.2017.6096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
377 Sun H, Shao Y, Huang J, Sun S, Liu Y, Zhou P, Yang H. Prognostic value of microRNA-9 in cancers: a systematic review and meta-analysis. Oncotarget 2016;7:67020-32. [PMID: 27563807 DOI: 10.18632/oncotarget.11466] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
378 Cai J, Xia L, Li J, Ni S, Song H, Wu X. Tumor-Associated Macrophages Derived TGF-β‒Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3-4/Snail Signaling Pathway. Cancer Res Treat 2019;51:252-66. [PMID: 29690747 DOI: 10.4143/crt.2017.613] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
379 Bueno MJ, Malumbres M. MicroRNAs and the cell cycle. Biochim Biophys Acta. 2011;1812:592-601. [PMID: 21315819 DOI: 10.1016/j.bbadis.2011.02.002] [Cited by in Crossref: 244] [Cited by in F6Publishing: 236] [Article Influence: 22.2] [Reference Citation Analysis]
380 Farzanehpour M, Mozhgani SH, Jalilvand S, Faghihloo E, Akhavan S, Salimi V, Azad TM. Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer. Virol J. 2019;16:116. [PMID: 31590680 DOI: 10.1186/s12985-019-1220-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
381 Fu SW, Chen L, Man YG. miRNA Biomarkers in Breast Cancer Detection and Management. J Cancer 2011;2:116-22. [PMID: 21479130 DOI: 10.7150/jca.2.116] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 6.2] [Reference Citation Analysis]
382 D'Ippolito E, Iorio MV. MicroRNAs and triple negative breast cancer. Int J Mol Sci 2013;14:22202-20. [PMID: 24284394 DOI: 10.3390/ijms141122202] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
383 Sengupta D, Deb M, Kar S, Pradhan N, Parbin S, Kirtana R, Singh SP, Suma SG, Niharika, Roy A, Manna S, Saha P, Chakraborty P, Dash S, Kausar C, Patra SK. Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention. Semin Cancer Biol 2021;72:46-64. [PMID: 32497683 DOI: 10.1016/j.semcancer.2020.05.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
384 Pacheco-Pinedo EC, Durham AC, Stewart KM, Goss AM, Lu MM, Demayo FJ, Morrisey EE. Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium. J Clin Invest 2011;121:1935-45. [PMID: 21490395 DOI: 10.1172/JCI44871] [Cited by in Crossref: 100] [Cited by in F6Publishing: 85] [Article Influence: 9.1] [Reference Citation Analysis]
385 Tanca A, Pagnozzi D, Burrai GP, Polinas M, Uzzau S, Antuofermo E, Addis MF. Comparability of differential proteomics data generated from paired archival fresh-frozen and formalin-fixed samples by GeLC-MS/MS and spectral counting. J Proteomics 2012;77:561-76. [PMID: 23043969 DOI: 10.1016/j.jprot.2012.09.033] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
386 Singh R, Mo YY. Role of microRNAs in breast cancer. Cancer Biol Ther. 2013;14:201-212. [PMID: 23291983 DOI: 10.4161/cbt.23296] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 8.1] [Reference Citation Analysis]
387 Nowek K, Sun SM, Bullinger L, Bindels EM, Exalto C, Dijkstra MK, van Lom K, Döhner H, Erkeland SJ, Löwenberg B, Jongen-Lavrencic M. Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG. Leukemia 2016;30:229-37. [PMID: 26174629 DOI: 10.1038/leu.2015.183] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
388 Cătană CS, Calin GA, Berindan-Neagoe I. Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players? Front Med (Lausanne) 2015;2:85. [PMID: 26697428 DOI: 10.3389/fmed.2015.00085] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
389 Díaz-López A, Moreno-Bueno G, Cano A. Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Cancer Manag Res 2014;6:205-16. [PMID: 24812525 DOI: 10.2147/CMAR.S38156] [Cited by in Crossref: 29] [Cited by in F6Publishing: 75] [Article Influence: 3.6] [Reference Citation Analysis]
390 Hu D, Wang Y, Zhang H, Kong D. Identification of miR-9 as a negative factor of insulin secretion from beta cells. J Physiol Biochem 2018;74:291-9. [PMID: 29470815 DOI: 10.1007/s13105-018-0615-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
391 Sugita F, Maki K, Nakamura Y, Sasaki K, Mitani K. Overexpression of MIR9 indicates poor prognosis in acute lymphoblastic leukemia. Leuk Lymphoma 2014;55:78-86. [PMID: 23547834 DOI: 10.3109/10428194.2013.790023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
392 Zhou L, Liu F, Wang X, Ouyang G. The roles of microRNAs in the regulation of tumor metastasis. Cell Biosci 2015;5:32. [PMID: 26146543 DOI: 10.1186/s13578-015-0028-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
393 Gomez GG, Wykosky J, Zanca C, Furnari FB, Cavenee WK. Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks. Cancer Biol Med 2013;10:192-205. [PMID: 24349829 DOI: 10.7497/j.issn.2095-3941.2013.04.003] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
394 Ehtesham N, Sharifi M. From conventional therapy toward microRNA-based therapy in acute promyelocytic leukemia. Adv Biomed Res 2016;5:187. [PMID: 28028527 DOI: 10.4103/2277-9175.190996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
395 Engedal N, Žerovnik E, Rudov A, Galli F, Olivieri F, Procopio AD, Rippo MR, Monsurrò V, Betti M, Albertini MC. From Oxidative Stress Damage to Pathways, Networks, and Autophagy via MicroRNAs. Oxid Med Cell Longev 2018;2018:4968321. [PMID: 29849898 DOI: 10.1155/2018/4968321] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
396 Tan G, Tang X, Tang F. The role of microRNAs in nasopharyngeal carcinoma. Tumour Biol 2015;36:69-79. [PMID: 25427638 DOI: 10.1007/s13277-014-2847-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
397 Shah NR, Chen H. MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment. World J Clin Oncol 2014; 5(2): 48-60 [PMID: 24829851 DOI: 10.5306/wjco.v5.i2.48] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
398 Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, Oeh J, Modrusan Z, Bais C, Sampath D, Ferrara N. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J 2012;31:3513-23. [PMID: 22773185 DOI: 10.1038/emboj.2012.183] [Cited by in Crossref: 313] [Cited by in F6Publishing: 301] [Article Influence: 31.3] [Reference Citation Analysis]
399 Li Y, Zhu Y, Prochownik EV. MicroRNA-based screens for synthetic lethal interactions with c-Myc. RNA Dis 2016;3:e1330. [PMID: 27975083 DOI: 10.14800/rd.1330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
400 Venneti S, Boateng LA, Friedman JR, Baldwin DA, Tobias JW, Judkins AR, Mourelatos Z, Lal P. MiRNA-9 and MiRNA-200a distinguish hemangioblastomas from metastatic clear cell renal cell carcinomas in the CNS. Brain Pathol 2012;22:522-9. [PMID: 22082152 DOI: 10.1111/j.1750-3639.2011.00551.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
401 Sánchez-Tilló E, Liu Y, de Barrios O, Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A, Postigo A. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci. 2012;69:3429-3456. [PMID: 22945800 DOI: 10.1007/s00018-012-1122-2] [Cited by in Crossref: 322] [Cited by in F6Publishing: 313] [Article Influence: 32.2] [Reference Citation Analysis]
402 Orangi E, Motovali-Bashi M. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women. Gene 2019;687:272-9. [PMID: 30468908 DOI: 10.1016/j.gene.2018.11.036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
403 Han L, Wang W, Ding W, Zhang L. MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7. J Cell Mol Med 2017;21:2000-8. [PMID: 28266181 DOI: 10.1111/jcmm.13120] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
404 De Leeneer K, Claes K. Non Coding RNA Molecules as Potential Biomarkers in Breast Cancer. Adv Exp Med Biol 2015;867:263-75. [PMID: 26530371 DOI: 10.1007/978-94-017-7215-0_16] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
405 Safarzadeh E, Asadzadeh Z, Safaei S, Hatefi A, Derakhshani A, Giovannelli F, Brunetti O, Silvestris N, Baradaran B. MicroRNAs and lncRNAs-A New Layer of Myeloid-Derived Suppressor Cells Regulation. Front Immunol 2020;11:572323. [PMID: 33133086 DOI: 10.3389/fimmu.2020.572323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
406 Nickel A, Stadler SC. Role of epigenetic mechanisms in epithelial-to-mesenchymal transition of breast cancer cells. Transl Res. 2014;Apr 12; Epub ahead of print. [PMID: 24768944 DOI: 10.1016/j.trsl.2014.04.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
407 Daks A, Petukhov A, Fedorova O, Shuvalov O, Merkulov V, Vasileva E, Antonov A, Barlev NA. E3 ubiquitin ligase Pirh2 enhances tumorigenic properties of human non-small cell lung carcinoma cells. Genes Cancer 2016;7:383-93. [PMID: 28191284 DOI: 10.18632/genesandcancer.123] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
408 Shen Y, Zhou J, Li Y, Ye F, Wan X, Lu W, Xie X, Cheng X. miR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT. PLoS One 2014;9:e109299. [PMID: 25330011 DOI: 10.1371/journal.pone.0109299] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
409 Shi JW, Liu W, Zhang TT, Wang SC, Lin XL, Li J, Jia JS, Sheng HF, Yao ZF, Zhao WT, Zhao ZL, Xie RY, Yang S, Gao F, Fan QR, Zhang MY, Yue M, Yuan J, Gu WW, Yao KT, Xiao D. The enforced expression of c-Myc in pig fibroblasts triggers mesenchymal-epithelial transition (MET) via F-actin reorganization and RhoA/Rock pathway inactivation. Cell Cycle 2013;12:1119-27. [PMID: 23466707 DOI: 10.4161/cc.24164] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
410 Sun Z, Han Q, Zhou N, Wang S, Lu S, Bai C, Zhao RC. MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma. Mol Oncol. 2013;7:884-894. [PMID: 23684102 DOI: 10.1016/j.molonc.2013.04.007] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 6.8] [Reference Citation Analysis]
411 Takahashi RU, Takeshita F, Fujiwara T, Ono M, Ochiya T. Cancer stem cells in breast cancer. Cancers (Basel) 2011;3:1311-28. [PMID: 24212663 DOI: 10.3390/cancers3011311] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
412 Palmini G, Brandi ML. microRNAs and bone tumours: Role of tiny molecules in the development and progression of chondrosarcoma, of giant cell tumour of bone and of Ewing's sarcoma. Bone 2021;149:115968. [PMID: 33892177 DOI: 10.1016/j.bone.2021.115968] [Reference Citation Analysis]
413 Yang Y, Li M, Sun X, Zhou C, Wang Y, Wang L, Chen L, Liang Z, Zhu L, Yang H. The selective cytotoxicity of DSF-Cu attributes to the biomechanical properties and cytoskeleton rearrangements in the normal and cancerous nasopharyngeal epithelial cells. Int J Biochem Cell Biol 2017;84:96-108. [PMID: 28111334 DOI: 10.1016/j.biocel.2017.01.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
414 Bohl CR, Harihar S, Denning WL, Sharma R, Welch DR. Metastasis suppressors in breast cancers: mechanistic insights and clinical potential. J Mol Med (Berl) 2014;92:13-30. [PMID: 24311119 DOI: 10.1007/s00109-013-1109-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
415 Masood Y, Kqueen CY, Rajadurai P. Role of miRNA in head and neck squamous cell carcinoma. Expert Review of Anticancer Therapy 2014;15:183-97. [DOI: 10.1586/14737140.2015.978294] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
416 Otake S, Itoh Y, Omata C, Saitoh M, Miyazawa K. ZEB1 and oncogenic Ras constitute a regulatory switch for stimulus-dependent E-cadherin downregulation. Cancer Sci 2021;112:205-16. [PMID: 33068045 DOI: 10.1111/cas.14701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
417 Ediriweera MK, Cho SK. Targeting miRNAs by histone deacetylase inhibitors (HDACi): Rationalizing epigenetics-based therapies for breast cancer. Pharmacol Ther 2020;206:107437. [PMID: 31715287 DOI: 10.1016/j.pharmthera.2019.107437] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
418 Psathas JN, Thomas-Tikhonenko A. MYC and the art of microRNA maintenance. Cold Spring Harb Perspect Med 2014;4:a014175. [PMID: 24737842 DOI: 10.1101/cshperspect.a014175] [Cited by in Crossref: 32] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
419 Wang X, Cai J, Zhao L, Zhang D, Xu G, Hu J, Zhang T, Jin M. NUMB suppression by miR-9-5P enhances CD44+ prostate cancer stem cell growth and metastasis. Sci Rep 2021;11:11210. [PMID: 34045601 DOI: 10.1038/s41598-021-90700-x] [Reference Citation Analysis]
420 Sekhon K, Bucay N, Majid S, Dahiya R, Saini S. MicroRNAs and epithelial-mesenchymal transition in prostate cancer. Oncotarget 2016;7:67597-611. [PMID: 27588490 DOI: 10.18632/oncotarget.11708] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
421 Xu QL, Luo Z, Zhang B, Qin GJ, Zhang RY, Kong XY, Tang HY, Jiang W. Methylation-associated silencing of miR-9-1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2. Cancer Sci 2021. [PMID: 34382305 DOI: 10.1111/cas.15103] [Reference Citation Analysis]
422 Zhao M, Ang L, Huang J, Wang J. MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis. Tumour Biol 2017;39:1010428317691682. [PMID: 28222665 DOI: 10.1177/1010428317691682] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
423 Blom JN, Feng Q. Cardiac repair by epicardial EMT: Current targets and a potential role for the primary cilium. Pharmacol Ther 2018;186:114-29. [PMID: 29352858 DOI: 10.1016/j.pharmthera.2018.01.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
424 Dubois-marshall S, Thomas JS, Faratian D, Harrison DJ, Katz E. Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer. Clin Exp Metastasis 2011;28:811-8. [DOI: 10.1007/s10585-011-9412-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
425 Onnis A, De Falco G, Antonicelli G, Onorati M, Bellan C, Sherman O, Sayed S, Leoncini L. Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma. PLoS One 2010;5:e12960. [PMID: 20930934 DOI: 10.1371/journal.pone.0012960] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
426 Liu H, Radisky DC, Yang D, Xu R, Radisky ES, Bissell MJ, Bishop JM. MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits. Nat Cell Biol 2012;14:567-74. [PMID: 22581054 DOI: 10.1038/ncb2491] [Cited by in Crossref: 130] [Cited by in F6Publishing: 132] [Article Influence: 13.0] [Reference Citation Analysis]
427 Falcone G, Felsani A, D'Agnano I. Signaling by exosomal microRNAs in cancer. J Exp Clin Cancer Res 2015;34:32. [PMID: 25886763 DOI: 10.1186/s13046-015-0148-3] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 13.7] [Reference Citation Analysis]
428 Choi YJ, Jang H. Gastric Cancer: Epithelial Mesenchymal Transition. In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016. pp. 275-91. [DOI: 10.1007/978-981-287-706-2_25] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
429 Box C, Rogers SJ, Mendiola M, Eccles SA. Tumour-microenvironmental interactions: paths to progression and targets for treatment. Seminars in Cancer Biology 2010;20:128-38. [DOI: 10.1016/j.semcancer.2010.06.004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 4.8] [Reference Citation Analysis]
430 Fenger JM, Roberts RD, Iwenofu OH, Bear MD, Zhang X, Couto JI, Modiano JF, Kisseberth WC, London CA. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines. BMC Cancer 2016;16:784. [PMID: 27724924 DOI: 10.1186/s12885-016-2837-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
431 Xin C, Buhe B, Hongting L, Chuanmin Y, Xiwei H, Hong Z, Lulu H, Qian D, Renjie W. MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression. FEBS J 2013;280:855-66. [PMID: 23176145 DOI: 10.1111/febs.12074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 24] [Article Influence: 0.8] [Reference Citation Analysis]
432 Cheung TH, Man KN, Yu MY, Yim SF, Siu NS, Lo KW, Doran G, Wong RR, Wang VW, Smith DI, Worley MJ Jr, Berkowitz RS, Chung TK, Wong YF. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 2012;11:2876-84. [PMID: 22801550 DOI: 10.4161/cc.21278] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 7.5] [Reference Citation Analysis]
433 Li X, Pan Q, Wan X, Mao Y, Lu W, Xie X, Cheng X. Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma. BMC Cancer 2015;15:509. [PMID: 26152689 DOI: 10.1186/s12885-015-1509-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
434 Hou J, Zhao D. MicroRNA regulation in renal pathophysiology. Int J Mol Sci 2013;14:13078-92. [PMID: 23799361 DOI: 10.3390/ijms140713078] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
435 Zhang Y, Wang Z, Gemeinhart RA. Progress in microRNA delivery. J Control Release. 2013;172:962-974. [PMID: 24075926 DOI: 10.1016/j.jconrel.2013.09.015] [Cited by in Crossref: 333] [Cited by in F6Publishing: 319] [Article Influence: 37.0] [Reference Citation Analysis]
436 Ceteci F, Ceteci S, Zanucco E, Thakur C, Becker M, El-Nikhely N, Fink L, Seeger W, Savai R, Rapp UR. E-cadherin controls bronchiolar progenitor cells and onset of preneoplastic lesions in mice. Neoplasia 2012;14:1164-77. [PMID: 23308049 DOI: 10.1593/neo.121088] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
437 Marcucci F, Stassi G, De Maria R. Epithelial-mesenchymal transition: a new target in anticancer drug discovery. Nat Rev Drug Discov. 2016;15:311-325. [PMID: 26822829 DOI: 10.1038/nrd.2015.13] [Cited by in Crossref: 182] [Cited by in F6Publishing: 184] [Article Influence: 30.3] [Reference Citation Analysis]
438 Hojo N, Huisken AL, Wang H, Chirshev E, Kim NS, Nguyen SM, Campos H, Glackin CA, Ioffe YJ, Unternaehrer JJ. Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer. Sci Rep 2018;8:8704. [PMID: 29880891 DOI: 10.1038/s41598-018-27021-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
439 Chou SD, Murshid A, Eguchi T, Gong J, Calderwood SK. HSF1 regulation of β-catenin in mammary cancer cells through control of HuR/elavL1 expression. Oncogene 2015;34:2178-88. [PMID: 24954509 DOI: 10.1038/onc.2014.177] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 6.8] [Reference Citation Analysis]
440 Zhou X, Bao W, Zhang D, Yang Y, Du X, Qiu G. NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC. Cancer Biol Ther 2021;22:196-203. [PMID: 33629937 DOI: 10.1080/15384047.2020.1842717] [Reference Citation Analysis]
441 Wang QY, Zhou CX, Zhan MN, Tang J, Wang CL, Ma CN, He M, Chen GQ, He JR, Zhao Q. MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer. Cell Death Dis 2018;9:752. [PMID: 29970901 DOI: 10.1038/s41419-018-0715-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
442 Gill KZ, Iwamoto F, Allen A, Hoehn D, Murty VV, Alobeid B, Bhagat G. MYC protein expression in primary diffuse large B-cell lymphoma of the central nervous system. PLoS One 2014;9:e114398. [PMID: 25479599 DOI: 10.1371/journal.pone.0114398] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
443 Monroig PD, Calin GA. MicroRNA and Epigenetics: Diagnostic and Therapeutic Opportunities. Curr Pathobiol Rep 2013;1:43-52. [PMID: 23515489 DOI: 10.1007/s40139-013-0008-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
444 Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, Jacks T, Anderson DG. Treating metastatic cancer with nanotechnology. Nat Rev Cancer. 2012;12:39-50. [PMID: 22193407 DOI: 10.1038/nrc3180] [Cited by in Crossref: 747] [Cited by in F6Publishing: 693] [Article Influence: 67.9] [Reference Citation Analysis]
445 Tsai LH, Wu JY, Cheng YW, Chen CY, Sheu GT, Wu TC, Lee H. The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss. Oncogene 2015;34:1641-9. [PMID: 24793789 DOI: 10.1038/onc.2014.118] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
446 Shan F, Li J, Huang QY. HIF-1 alpha-induced up-regulation of miR-9 contributes to phenotypic modulation in pulmonary artery smooth muscle cells during hypoxia. J Cell Physiol 2014;229:1511-20. [PMID: 24615545 DOI: 10.1002/jcp.24593] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
447 Wang M, Xia F, Wei Y, Wei X. Molecular mechanisms and clinical management of cancer bone metastasis. Bone Res 2020;8:30. [PMID: 34321455 DOI: 10.1038/s41413-020-00105-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
448 Zhang J, Ma L. MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev 2012;31:653-62. [PMID: 22684369 DOI: 10.1007/s10555-012-9368-6] [Cited by in Crossref: 166] [Cited by in F6Publishing: 164] [Article Influence: 18.4] [Reference Citation Analysis]
449 Parasramka MA, Ho E, Williams DE, Dashwood RH. MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals. Mol Carcinog 2012;51:213-30. [PMID: 21739482 DOI: 10.1002/mc.20822] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 7.1] [Reference Citation Analysis]
450 Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52:710-718. [PMID: 26358722 DOI: 10.1136/jmedgenet-2015-103334] [Cited by in Crossref: 411] [Cited by in F6Publishing: 455] [Article Influence: 58.7] [Reference Citation Analysis]
451 Bhat NS, Colden M, Dar AA, Saini S, Arora P, Shahryari V, Yamamura S, Tanaka Y, Kato T, Majid S, Dahiya R. MicroRNA-720 Regulates E-cadherin-αE-catenin Complex and Promotes Renal Cell Carcinoma. Mol Cancer Ther 2017;16:2840-8. [PMID: 28802251 DOI: 10.1158/1535-7163.MCT-17-0400] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
452 Hu H, Zhang Y, Cai XH, Huang JF, Cai L. Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts. Oncol Lett 2012;4:1037-42. [PMID: 23162647 DOI: 10.3892/ol.2012.866] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
453 Weidle UH, Dickopf S, Hintermair C, Kollmorgen G, Birzele F, Brinkmann U. The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets. Cancer Genomics Proteomics 2018;15:17-39. [PMID: 29275360 DOI: 10.21873/cgp.20062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
454 Bigagli E, Luceri C, Guasti D, Cinci L. Exosomes secreted from human colon cancer cells influence the adhesion of neighboring metastatic cells: Role of microRNA-210. Cancer Biol Ther. 2016;17:1062-1069. [PMID: 27611932 DOI: 10.1080/15384047.2016.1219815] [Cited by in Crossref: 47] [Cited by in F6Publishing: 60] [Article Influence: 7.8] [Reference Citation Analysis]
455 Bersaas A, Arnoldussen YJ, Sjøberg M, Haugen A, Mollerup S. Epithelial-mesenchymal transition and FOXA genes during tobacco smoke carcinogen induced transformation of human bronchial epithelial cells. Toxicol In Vitro 2016;35:55-65. [PMID: 27221058 DOI: 10.1016/j.tiv.2016.04.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
456 Chong ZX, Yeap SK, Ho WY. Angiogenesis regulation by microRNAs and long non-coding RNAs in human breast cancer. Pathol Res Pract 2021;219:153326. [PMID: 33601152 DOI: 10.1016/j.prp.2020.153326] [Reference Citation Analysis]
457 Piao HL, Ma L. Non-coding RNAs as regulators of mammary development and breast cancer. J Mammary Gland Biol Neoplasia. 2012;17:33-42. [PMID: 22350981 DOI: 10.1007/s10911-012-9245-5] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
458 Maheshwari S, Singh AK, Arya RK, Pandey D, Singh A, Datta D. Exosomes: Emerging Players of Intercellular Communication in Tumor Microenvironment. Discoveries (Craiova) 2014;2:e26. [PMID: 32309554 DOI: 10.15190/d.2014.18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
459 Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM, Zhang GZ. Biological functions of microRNAs: a review. J Physiol Biochem. 2011;67:129-139. [PMID: 20981514 DOI: 10.1007/s13105-010-0050-6] [Cited by in Crossref: 392] [Cited by in F6Publishing: 385] [Article Influence: 32.7] [Reference Citation Analysis]
460 Khordadmehr M, Shahbazi R, Ezzati H, Jigari-Asl F, Sadreddini S, Baradaran B. Key microRNAs in the biology of breast cancer; emerging evidence in the last decade. J Cell Physiol 2019;234:8316-26. [PMID: 30422324 DOI: 10.1002/jcp.27716] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
461 Liang Z, Bian X, Shim H. Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression. Breast Cancer Res Treat 2014;146:535-42. [PMID: 25030358 DOI: 10.1007/s10549-014-3053-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
462 Tan S, Kirchner R, Jin J, Hofmann O, Mcreynolds L, Hide W, Lieberman J. Sequencing of Captive Target Transcripts Identifies the Network of Regulated Genes and Functions of Primate-Specific miR-522. Cell Reports 2014;8:1225-39. [DOI: 10.1016/j.celrep.2014.07.023] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
463 Gong Y, Hou J. Claudin-14 underlies Ca⁺⁺-sensing receptor-mediated Ca⁺⁺ metabolism via NFAT-microRNA-based mechanisms. J Am Soc Nephrol 2014;25:745-60. [PMID: 24335970 DOI: 10.1681/ASN.2013050553] [Cited by in Crossref: 58] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
464 Bofill-De Ros X, Kasprzak WK, Bhandari Y, Fan L, Cavanaugh Q, Jiang M, Dai L, Yang A, Shao TJ, Shapiro BA, Wang YX, Gu S. Structural Differences between Pri-miRNA Paralogs Promote Alternative Drosha Cleavage and Expand Target Repertoires. Cell Rep 2019;26:447-459.e4. [PMID: 30625327 DOI: 10.1016/j.celrep.2018.12.054] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
465 Baier SR, Wan Y. MicroRNA Exert Macro Effects on Cancer Bone Metastasis. Curr Osteoporos Rep 2016;14:163-9. [DOI: 10.1007/s11914-016-0316-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
466 Almeida MI, Reis RM, Calin GA. MYC-microRNA-9-metastasis connection in breast cancer. Cell Res 2010;20:603-4. [DOI: 10.1038/cr.2010.70] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
467 Huo L, Wang Y, Gong Y, Krishnamurthy S, Wang J, Diao L, Liu CG, Liu X, Lin F, Symmans WF, Wei W, Zhang X, Sun L, Alvarez RH, Ueno NT, Fouad TM, Harano K, Debeb BG, Wu Y, Reuben J, Cristofanilli M, Zuo Z. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Mod Pathol 2016;29:330-46. [PMID: 26916073 DOI: 10.1038/modpathol.2016.38] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
468 Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y, Baba H. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol. 2012;19 Suppl 3:S656-S664. [PMID: 22311119 DOI: 10.1245/s10434-012-2217-6] [Cited by in Crossref: 115] [Cited by in F6Publishing: 118] [Article Influence: 11.5] [Reference Citation Analysis]
469 Majid S, Dar AA, Saini S, Shahryari V, Arora S, Zaman MS, Chang I, Yamamura S, Tanaka Y, Chiyomaru T, Deng G, Dahiya R. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Clin Cancer Res 2013;19:73-84. [PMID: 23147995 DOI: 10.1158/1078-0432.CCR-12-2952] [Cited by in Crossref: 80] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
470 Arora A, Singh S, Bhatt AN, Pandey S, Sandhir R, Dwarakanath BS. Interplay Between Metabolism and Oncogenic Process: Role of microRNAs. Transl Oncogenomics 2015;7:11-27. [PMID: 26740741 DOI: 10.4137/TOG.S29652] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
471 Xue H, Guo X, Han X, Yan S, Zhang J, Xu S, Li T, Guo X, Zhang P, Gao X, Liu Q, Li G. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1. Oncotarget 2016;7:4785-805. [PMID: 26715733 DOI: 10.18632/oncotarget.6735] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
472 Tsai KW, Liao YL, Wu CW, Hu LY, Li SC, Chan WC, Ho MR, Lai CH, Kao HW, Fang WL, Huang KH, Lin WC. Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics 2011;6:1189-97. [PMID: 21931274 DOI: 10.4161/epi.6.10.16535] [Cited by in Crossref: 81] [Cited by in F6Publishing: 82] [Article Influence: 7.4] [Reference Citation Analysis]
473 Sahabi K, Selvarajah GT, Abdullah R, Cheah YK, Tan GC. Comparative aspects of microRNA expression in canine and human cancers. J Vet Sci 2018;19:162-71. [PMID: 28927253 DOI: 10.4142/jvs.2018.19.2.162] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
474 Lima JF, Carvalho J, Pinto-Ribeiro I, Almeida C, Wengel J, Cerqueira L, Figueiredo C, Oliveira C, Azevedo NF. Targeting miR-9 in gastric cancer cells using locked nucleic acid oligonucleotides. BMC Mol Biol 2018;19:6. [PMID: 29879907 DOI: 10.1186/s12867-018-0107-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
475 Gao H, Lan X, Li S, Xue Y. Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer. Tumour Biol 2017;39:101042831769836. [DOI: 10.1177/1010428317698368] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
476 Lu JJ, Yang WM, Li F, Zhu W, Chen Z. Tunneling Nanotubes Mediated microRNA-155 Intercellular Transportation Promotes Bladder Cancer Cells' Invasive and Proliferative Capacity. Int J Nanomedicine 2019;14:9731-43. [PMID: 31849465 DOI: 10.2147/IJN.S217277] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
477 Wang SC, Zhang ZS, Xia XZ, Lan HT, Liu Q, Wu SW, Xue CN. Expression of Galectin-3 and E-cadherin in gastric adenocarcinoma tissue: Relationship with angiogenesis. Shijie Huaren Xiaohua Zazhi 2015; 23(21): 3361-3365 [DOI: 10.11569/wcjd.v23.i21.3361] [Reference Citation Analysis]
478 Batool A, Wang YQ, Hao XX, Chen SR, Liu YX. A miR-125b/CSF1-CX3CL1/tumor-associated macrophage recruitment axis controls testicular germ cell tumor growth. Cell Death Dis 2018;9:962. [PMID: 30237497 DOI: 10.1038/s41419-018-1021-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
479 Stachowicz-Stencel T, Synakiewicz A. Biomarkers for pediatric cancer detection: latest advances and future perspectives. Biomark Med 2020;14:391-400. [PMID: 32270691 DOI: 10.2217/bmm-2019-0613] [Reference Citation Analysis]
480 Cekaite L, Rantala JK, Bruun J, Guriby M, Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe RA, Skotheim RI. MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia. 2012;14:868-879. [PMID: 23019418 DOI: 10.1593/neo.121094] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 11.2] [Reference Citation Analysis]
481 Peng JC, Shen J, Ran ZH. Transcribed ultraconserved region in human cancers. RNA Biol. 2013;10:1771-1777. [PMID: 24384562 DOI: 10.4161/rna.26995] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
482 Yi B, Chang H, Ma R, Feng X, Li W, Piazza GA, Xi Y. Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling. Oncotarget 2016;7:7979-92. [PMID: 26769851 DOI: 10.18632/oncotarget.6888] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
483 Lopez-Bertoni H, Li Y, Laterra J. Cancer Stem Cells: Dynamic Entities in an Ever-Evolving Paradigm. Biol Med (Aligarh) 2015;7:001. [PMID: 27158195 DOI: 10.4172/0974-8369.1000S2-001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
484 Gomarasca M, Maroni P, Banfi G, Lombardi G. microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics. Int J Mol Sci 2020;21:E2805. [PMID: 32316552 DOI: 10.3390/ijms21082805] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
485 Tavakolian S, Goudarzi H, Torfi F, Faghihloo E. Evaluation of microRNA-9 and -192 expression levels as biomarkers in patients suffering from breast cancer. Biomed Rep 2020;12:30-4. [PMID: 31839947 DOI: 10.3892/br.2019.1257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
486 Zhai H, Ju J. Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics. Front Genet 2011;2:00078. [PMID: 22114584 DOI: 10.3389/fgene.2011.00078] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
487 Gholami M, Larijani B, Zahedi Z, Mahmoudian F, Bahrami S, Omran SP, Saadatian Z, Hasani-Ranjbar S, Taslimi R, Bastami M, Amoli MM. Inflammation related miRNAs as an important player between obesity and cancers. J Diabetes Metab Disord 2019;18:675-92. [PMID: 31890692 DOI: 10.1007/s40200-019-00459-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
488 Ren D, Yang Q, Dai Y, Guo W, Du H, Song L, Peng X. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway. Mol Cancer 2017;16:117. [PMID: 28693582 DOI: 10.1186/s12943-017-0688-6] [Cited by in Crossref: 95] [Cited by in F6Publishing: 104] [Article Influence: 19.0] [Reference Citation Analysis]
489 Majid S, Dahiya R. MicroRNA Based Therapeutic Strategies for Cancer: Emphasis on Advances in Renal Cell Carcinoma. In: Sarkar FH, editor. MicroRNA Targeted Cancer Therapy. Cham: Springer International Publishing; 2014. pp. 175-88. [DOI: 10.1007/978-3-319-05134-5_10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
490 Kolarz B, Majdan M. Epigenetic aspects of rheumatoid arthritis: contribution of non-coding RNAs. Seminars in Arthritis and Rheumatism 2017;46:724-31. [DOI: 10.1016/j.semarthrit.2017.01.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
491 Yao H, Ma R, Yang L, Hu G, Chen X, Duan M, Kook Y, Niu F, Liao K, Fu M, Hu G, Kolattukudy P, Buch S. MiR-9 promotes microglial activation by targeting MCPIP1. Nat Commun 2014;5:4386. [PMID: 25019481 DOI: 10.1038/ncomms5386] [Cited by in Crossref: 86] [Cited by in F6Publishing: 94] [Article Influence: 10.8] [Reference Citation Analysis]
492 Gao Y, Zeng F, Wu JY, Li HY, Fan JJ, Mai L, Zhang J, Ma DM, Li Y, Song FZ. MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met. Tumour Biol 2015;36:2875-83. [PMID: 25492484 DOI: 10.1007/s13277-014-2917-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
493 Souri Z, Wierenga APA, Kiliç E, Brosens E, Böhringer S, Kroes WGM, Verdijk RM, van der Velden PA, Luyten GPM, Jager MJ. MiRNAs Correlate with HLA Expression in Uveal Melanoma: Both Up- and Downregulation Are Related to Monosomy 3. Cancers (Basel) 2021;13:4020. [PMID: 34439175 DOI: 10.3390/cancers13164020] [Reference Citation Analysis]
494 Tian J, Rui K, Tang X, Ma J, Wang Y, Tian X, Zhang Y, Xu H, Lu L, Wang S. MicroRNA-9 Regulates the Differentiation and Function of Myeloid-Derived Suppressor Cells via Targeting Runx1. J Immunol 2015;195:1301-11. [PMID: 26091714 DOI: 10.4049/jimmunol.1500209] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 7.6] [Reference Citation Analysis]
495 Ye Q, Wang X, Yuan M, Cui S, Chen Y, Hu Z, Liu D, Han C, Li B, Chen D. miR-219-5p targets TBXT and inhibits breast cancer cell EMT and cell migration and invasion. Biosci Rep 2021;41:BSR20210318. [PMID: 34339487 DOI: 10.1042/BSR20210318] [Reference Citation Analysis]
496 Fallah P, Amirizadeh N, Poopak B, Toogeh G, Arefian E, Kohram F, Hosseini Rad SM, Kohram M, Teimori Naghadeh H, Soleimani M. Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Int J Lab Hematol 2015;37:560-8. [PMID: 25833191 DOI: 10.1111/ijlh.12351] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
497 Huang S, He X. microRNAs: tiny RNA molecules, huge driving forces to move the cell. Protein Cell 2010;1:916-26. [PMID: 21204018 DOI: 10.1007/s13238-010-0116-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
498 Bruzgielewicz A, Osuch-Wojcikiewicz E, Niemczyk K, Sieniawska-Buccella O, Siwak M, Walczak A, Nowak A, Majsterek I. Altered Expression of miRNAs Is Related to Larynx Cancer TNM Stage and Patients' Smoking Status. DNA Cell Biol 2017;36:581-8. [PMID: 28430523 DOI: 10.1089/dna.2016.3464] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
499 Liu Y, Lei P, Qiao H, Sun K, Lu X, Bao F, Yu R, Lian C, Li Y, Chen W, Xue F. miR-9 Enhances the Chemosensitivity of AML Cells to Daunorubicin by Targeting the EIF5A2/MCL-1 Axis. Int J Biol Sci 2019;15:579-86. [PMID: 30745844 DOI: 10.7150/ijbs.29775] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
500 Tu R, Chen Z, Bao Q, Liu H, Qing G. Crosstalk between oncogenic MYC and noncoding RNAs in cancer. Seminars in Cancer Biology 2020. [DOI: 10.1016/j.semcancer.2020.10.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
501 Guo W, Ren D, Chen X, Tu X, Huang S, Wang M, Song L, Zou X, Peng X. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145. J Cell Biochem 2013;114:1606-15. [PMID: 23355420 DOI: 10.1002/jcb.24502] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 8.0] [Reference Citation Analysis]
502 Ulasov I, Borovjagin A, Fares J, Yakushov S, Malin D, Timashev P, Lesniak MS. MicroRNA 345 (miR345) regulates KISS1-E-cadherin functional interaction in breast cancer brain metastases. Cancer Lett 2020;481:24-31. [PMID: 32246957 DOI: 10.1016/j.canlet.2020.03.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
503 Zhang R, Tang L, Zhao B, Tian Y, Zhou B, Mu Y, Yang L. A Peptide-Based Small RNA Delivery System to Suppress Tumor Growth by Remodeling the Tumor Microenvironment. Mol Pharm 2021;18:1431-43. [PMID: 33522823 DOI: 10.1021/acs.molpharmaceut.0c01253] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
504 Hu JY, Yi W, Wei X, Zhang MY, Xu R, Zeng LS, Huang ZJ, Chen JS. miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer. Biomed Pharmacother. 2016;79:247-253. [PMID: 27044835 DOI: 10.1016/j.biopha.2016.02.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
505 Rong GQ, Zhang XM, Chen B, Yang XD, Wu HR, Gong W. MicroRNA gene polymorphisms and the risk of colorectal cancer. Oncol Lett 2017;13:3617-23. [PMID: 28521462 DOI: 10.3892/ol.2017.5885] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
506 Westermark UK, Wilhelm M, Frenzel A, Henriksson MA. The MYCN oncogene and differentiation in neuroblastoma. Semin Cancer Biol 2011;21:256-66. [PMID: 21849159 DOI: 10.1016/j.semcancer.2011.08.001] [Cited by in Crossref: 92] [Cited by in F6Publishing: 82] [Article Influence: 8.4] [Reference Citation Analysis]
507 Hong JS, Kim NH, Choi CY, Lee JS, Na D, Chun T, Lee YS. Changes in cellular microRNA expression induced by porcine circovirus type 2-encoded proteins. Vet Res 2015;46:39. [PMID: 25885539 DOI: 10.1186/s13567-015-0172-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
508 Cichon C, Sabharwal H, Rüter C, Schmidt MA. MicroRNAs regulate tight junction proteins and modulate epithelial/endothelial barrier functions. Tissue Barriers. 2014;2:e944446. [PMID: 25610754 DOI: 10.4161/21688362.2014.944446] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
509 Chen D, Sun Y, Wei Y, Zhang P, Rezaeian AH, Teruya-Feldstein J, Gupta S, Liang H, Lin HK, Hung MC. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat Med. 2012;18:1511-1517. [PMID: 23001183 DOI: 10.1038/nm.2940] [Cited by in Crossref: 268] [Cited by in F6Publishing: 262] [Article Influence: 26.8] [Reference Citation Analysis]
510 Cheng Q, Yi B, Wang A, Jiang X. Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis. Onco Targets Ther 2013;6:1675-84. [PMID: 24273410 DOI: 10.2147/OTT.S52730] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
511 Yigit MV, Ghosh SK, Kumar M, Petkova V, Kavishwar A, Moore A, Medarova Z. Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis. Oncogene 2013;32:1530-8. [PMID: 22580603 DOI: 10.1038/onc.2012.173] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 6.1] [Reference Citation Analysis]
512 Filková M, Jüngel A, Gay RE, Gay S. MicroRNAs in rheumatoid arthritis: potential role in diagnosis and therapy. BioDrugs. 2012;26:131-141. [PMID: 22494429 DOI: 10.2165/11631480-000000000-00000] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 7.1] [Reference Citation Analysis]
513 Zhou S, Tang X, Tang F. Krüppel-like factor 17, a novel tumor suppressor: its low expression is involved in cancer metastasis. Tumour Biol 2016;37:1505-13. [PMID: 26662959 DOI: 10.1007/s13277-015-4588-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
514 Terrile M, Bryan K, Vaughan L, Hallsworth A, Webber H, Chesler L, Stallings RL. miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAs. PLoS One 2011;6:e28356. [PMID: 22164278 DOI: 10.1371/journal.pone.0028356] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
515 Lee KB, Ye S, Park MH, Park BH, Lee JS, Kim SM. p63-Mediated activation of the β-catenin/c-Myc signaling pathway stimulates esophageal squamous carcinoma cell invasion and metastasis. Cancer Lett 2014;353:124-32. [PMID: 25045846 DOI: 10.1016/j.canlet.2014.07.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
516 Chang S, He S, Qiu G, Lu J, Wang J, Liu J, Fan L, Zhao W, Che X. MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1. Tumour Biol 2016;37:12141-51. [PMID: 27220320 DOI: 10.1007/s13277-016-5094-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
517 Tomasetti M, Amati M, Santarelli L, Neuzil J. MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis. Int J Mol Sci 2016;17:E754. [PMID: 27213336 DOI: 10.3390/ijms17050754] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
518 Samatov TR, Tonevitsky AG, Schumacher U. Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds. Mol Cancer. 2013;12:107. [PMID: 24053443 DOI: 10.1186/1476-4598-12-107] [Cited by in Crossref: 86] [Cited by in F6Publishing: 83] [Article Influence: 9.6] [Reference Citation Analysis]
519 Ferreira HJ, Esteller M. Non-coding RNAs, epigenetics, and cancer: tying it all together. Cancer Metastasis Rev 2018;37:55-73. [PMID: 29374363 DOI: 10.1007/s10555-017-9715-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 15.7] [Reference Citation Analysis]
520 Sarveswaran S, Chakraborty D, Chitale D, Sears R, Ghosh J. Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells. J Biol Chem 2015;290:4994-5006. [PMID: 25540201 DOI: 10.1074/jbc.M114.599035] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
521 Khalife H, Skafi N, Fayyad-Kazan M, Badran B. MicroRNAs in breast cancer: New maestros defining the melody. Cancer Genet 2020;246-247:18-40. [PMID: 32805688 DOI: 10.1016/j.cancergen.2020.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
522 Sun XH, Geng XL, Zhang J, Zhang C. miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2). Tumour Biol 2015;36:2127-34. [PMID: 25403884 DOI: 10.1007/s13277-014-2822-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 5.5] [Reference Citation Analysis]
523 Tufman A, Tian F, Huber RM. Can microRNAs improve the management of lung cancer patients? A clinician's perspective. Theranostics 2013;3:953-63. [PMID: 24396506 DOI: 10.7150/thno.6615] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
524 Andl CD. The Misregulation of Cell Adhesion Components during Tumorigenesis: Overview and Commentary. J Oncol 2010;2010:174715. [PMID: 20953359 DOI: 10.1155/2010/174715] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
525 El-Gazzar A, Cai X, Reeves RS, Dai Z, Caballero-Benitez A, McDonald DL, Vazquez J, Gooley TA, Sale GE, Spies T, Groh V. Effects on tumor development and metastatic dissemination by the NKG2D lymphocyte receptor expressed on cancer cells. Oncogene 2014;33:4932-40. [PMID: 24141776 DOI: 10.1038/onc.2013.435] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
526 Scimeca M, Trivigno D, Bonfiglio R, Ciuffa S, Urbano N, Schillaci O, Bonanno E. Breast cancer metastasis to bone: From epithelial to mesenchymal transition to breast osteoblast-like cells. Semin Cancer Biol 2021;72:155-64. [PMID: 32045651 DOI: 10.1016/j.semcancer.2020.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
527 Wang H, Tao Z, Feng M, Li X, Deng Z, Zhao G, Yin H, Pan T, Chen G, Feng Z, Li Y, Zhou Y. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC. Biochem Biophys Res Commun 2020;533:368-75. [PMID: 32962858 DOI: 10.1016/j.bbrc.2020.09.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
528 Faria AM, Sbiera S, Ribeiro TC, Soares IC, Mariani BM, Freire DS, de Sousa GR, Lerario AM, Ronchi CL, Deutschbein T, Wakamatsu A, Alves VA, Zerbini MC, Mendonca BB, Fragoso MC, Latronico AC, Fassnacht M, Almeida MQ. Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer. Clin Endocrinol (Oxf) 2015;82:481-8. [PMID: 25200669 DOI: 10.1111/cen.12607] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
529 Wu YJ, Neoh CA, Tsao CY, Su JH, Li HH. Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways. Int J Mol Sci 2015;16:16469-82. [PMID: 26204832 DOI: 10.3390/ijms160716469] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
530 Chang CM, Wong HS, Huang CY, Hsu WL, Maio ZF, Chiu SJ, Tsai YT, Chen BK, Wan YY, Wang JY, Chang WC. Functional Effects of let-7g Expression in Colon Cancer Metastasis. Cancers (Basel) 2019;11:E489. [PMID: 30959863 DOI: 10.3390/cancers11040489] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
531 Gou Y, Zhai F, Zhang L, Cui L. RUNX3 regulates hepatocellular carcinoma cell metastasis via targeting miR-186/E-cadherin/EMT pathway. Oncotarget 2017;8:61475-86. [PMID: 28977878 DOI: 10.18632/oncotarget.18424] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
532 Samaraweera L, Spengler BA, Ross RA. Reciprocal antagonistic regulation of N-myc mRNA by miR‑17 and the neuronal-specific RNA-binding protein HuD. Oncol Rep 2017;38:545-50. [PMID: 28560387 DOI: 10.3892/or.2017.5664] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
533 Nowek K, Wiemer EAC, Jongen-Lavrencic M. The versatile nature of miR-9/9* in human cancer. Oncotarget 2018;9:20838-54. [PMID: 29755694 DOI: 10.18632/oncotarget.24889] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
534 Zhang H, Cai K, Wang J, Wang X, Cheng K, Shi F, Jiang L, Zhang Y, Dou J. MiR-7, inhibited indirectly by lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway. Stem Cells. 2014;32:2858-2868. [PMID: 25070049 DOI: 10.1002/stem.1795] [Cited by in Crossref: 225] [Cited by in F6Publishing: 216] [Article Influence: 32.1] [Reference Citation Analysis]
535 Huang R, Zong X. Aberrant cancer metabolism in epithelial–mesenchymal transition and cancer metastasis: Mechanisms in cancer progression. Critical Reviews in Oncology/Hematology 2017;115:13-22. [DOI: 10.1016/j.critrevonc.2017.04.005] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 10.8] [Reference Citation Analysis]
536 Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol. 2013;15:546-554. [PMID: 23728460 DOI: 10.1038/ncb2769] [Cited by in Crossref: 210] [Cited by in F6Publishing: 215] [Article Influence: 23.3] [Reference Citation Analysis]
537 Venkateswaran N, Conacci-Sorrell M. MYC leads the way. Small GTPases 2020;11:86-94. [PMID: 29173017 DOI: 10.1080/21541248.2017.1364821] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
538 Boyle DP, McCourt CM, Matchett KB, Salto-Tellez M. Molecular and clinicopathological markers of prognosis in breast cancer. Expert Rev Mol Diagn 2013;13:481-98. [PMID: 23782255 DOI: 10.1586/erm.13.29] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
539 Kopecky B, Fritzsch B. Regeneration of Hair Cells: Making Sense of All the Noise. Pharmaceuticals (Basel) 2011;4:848-79. [PMID: 21966254 DOI: 10.3390/ph4060848] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
540 Škovierová H, Okajčeková T, Strnádel J, Vidomanová E, Halašová E. Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review). Int J Mol Med 2018;41:1187-200. [PMID: 29286071 DOI: 10.3892/ijmm.2017.3320] [Cited by in Crossref: 21] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
541 de Yébenes VG, Bartolomé-Izquierdo N, Ramiro AR. Regulation of B-cell development and function by microRNAs. Immunol Rev. 2013;253:25-39. [PMID: 23550636 DOI: 10.1111/imr.12046] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
542 Zhao HM, Wei W, Sun YH, Gao JH, Wang Q, Zheng JH. MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells. Tumour Biol 2015;36:6867-73. [PMID: 25846738 DOI: 10.1007/s13277-015-3399-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
543 Grzywa TM, Klicka K, Włodarski PK. Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis. Cancers (Basel) 2020;12:E3709. [PMID: 33321819 DOI: 10.3390/cancers12123709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
544 Huang M, Weiss WA. Neuroblastoma and MYCN. Cold Spring Harb Perspect Med 2013;3:a014415. [PMID: 24086065 DOI: 10.1101/cshperspect.a014415] [Cited by in Crossref: 278] [Cited by in F6Publishing: 274] [Article Influence: 30.9] [Reference Citation Analysis]
545 Ghahhari NM, Babashah S. Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer. Eur J Cancer 2015;51:1638-49. [PMID: 26025765 DOI: 10.1016/j.ejca.2015.04.021] [Cited by in Crossref: 126] [Cited by in F6Publishing: 142] [Article Influence: 18.0] [Reference Citation Analysis]
546 Thiery JP, Chua K, Sim WJ, Huang R. [Epithelial mesenchymal transition during development in fibrosis and in the progression of carcinoma]. Bull Cancer. 2010;97:1285-1295. [PMID: 21084241 DOI: 10.1684/bdc.2010.1206] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
547 Setti Boubaker N, Cicchillitti L, Said R, Gurtner A, Ayed H, Blel A, Karray O, Essid MA, Gharbi M, Bouzouita A, Rammeh Rommeni S, Chebil M, Piaggio G, Ouerhani S. The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer. Mol Biol Rep 2019;46:4743-50. [DOI: 10.1007/s11033-019-04920-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
548 Profumo V, Doldi V, Gandellini P, Zaffaroni N. Targeting microRNAs to withstand cancer metastasis. Methods Mol Biol 2015;1218:415-37. [PMID: 25319666 DOI: 10.1007/978-1-4939-1538-5_25] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
549 Kim DH, Xing T, Yang Z, Dudek R, Lu Q, Chen YH. Epithelial Mesenchymal Transition in Embryonic Development, Tissue Repair and Cancer: A Comprehensive Overview. J Clin Med 2017;7:E1. [PMID: 29271928 DOI: 10.3390/jcm7010001] [Cited by in Crossref: 98] [Cited by in F6Publishing: 89] [Article Influence: 19.6] [Reference Citation Analysis]
550 Kang J, Lee SY, Lee SY, Kim YJ, Park JY, Kwon SJ, Na MJ, Lee EJ, Jeon HS, Son JW. microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3. Exp Ther Med 2012;3:149-53. [PMID: 22969861 DOI: 10.3892/etm.2011.366] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
551 Qin XY, Gailhouste L. Non-Genomic Control of Dynamic MYCN Gene Expression in Liver Cancer. Front Oncol 2020;10:618515. [PMID: 33937011 DOI: 10.3389/fonc.2020.618515] [Reference Citation Analysis]
552 Janse van Rensburg HJ, Yang X. The roles of the Hippo pathway in cancer metastasis. Cellular Signalling 2016;28:1761-72. [DOI: 10.1016/j.cellsig.2016.08.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 8.2] [Reference Citation Analysis]
553 Wu ZS, Wang CQ, Xiang R, Liu X, Ye S, Yang XQ, Zhang GH, Xu XC, Zhu T, Wu Q. Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer. 2012;12:51. [PMID: 22292984 DOI: 10.1186/1471-2407-12-51] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 6.9] [Reference Citation Analysis]
554 Hussen BM, Abdullah ST, Rasul MF, Salihi A, Ghafouri-Fard S, Hidayat HJ, Taheri M. MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets. Front Mol Biosci 2021;8:764025. [PMID: 34778378 DOI: 10.3389/fmolb.2021.764025] [Reference Citation Analysis]
555 Lv QL, Zhu HT, Li HM, Cheng XH, Zhou HH, Chen SH. Down-regulation of miRNA-320c promotes tumor growth and metastasis and predicts poor prognosis in human glioma. Brain Res Bull 2018;139:125-32. [PMID: 29438779 DOI: 10.1016/j.brainresbull.2018.02.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
556 Jiang H, Wang P, Wang Q, Wang B, Mu J, Zhuang X, Zhang L, Yan J, Miller D, Zhang HG. Quantitatively controlling expression of miR-17~92 determines colon tumor progression in a mouse tumor model. Am J Pathol 2014;184:1355-68. [PMID: 24681249 DOI: 10.1016/j.ajpath.2014.01.037] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
557 Zhu L, Chen H, Zhou D, Li D, Bai R, Zheng S, Ge W. MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. Med Oncol. 2012;29:1037-1043. [PMID: 21562850 DOI: 10.1007/s12032-011-9975-z] [Cited by in Crossref: 63] [Cited by in F6Publishing: 75] [Article Influence: 5.7] [Reference Citation Analysis]
558 Bouyssou JM, Manier S, Huynh D, Issa S, Roccaro AM, Ghobrial IM. Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta. 2014;1845:255-265. [PMID: 24569228 DOI: 10.1016/j.bbcan.2014.02.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 96] [Article Influence: 4.8] [Reference Citation Analysis]
559 Watahiki A, Wang Y, Morris J, Dennis K, O'Dwyer HM, Gleave M, Gout PW, Wang Y. MicroRNAs associated with metastatic prostate cancer. PLoS One 2011;6:e24950. [PMID: 21980368 DOI: 10.1371/journal.pone.0024950] [Cited by in Crossref: 142] [Cited by in F6Publishing: 132] [Article Influence: 12.9] [Reference Citation Analysis]
560 Wang J, Song C, Tang H, Zhang C, Tang J, Li X, Chen B, Xie X. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer. Breast Cancer Res 2017;19:72. [PMID: 28629464 DOI: 10.1186/s13058-017-0865-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
561 Kiani S, Akhavan-niaki H, Fattahi S, Kavoosian S, Babaian Jelodar N, Bagheri N, Najafi Zarrini H. Purified sulforaphane from broccoli (Brassica oleracea var. italica) leads to alterations of CDX1 and CDX2 expression and changes in miR-9 and miR-326 levels in human gastric cancer cells. Gene 2018;678:115-23. [DOI: 10.1016/j.gene.2018.08.026] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
562 Thulin P, Wei T, Werngren O, Cheung L, Fisher RM, Grandér D, Corcoran M, Ehrenborg E. MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor δ in human monocytes during the inflammatory response. Int J Mol Med 2013;31:1003-10. [PMID: 23525285 DOI: 10.3892/ijmm.2013.1311] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 5.9] [Reference Citation Analysis]
563 Arif KMT, Elliott EK, Haupt LM, Griffiths LR. Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets. Cancers (Basel) 2020;12:E2922. [PMID: 33050637 DOI: 10.3390/cancers12102922] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
564 Wolfer A, Ramaswamy S. MYC and metastasis. Cancer Res 2011;71:2034-7. [PMID: 21406394 DOI: 10.1158/0008-5472.CAN-10-3776] [Cited by in Crossref: 111] [Cited by in F6Publishing: 82] [Article Influence: 10.1] [Reference Citation Analysis]
565 Louis CU, Shohet JM. Neuroblastoma: molecular pathogenesis and therapy. Annu Rev Med. 2015;66:49-63. [PMID: 25386934 DOI: 10.1146/annurev-med-011514-023121] [Cited by in Crossref: 176] [Cited by in F6Publishing: 157] [Article Influence: 22.0] [Reference Citation Analysis]
566 Farazi TA, Hoell JI, Morozov P, Tuschl T. MicroRNAs in human cancer. Adv Exp Med Biol. 2013;774:1-20. [PMID: 23377965 DOI: 10.1007/978-94-007-5590-1_1] [Cited by in Crossref: 426] [Cited by in F6Publishing: 432] [Article Influence: 47.3] [Reference Citation Analysis]
567 Wang LQ, Kwong YL, Kho CS, Wong KF, Wong KY, Ferracin M, Calin GA, Chim CS. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway. Mol Cancer 2013;12:173. [PMID: 24373626 DOI: 10.1186/1476-4598-12-173] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
568 Chen JF, Yan Q. The roles of epigenetics in cancer progression and metastasis. Biochem J 2021;478:3373-93. [PMID: 34520519 DOI: 10.1042/BCJ20210084] [Reference Citation Analysis]
569 Li X, Wang S, Li Z, Long X, Guo Z, Zhang G, Zu J, Chen Y, Wen L. The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer. Int J Biol Macromol 2017;105:346-53. [PMID: 28720546 DOI: 10.1016/j.ijbiomac.2017.07.053] [Cited by in Crossref: 70] [Cited by in F6Publishing: 80] [Article Influence: 14.0] [Reference Citation Analysis]
570 Hsu CY, Yi YH, Chang KP, Chang YS, Chen SJ, Chen HC. The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma. PLoS Pathog 2014;10:e1003974. [PMID: 24586173 DOI: 10.1371/journal.ppat.1003974] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 8.6] [Reference Citation Analysis]
571 Jiang Y, Qin Z, Hu Z, Guan X, Wang Y, He Y, Xue J, Liu X, Chen J, Dai J, Jin G, Ma H, Wang S, Shen H. Genetic variation in a hsa-let-7 binding site in RAD52 is associated with breast cancer susceptibility. Carcinogenesis. 2013;34:689-693. [PMID: 23188672 DOI: 10.1093/carcin/bgs373] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
572 Chen X, Fan Z, McGee W, Chen M, Kong R, Wen P, Xiao T, Chen X, Liu J, Zhu L, Chen R, Wu JY. TDP-43 regulates cancer-associated microRNAs. Protein Cell 2018;9:848-66. [PMID: 28952053 DOI: 10.1007/s13238-017-0480-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
573 Suzuki H, Maruyama R, Yamamoto E, Kai M. DNA methylation and microRNA dysregulation in cancer. Mol Oncol. 2012;6:567-578. [PMID: 22902148 DOI: 10.1016/j.molonc.2012.07.007] [Cited by in Crossref: 160] [Cited by in F6Publishing: 151] [Article Influence: 16.0] [Reference Citation Analysis]
574 Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. J Exp Clin Cancer Res 2013;32:62. [PMID: 24011086 DOI: 10.1186/1756-9966-32-62] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
575 Guz M, Dworzański T, Jeleniewicz W, Cybulski M, Kozicka J, Stepulak A, Celiński K. Elevated miRNA Inversely Correlates with E-cadherin Gene Expression in Tissue Biopsies from Crohn Disease Patients in contrast to Ulcerative Colitis Patients. Biomed Res Int 2020;2020:4250329. [PMID: 32775420 DOI: 10.1155/2020/4250329] [Reference Citation Analysis]
576 Zhang J, Han C, Wu T. MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin. Gastroenterology. 2012;143:246-56.e8. [PMID: 22484120 DOI: 10.1053/j.gastro.2012.03.045] [Cited by in Crossref: 117] [Cited by in F6Publishing: 121] [Article Influence: 11.7] [Reference Citation Analysis]
577 Moazzeni H, Najafi A, Khani M. Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231. Mol Cell Probes 2017;34:45-52. [PMID: 28546132 DOI: 10.1016/j.mcp.2017.05.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
578 Donzelli S, Mori F, Bellissimo T, Sacconi A, Casini B, Frixa T, Roscilli G, Aurisicchio L, Facciolo F, Pompili A, Carosi MA, Pescarmona E, Segatto O, Pond G, Muti P, Telera S, Strano S, Yarden Y, Blandino G. Epigenetic silencing of miR-145-5p contributes to brain metastasis. Oncotarget 2015;6:35183-201. [PMID: 26440147 DOI: 10.18632/oncotarget.5930] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 7.5] [Reference Citation Analysis]
579 Lujambio A, Lowe SW. The microcosmos of cancer. Nature. 2012;482:347-355. [PMID: 22337054 DOI: 10.1038/nature10888] [Cited by in Crossref: 742] [Cited by in F6Publishing: 722] [Article Influence: 74.2] [Reference Citation Analysis]
580 Hersi HM, Raulf N, Gaken J, Folarin N, Tavassoli M. MicroRNA-9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4. Mol Oncol 2018;12:2023-41. [PMID: 29959873 DOI: 10.1002/1878-0261.12352] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
581 Bos PD, Nguyen DX, Massagué J. Modeling metastasis in the mouse. Curr Opin Pharmacol 2010;10:571-7. [PMID: 20598638 DOI: 10.1016/j.coph.2010.06.003] [Cited by in Crossref: 81] [Cited by in F6Publishing: 68] [Article Influence: 6.8] [Reference Citation Analysis]
582 Wang MC, Li CL, Cui J, Jiao M, Wu T, Jing LI, Nan KJ. BMI-1, a promising therapeutic target for human cancer. Oncol Lett 2015;10:583-8. [PMID: 26622537 DOI: 10.3892/ol.2015.3361] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
583 Shah K, Rawal RM. MicroRNAs in Cancer: From Diagnosis to Therapeutics. In: Masood N, Shakil Malik S, editors. 'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine. Singapore: Springer; 2020. pp. 199-236. [DOI: 10.1007/978-981-15-1067-0_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
584 Hasanzadeh A, Mesrian Tanha H, Ghaedi K, Madani M. Aberrant expression of miR-9 in benign and malignant breast tumors. Mol Cell Probes 2016;30:279-84. [PMID: 27725294 DOI: 10.1016/j.mcp.2016.10.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
585 Teo AYT, Xiang X, Le MT, Wong AL, Zeng Q, Wang L, Goh BC. Tiny miRNAs Play a Big Role in the Treatment of Breast Cancer Metastasis. Cancers (Basel) 2021;13:337. [PMID: 33477629 DOI: 10.3390/cancers13020337] [Reference Citation Analysis]
586 Guinde J, Frankel D, Perrin S, Delecourt V, Lévy N, Barlesi F, Astoul P, Roll P, Kaspi E. Lamins in Lung Cancer: Biomarkers and Key Factors for Disease Progression through miR-9 Regulation? Cells 2018;7:E78. [PMID: 30012957 DOI: 10.3390/cells7070078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
587 van Schooneveld E, Wildiers H, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management. Breast Cancer Res 2015;17:21. [PMID: 25849621 DOI: 10.1186/s13058-015-0526-y] [Cited by in Crossref: 160] [Cited by in F6Publishing: 162] [Article Influence: 22.9] [Reference Citation Analysis]
588 Xu J, Wang Y, Tan X, Jing H. MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis. Autophagy 2012;8:873-82. [PMID: 22441107 DOI: 10.4161/auto.19629] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 8.9] [Reference Citation Analysis]
589 Gong Z, Wang J, Wang D, Buas MF, Ren X, Freudenheim JL, Belinsky SA, Liu S, Ambrosone CB, Higgins MJ. Differences in microRNA expression in breast cancer between women of African and European ancestry. Carcinogenesis 2019;40:61-9. [PMID: 30321299 DOI: 10.1093/carcin/bgy134] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
590 Carvalho J, van Grieken NC, Pereira PM, Sousa S, Tijssen M, Buffart TE, Diosdado B, Grabsch H, Santos MA, Meijer G, Seruca R, Carvalho B, Oliveira C. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J Pathol. 2012;228:31-44. [PMID: 22450781 DOI: 10.1002/path.4032] [Cited by in Crossref: 28] [Cited by in F6Publishing: 73] [Article Influence: 2.8] [Reference Citation Analysis]
591 Nakanuma Y, Uchida T, Sato Y, Uesaka K. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma. Hum Pathol. 2017;60:46-57. [PMID: 27984121 DOI: 10.1016/j.humpath.2016.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
592 Zhao B, Lv Y. Suspension state and shear stress enhance breast tumor cells EMT through YAP by microRNA-29b. Cell Biol Toxicol 2021. [PMID: 34618275 DOI: 10.1007/s10565-021-09661-6] [Reference Citation Analysis]
593 Goh JN, Loo SY, Datta A, Siveen KS, Yap WN, Cai W, Shin EM, Wang C, Kim JE, Chan M, Dharmarajan AM, Lee AS, Lobie PE, Yap CT, Kumar AP. microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer: microRNAs in breast cancer. Biol Rev 2016;91:409-28. [DOI: 10.1111/brv.12176] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
594 Yu Y, Yao Y, Yan H, Wang R, Zhang Z, Sun X, Zhao L, Ao X, Xie Z, Wu Q. A Tumor-specific MicroRNA Recognition System Facilitates the Accurate Targeting to Tumor Cells by Magnetic Nanoparticles. Mol Ther Nucleic Acids 2016;5:e318. [PMID: 27138178 DOI: 10.1038/mtna.2016.28] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
595 Adinew GM, Taka E, Mendonca P, Messeha SS, Soliman KFA. The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer. Nutrients 2021;13:1212. [PMID: 33916931 DOI: 10.3390/nu13041212] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
596 Khorshidi A, Dhaliwal P, Yang BB. Noncoding RNAs in Tumor Angiogenesis. Adv Exp Med Biol 2016;927:217-41. [PMID: 27376737 DOI: 10.1007/978-981-10-1498-7_8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
597 Xiao Y, Guo S, Zhang Y, Bian Z, Jia L, Hu Y, Chen J, Yin C, Li N, Zhang D, Zhao X, Wang J. Diabetic nephropathy: serum miR-9 confers a poor prognosis in and is associated with level changes of vascular endothelial growth factor and pigment epithelium-derived factor. Biotechnol Lett 2017;39:1583-90. [PMID: 28667418 DOI: 10.1007/s10529-017-2390-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
598 Naeem H, Küffner R, Zimmer R. MIRTFnet: analysis of miRNA regulated transcription factors. PLoS One 2011;6:e22519. [PMID: 21857930 DOI: 10.1371/journal.pone.0022519] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
599 Tourvas AD, Frangos CC. Towards an extension of the two-variable model of carcinogenesis through oncogenes and tumour suppressor genes. Med Hypotheses 2011;77:956-8. [PMID: 21903334 DOI: 10.1016/j.mehy.2011.08.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
600 Hemmatzadeh M, Mohammadi H, Jadidi-niaragh F, Asghari F, Yousefi M. The role of oncomirs in the pathogenesis and treatment of breast cancer. Biomedicine & Pharmacotherapy 2016;78:129-39. [DOI: 10.1016/j.biopha.2016.01.026] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 9.0] [Reference Citation Analysis]
601 Miguel V, Busnadiego O, Fierro-Fernández M, Lamas S. Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts. Fibrogenesis Tissue Repair 2016;9:7. [PMID: 27274768 DOI: 10.1186/s13069-016-0044-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
602 Orso F, Quirico L, Dettori D, Coppo R, Virga F, Ferreira LC, Paoletti C, Baruffaldi D, Penna E, Taverna D. Role of miRNAs in tumor and endothelial cell interactions during tumor progression. Seminars in Cancer Biology 2020;60:214-24. [DOI: 10.1016/j.semcancer.2019.07.024] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 19.5] [Reference Citation Analysis]
603 Zhang H, Zhang Z, Wang S, Zhang S, Bi J. The mechanisms involved in miR-9 regulated apoptosis in cervical cancer by targeting FOXO3. Biomedicine & Pharmacotherapy 2018;102:626-32. [DOI: 10.1016/j.biopha.2018.03.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
604 Sreekumar R, Sayan BS, Mirnezami AH, Sayan AE. MicroRNA Control of Invasion and Metastasis Pathways. Front Genet. 2011;2:58. [PMID: 22303353 DOI: 10.3389/fgene.2011.00058] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
605 Place TL, Nauseef JT, Peterson MK, Henry MD, Mezhir JJ, Domann FE. Prolyl-4-hydroxylase 3 (PHD3) expression is downregulated during epithelial-to-mesenchymal transition. PLoS One 2013;8:e83021. [PMID: 24367580 DOI: 10.1371/journal.pone.0083021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
606 Liu B, Shyr Y, Cai J, Liu Q. Interplay between miRNAs and host genes and their role in cancer. Brief Funct Genomics 2018;18:255-66. [PMID: 30785618 DOI: 10.1093/bfgp/elz002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 11.7] [Reference Citation Analysis]
607 Stigliani S, Scaruffi P, Lagazio C, Persico L, Carlini B, Varesio L, Morandi F, Morini M, Gigliotti AR, Esposito MR, Viscardi E, Cecinati V, Conte M, Corrias MV. Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients. Oncotarget 2015;6:13295-308. [PMID: 25980492 DOI: 10.18632/oncotarget.3745] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
608 Lin CW, Chang YL, Chang YC, Lin JC, Chen CC, Pan SH, Wu CT, Chen HY, Yang SC, Hong TM. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun. 2013;4:1877. [PMID: 23695671 DOI: 10.1038/ncomms2876] [Cited by in Crossref: 199] [Cited by in F6Publishing: 195] [Article Influence: 22.1] [Reference Citation Analysis]
609 Miller AJ, Chang A, Cunningham PN. Chronic Microangiopathy Due to DCR-MYC, a Myc-Targeted Short Interfering RNA. Am J Kidney Dis 2020;75:513-6. [PMID: 31866228 DOI: 10.1053/j.ajkd.2019.09.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
610 Jones M, Lal A. MicroRNAs, wild-type and mutant p53: more questions than answers. RNA Biol 2012;9:781-91. [PMID: 22664917 DOI: 10.4161/rna.20146] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
611 Schwentner R, Herrero-Martin D, Kauer MO, Mutz CN, Katschnig AM, Sienski G, Alonso J, Aryee DN, Kovar H. The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma. Oncotarget 2017;8:10980-93. [PMID: 28030800 DOI: 10.18632/oncotarget.14091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
612 Lu W, Kang Y. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis. Dev Cell 2019;49:361-74. [PMID: 31063755 DOI: 10.1016/j.devcel.2019.04.010] [Cited by in Crossref: 211] [Cited by in F6Publishing: 210] [Article Influence: 105.5] [Reference Citation Analysis]
613 Grisard E, Nicoloso MS. Following MicroRNAs Through the Cancer Metastatic Cascade. Int Rev Cell Mol Biol 2017;333:173-228. [PMID: 28729025 DOI: 10.1016/bs.ircmb.2017.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
614 Li S, Feng TT, Guo Y, Yu X, Huang Q, Zhang L, Tang W, Liu Y. Expression of cancerous inhibitor of protein phosphatase 2A in human triple negative breast cancer correlates with tumor survival, invasion and autophagy. Oncol Lett 2016;12:5370-6. [PMID: 28101248 DOI: 10.3892/ol.2016.5374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
615 Chen BJ, Wu YL, Tanaka Y, Zhang W. Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics. Int J Biol Sci. 2014;10:1084-1096. [PMID: 25332683 DOI: 10.7150/ijbs.10190] [Cited by in Crossref: 130] [Cited by in F6Publishing: 131] [Article Influence: 16.3] [Reference Citation Analysis]
616 Kwak SY, Yoo JO, An HJ, Bae IH, Park MJ, Kim J, Han YH. miR-5003-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization and direct targeting of E-cadherin. J Mol Cell Biol. 2016; Jun 9. [Epub ahead of print]. [PMID: 27282406 DOI: 10.1093/jmcb/mjw026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
617 Goto A, Dobashi Y, Tsubochi H, Maeda D, Ooi A. MicroRNAs associated with increased AKT gene number in human lung carcinoma. Hum Pathol 2016;56:1-10. [PMID: 27189341 DOI: 10.1016/j.humpath.2016.04.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
618 Tao J, Zhao X, Tao J. c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies. Cell Cycle. 2014;13:191-198. [PMID: 24394940 DOI: 10.4161/cc.27646] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
619 Zhu X, Liu Y, Jing R, Huang Y, Guo J, Lin Y, Liang Y, Li Y, Li M. Network characteristics of human RNA-RNA interactions and application in the discovery of breast cancer-associated RNAs. Chemometrics and Intelligent Laboratory Systems 2020;206:104164. [DOI: 10.1016/j.chemolab.2020.104164] [Reference Citation Analysis]
620 Ma M, Wu W, Li Q, Li J, Sheng Z, Shi J, Zhang M, Yang H, Wang Z, Sun R, Fei J. N-myc is a key switch regulating the proliferation cycle of postnatal cerebellar granule cell progenitors. Sci Rep 2015;5:12740. [PMID: 26238256 DOI: 10.1038/srep12740] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
621 Zhou X, Chen J, Tang W. The molecular mechanism of HOTAIR in tumorigenesis, metastasis, and drug resistance. Acta Biochim Biophys Sin (Shanghai). 2014;46:1011-1015. [PMID: 25385164 DOI: 10.1093/abbs/gmu104] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
622 Wang D, Tang X, Liang Q, Zeng X, Yang J, Xu J. microRNA‐599 promotes apoptosis and represses proliferation and epithelial‐mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2‐depentent Notch signaling pathway. J Cell Physiol 2020;235:2492-505. [DOI: 10.1002/jcp.29154] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
623 Idiiatullina E, Al-Azab M, Walana W, Pavlov V, Liu B. EnDuo, a novel derivative of Endostar, inhibits the migration of colon cancer cells, suppresses matrix metalloproteinase-2/9 expression and impedes AKT/ERK activation. Biomed Pharmacother 2021;134:111136. [PMID: 33341042 DOI: 10.1016/j.biopha.2020.111136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
624 Edvardsson K, Nguyen-Vu T, Kalasekar SM, Pontén F, Gustafsson JÅ, Williams C. Estrogen receptor β expression induces changes in the microRNA pool in human colon cancer cells. Carcinogenesis 2013;34:1431-41. [PMID: 23436804 DOI: 10.1093/carcin/bgt067] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
625 Wu Y, Sarkissyan M, Vadgama JV. Epithelial-Mesenchymal Transition and Breast Cancer. J Clin Med 2016;5:E13. [PMID: 26821054 DOI: 10.3390/jcm5020013] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 17.2] [Reference Citation Analysis]
626 Peng X, Guo W, Liu T, Wang X, Tu X, Xiong D, Chen S, Lai Y, Du H, Chen G, Liu G, Tang Y, Huang S, Zou X. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS One 2011;6:e20341. [PMID: 21647377 DOI: 10.1371/journal.pone.0020341] [Cited by in Crossref: 153] [Cited by in F6Publishing: 151] [Article Influence: 13.9] [Reference Citation Analysis]
627 Chen LL, Gao GX, Shen FX, Chen X, Gong XH, Wu WJ. SDC4 Gene Silencing Favors Human Papillary Thyroid Carcinoma Cell Apoptosis and Inhibits Epithelial Mesenchymal Transition via Wnt/β-Catenin Pathway. Mol Cells 2018;41:853-67. [PMID: 30165731 DOI: 10.14348/molcells.2018.0103] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
628 Azizmohammadi S, Safari A, Azizmohammadi S, Kaghazian M, Sadrkhanlo M, Yahaghi E, Farshgar R, Seifoleslami M. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection. QJM 2017;110:11-5. [PMID: 27345415 DOI: 10.1093/qjmed/hcw101] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
629 Paliouras AR, Monteverde T, Garofalo M. Oncogene-induced regulation of microRNA expression: Implications for cancer initiation, progression and therapy. Cancer Lett 2018;421:152-60. [PMID: 29476790 DOI: 10.1016/j.canlet.2018.02.029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
630 Dong Y, Lin Y, Gao X, Zhao Y, Wan Z, Wang H, Wei M, Chen X, Qin W, Yang G, Liu L. Targeted blocking of miR328 lysosomal degradation with alkalized exosomes sensitizes the chronic leukemia cells to imatinib. Appl Microbiol Biotechnol 2019;103:9569-82. [PMID: 31701195 DOI: 10.1007/s00253-019-10127-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
631 van Kempen LC, van den Hurk K, Lazar V, Michiels S, Winnepenninckx V, Stas M, Spatz A, van den Oord JJ. Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression. Virchows Arch 2012;461:441-8. [PMID: 22956368 DOI: 10.1007/s00428-012-1309-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
632 Cui L, Lyu Y, Jin X, Wang Y, Li X, Wang J, Zhang J, Deng Z, Yang N, Zheng Z, Guo Y, Wang C, Mao R, Xu J, Gao F, Jin C, Zhang J, Tian H, Xu GT, Lu L. miR-194 suppresses epithelial-mesenchymal transition of retinal pigment epithelial cells by directly targeting ZEB1. Ann Transl Med 2019;7:751. [PMID: 32042767 DOI: 10.21037/atm.2019.11.90] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
633 Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11:597-610. [PMID: 20661255 DOI: 10.1038/nrg2843] [Cited by in Crossref: 2768] [Cited by in F6Publishing: 2728] [Article Influence: 230.7] [Reference Citation Analysis]
634 Wei S, Zhang ZY, Fu SL, Xie JG, Liu XS, Xu YJ, Zhao JP, Xiong WN. Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma. Cell Death Dis 2016;7:e2388. [PMID: 27685632 DOI: 10.1038/cddis.2016.260] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
635 Chen H, Li L, Wang S, Lei Y, Ge Q, Lv N, Zhou X, Chen C. Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A. Oncotarget 2014;5:11873-85. [PMID: 25428912 DOI: 10.18632/oncotarget.2662] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 12.1] [Reference Citation Analysis]
636 Liao W, Lin S, Sunny Sun H, Tsai S. Hypoxia-induced tumor malignancy and drug resistance: Role of microRNAs. Biomarkers and Genomic Medicine 2014;6:1-11. [DOI: 10.1016/j.bgm.2014.01.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
637 Li X, Zheng L, Zhang F, Hu J, Chou J, Liu Y, Xing Y, Xi T. STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer. Oncotarget. 2016;7:23197-23211. [PMID: 26985770 DOI: 10.18632/oncotarget.8099] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
638 Serpico D, Molino L, Di Cosimo S. microRNAs in breast cancer development and treatment. Cancer Treat Rev. 2014;40:595-604. [PMID: 24286642 DOI: 10.1016/j.ctrv.2013.11.002] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 9.3] [Reference Citation Analysis]
639 Babion I, Jaspers A, van Splunter AP, van der Hoorn IAE, Wilting SM, Steenbergen RDM. miR-9-5p Exerts a Dual Role in Cervical Cancer and Targets Transcription Factor TWIST1. Cells 2019;9:E65. [PMID: 31888045 DOI: 10.3390/cells9010065] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
640 Huang Q, Ouyang X. The role of miRNAs in bone metastasis and their significance in the detection of bone metastasis: a review of the published data. Future Oncol 2015;11:141-51. [PMID: 25572789 DOI: 10.2217/fon.14.161] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
641 Huang Y, Wang W, Chen Y, Huang Y, Zhang J, He S, Tan Y, Qiang F, Li A, Røe OD. The opposite prognostic significance of nuclear and cytoplasmic p21 expression in resectable gastric cancer patients. J Gastroenterol. 2014;49:1441-1452. [PMID: 24127074 DOI: 10.1007/s00535-013-0900-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
642 Petri BJ, Klinge CM. Regulation of breast cancer metastasis signaling by miRNAs. Cancer Metastasis Rev 2020;39:837-86. [PMID: 32577859 DOI: 10.1007/s10555-020-09905-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
643 Dalla Pozza E, Forciniti S, Palmieri M, Dando I. Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development. Semin Cell Dev Biol 2018;78:62-72. [PMID: 28673679 DOI: 10.1016/j.semcdb.2017.06.027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
644 Amorim M, Salta S, Henrique R, Jerónimo C. Decoding the usefulness of non-coding RNAs as breast cancer markers. J Transl Med 2016;14:265. [PMID: 27629831 DOI: 10.1186/s12967-016-1025-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
645 Banerjee P, Dutta S, Pal R. Dysregulation of Wnt-Signaling and a Candidate Set of miRNAs Underlie the Effect of Metformin on Neural Crest Cell Development: Effect of Metformin on Neural Crest Development. Stem Cells 2016;34:334-45. [DOI: 10.1002/stem.2245] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
646 Cao M, Seike M, Soeno C, Mizutani H, Kitamura K, Minegishi Y, Noro R, Yoshimura A, Cai L, Gemma A. MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells. Int J Oncol 2012;41:869-75. [PMID: 22752005 DOI: 10.3892/ijo.2012.1535] [Cited by in Crossref: 112] [Cited by in F6Publishing: 119] [Article Influence: 11.2] [Reference Citation Analysis]
647 Vannini I, Fanini F, Fabbri M. Emerging roles of microRNAs in cancer. Curr Opin Genet Dev 2018;48:128-33. [PMID: 29429825 DOI: 10.1016/j.gde.2018.01.001] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 19.0] [Reference Citation Analysis]
648 Masliah-Planchon J, Pasmant E, Luscan A, Laurendeau I, Ortonne N, Hivelin M, Varin J, Valeyrie-Allanore L, Dumaine V, Lantieri L, Leroy K, Parfait B, Wolkenstein P, Vidaud M, Vidaud D, Bièche I. MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis. BMC Genomics 2013;14:473. [PMID: 23848554 DOI: 10.1186/1471-2164-14-473] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
649 Shah MY, Calin GA. MicroRNAs as therapeutic targets in human cancers. Wiley Interdiscip Rev RNA. 2014;5:537-548. [PMID: 24687772 DOI: 10.1002/wrna.1229] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
650 Khawar MB, Fatima N, Abbasi MH, Mehmood R, Suqaina SK, Sheikh N. Head and Neck Cancer: Epidemiology and Role of MicroRNAs. In: Akarslan Z, editor. Diagnosis and Management of Head and Neck Cancer. InTech; 2017. [DOI: 10.5772/intechopen.69418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
651 Meškytė EM, Keskas S, Ciribilli Y. MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis. Int J Mol Sci 2020;21:E7710. [PMID: 33081056 DOI: 10.3390/ijms21207710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
652 Shigehara K, Yokomuro S, Ishibashi O, Mizuguchi Y, Arima Y, Kawahigashi Y, Kanda T, Akagi I, Tajiri T, Yoshida H, Takizawa T, Uchida E. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One. 2011;6:e23584. [PMID: 21858175 DOI: 10.1371/journal.pone.0023584] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 8.5] [Reference Citation Analysis]
653 Wang H, Wu Q, Zhang Y, Zhang HN, Wang YB, Wang W. TGF-β1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin. Cell Mol Biol Lett 2017;22:22. [PMID: 29118814 DOI: 10.1186/s11658-017-0053-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
654 Nagy Z, Igaz P. Introduction to microRNAs: Biogenesis, Action, Relevance of Tissue microRNAs in Disease Pathogenesis, Diagnosis and Therapy-The Concept of Circulating microRNAs. Exp Suppl 2015;106:3-30. [PMID: 26608197 DOI: 10.1007/978-3-0348-0955-9_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
655 Grange C, Collino F, Tapparo M, Camussi G. Oncogenic micro-RNAs and Renal Cell Carcinoma. Front Oncol 2014;4:49. [PMID: 24672771 DOI: 10.3389/fonc.2014.00049] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
656 Morales-prieto D, Chaiwangyen W, Ospina-prieto S, Schneider U, Herrmann J, Gruhn B, Markert U. MicroRNA expression profiles of trophoblastic cells. Placenta 2012;33:725-34. [DOI: 10.1016/j.placenta.2012.05.009] [Cited by in Crossref: 165] [Cited by in F6Publishing: 155] [Article Influence: 16.5] [Reference Citation Analysis]
657 Carron J, Torricelli C, Silva JK, Queiroz GSR, Ortega MM, Lima CSP, Lourenço GJ. microRNAs deregulation in head and neck squamous cell carcinoma. Head Neck 2021;43:645-67. [PMID: 33159410 DOI: 10.1002/hed.26533] [Reference Citation Analysis]
658 Seitz V, Butzhammer P, Hirsch B, Hecht J, Gütgemann I, Ehlers A, Lenze D, Oker E, Sommerfeld A, von der Wall E, König C, Zinser C, Spang R, Hummel M. Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma. PLoS One 2011;6:e26837. [PMID: 22102868 DOI: 10.1371/journal.pone.0026837] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 6.3] [Reference Citation Analysis]
659 Zeng Y, Yao X, Liu X, He X, Li L, Liu X, Yan Z, Wu J, Fu BM. Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis. J Extracell Vesicles 2019;8:1629865. [PMID: 31258881 DOI: 10.1080/20013078.2019.1629865] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 12.7] [Reference Citation Analysis]
660 Lopez-Camarillo C, Marchat LA, Arechaga-Ocampo E, Perez-Plasencia C, Del Moral-Hernandez O, Castaneda-Ortiz EJ, Rodriguez-Cuevas S. MetastamiRs: Non-Coding MicroRNAs Driving Cancer Invasion and Metastasis. Int J Mol Sci. 2012;13:1347-1379. [PMID: 22408395 DOI: 10.3390/ijms13021347] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
661 Zhang J, Jia J, Zhao L, Li X, Xie Q, Chen X, Wang J, Lu F. Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell. Mol Carcinog 2016;55:732-42. [PMID: 25809226 DOI: 10.1002/mc.22317] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
662 Voutsadakis IA. Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer. Tumour Biol. 2012;33:897-910. [PMID: 22399444 DOI: 10.1007/s13277-012-0355-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
663 Hao J, Zhang Y, Deng M, Ye R, Zhao S, Wang Y, Li J, Zhao Z. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells. Int J Cancer 2014;135:1019-27. [PMID: 24500893 DOI: 10.1002/ijc.28761] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
664 Edmonds MD, Eischen CM. Differences in miRNA expression in early stage lung adenocarcinomas that did and did not relapse. PLoS One 2014;9:e101802. [PMID: 25028925 DOI: 10.1371/journal.pone.0101802] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
665 Ngalame NNO, Luz AL, Makia N, Tokar EJ. Arsenic Alters Exosome Quantity and Cargo to Mediate Stem Cell Recruitment Into a Cancer Stem Cell-Like Phenotype. Toxicol Sci 2018;165:40-9. [PMID: 30169766 DOI: 10.1093/toxsci/kfy176] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
666 Wierstra I. FOXM1 (Forkhead box M1) in Tumorigenesis. Elsevier; 2013. pp. 191-419. [DOI: 10.1016/b978-0-12-407190-2.00016-2] [Cited by in Crossref: 103] [Cited by in F6Publishing: 71] [Article Influence: 11.4] [Reference Citation Analysis]
667 Cuninghame S, Jackson R, Zehbe I. Hypoxia-inducible factor 1 and its role in viral carcinogenesis. Virology. 2014;456-457:370-383. [PMID: 24698149 DOI: 10.1016/j.virol.2014.02.027] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
668 Tian Y, Zhang Y, Hurd L, Hannenhalli S, Liu F, Lu MM, Morrisey EE. Regulation of lung endoderm progenitor cell behavior by miR302/367. Development. 2011;138:1235-1245. [PMID: 21350014 DOI: 10.1242/dev.061762] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
669 Yao X, Xie L, Zeng Y. MiR-9 Promotes Angiogenesis via Targeting on Sphingosine-1- Phosphate Receptor 1. Front Cell Dev Biol 2020;8:755. [PMID: 32850858 DOI: 10.3389/fcell.2020.00755] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
670 Liu S, Kumar SM, Lu H, Liu A, Yang R, Pushparajan A, Guo W, Xu X. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma. J Pathol 2012;226:61-72. [PMID: 22131135 DOI: 10.1002/path.2964] [Cited by in Crossref: 106] [Cited by in F6Publishing: 107] [Article Influence: 9.6] [Reference Citation Analysis]
671 Zou C, Xu Q, Mao F, Li D, Bian C, Liu LZ, Jiang Y, Chen X, Qi Y, Zhang X. MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF. Cell Cycle. 2012;11:2137-2145. [PMID: 22592534 DOI: 10.4161/cc.20598] [Cited by in Crossref: 90] [Cited by in F6Publishing: 88] [Article Influence: 9.0] [Reference Citation Analysis]
672 Levy C, Khaled M, Iliopoulos D, Janas MM, Schubert S, Pinner S, Chen PH, Li S, Fletcher AL, Yokoyama S. Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell. 2010;40:841-849. [PMID: 21109473 DOI: 10.1016/j.molcel.2010.11.020] [Cited by in Crossref: 195] [Cited by in F6Publishing: 191] [Article Influence: 16.3] [Reference Citation Analysis]
673 Karanth AV, Maniswami RR, Prashanth S, Govindaraj H, Padmavathy R, Jegatheesan SK, Mullangi R, Rajagopal S. Emerging role of SETDB1 as a therapeutic target. Expert Opin Ther Targets 2017;21:319-31. [PMID: 28076698 DOI: 10.1080/14728222.2017.1279604] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
674 Tanabe S, Quader S, Ono R, Cabral H, Aoyagi K, Hirose A, Yokozaki H, Sasaki H. Molecular Network Profiling in Intestinal- and Diffuse-Type Gastric Cancer. Cancers (Basel). 2020;12. [PMID: 33353109 DOI: 10.3390/cancers12123833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
675 Liu M, Zhu H, Yang S, Wang Z, Bai J, Xu N. c-Myc suppressed E-cadherin through miR-9 at the post-transcriptional level. Cell Biol Int 2013;37:197-202. [PMID: 23364919 DOI: 10.1002/cbin.10039] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
676 Matsushita S, Onishi H, Nakano K, Nagamatsu I, Imaizumi A, Hattori M, Oda Y, Tanaka M, Katano M. Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer. Cancer Sci. 2014;105:272-280. [PMID: 24438533 DOI: 10.1111/cas.12354] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
677 Wang LQ, Chim CS. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia. Epigenomics 2015;7:461-73. [PMID: 25650645 DOI: 10.2217/epi.15.6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
678 Bullock MD, Sayan AE, Packham GK, Mirnezami AH. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biology of the Cell 2012;104:3-12. [DOI: 10.1111/boc.201100115] [Cited by in Crossref: 101] [Cited by in F6Publishing: 101] [Article Influence: 9.2] [Reference Citation Analysis]
679 Markouli M, Strepkos D, Basdra EK, Papavassiliou AG, Piperi C. Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis. Int J Mol Sci 2021;22:2778. [PMID: 33803458 DOI: 10.3390/ijms22052778] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
680 Boominathan L. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network. Cancer Metastasis Rev 2010;29:613-39. [PMID: 20922462 DOI: 10.1007/s10555-010-9257-9] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 7.5] [Reference Citation Analysis]
681 Wei WF, Zhou CF, Wu XG, He LN, Wu LF, Chen XJ, Yan RM, Zhong M, Yu YH, Liang L, Wang W. MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2. Cell Death Dis 2017;8:3220. [PMID: 29242498 DOI: 10.1038/s41419-017-0077-5] [Cited by in Crossref: 51] [Cited by in F6Publishing: 61] [Article Influence: 10.2] [Reference Citation Analysis]
682 Halberg N, Alarcón C, Tavazoie SF. microRNA regulation of cancer-endothelial interactions: vesicular microRNAs on the move…. EMBO J 2012;31:3509-10. [PMID: 22828867 DOI: 10.1038/emboj.2012.198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
683 Yi B, Piazza GA, Su X, Xi Y. MicroRNA and cancer chemoprevention. Cancer Prev Res (Phila). 2013;6:401-409. [PMID: 23531448 DOI: 10.1158/1940-6207.CAPR-13-0032] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
684 Tinsley HN, Grizzle WE, Abadi A, Keeton A, Zhu B, Xi Y, Piazza GA. New NSAID targets and derivatives for colorectal cancer chemoprevention. Recent Results Cancer Res 2013;191:105-20. [PMID: 22893202 DOI: 10.1007/978-3-642-30331-9_6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
685 Gao F, Zhao ZL, Zhao WT, Fan QR, Wang SC, Li J, Zhang YQ, Shi JW, Lin XL, Yang S. miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 2013;431:610-616. [PMID: 23291181 DOI: 10.1016/j.bbrc.2012.12.097] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87